iso_3_code,countryname,who_region,year,vaccinecode,vaccine_description,schedulerounds,targetpop,targetpop_description,geoarea,ageadministered
ABW,Aruba,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
ABW,Aruba,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
ABW,Aruba,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
ABW,Aruba,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15
ABW,Aruba,AMRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
ABW,Aruba,AMRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,6.0,,General/routine,NATIONAL,Y10
ABW,Aruba,AMRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
ABW,Aruba,AMRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
ABW,Aruba,AMRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M5
ABW,Aruba,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
ABW,Aruba,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+M6
ABW,Aruba,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
ABW,Aruba,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+M6
ABW,Aruba,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
ABW,Aruba,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M5
ABW,Aruba,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
ABW,Aruba,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M5
ABW,Aruba,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
ABW,Aruba,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
ABW,Aruba,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,M1
ABW,Aruba,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M3
ABW,Aruba,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M9
ABW,Aruba,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y11
ABW,Aruba,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
ABW,Aruba,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
ABW,Aruba,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,1st contact
ABW,Aruba,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
ABW,Aruba,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
ABW,Aruba,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ABW,Aruba,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
ABW,Aruba,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
ABW,Aruba,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y4
ABW,Aruba,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
ABW,Aruba,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
ABW,Aruba,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
ABW,Aruba,AMRO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y1
ABW,Aruba,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
AFG,Afghanistan,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
AFG,Afghanistan,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
AFG,Afghanistan,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
AFG,Afghanistan,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
AFG,Afghanistan,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
AFG,Afghanistan,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
AFG,Afghanistan,EMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
AFG,Afghanistan,EMRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
AFG,Afghanistan,EMRO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,M18
AFG,Afghanistan,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
AFG,Afghanistan,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
AFG,Afghanistan,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
AFG,Afghanistan,EMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
AFG,Afghanistan,EMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,M9
AFG,Afghanistan,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
AFG,Afghanistan,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
AFG,Afghanistan,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
AFG,Afghanistan,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
AFG,Afghanistan,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
AFG,Afghanistan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
AFG,Afghanistan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
AFG,Afghanistan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
AFG,Afghanistan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
AFG,Afghanistan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
AGO,Angola,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
AGO,Angola,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
AGO,Angola,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
AGO,Angola,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
AGO,Angola,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
AGO,Angola,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M4
AGO,Angola,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
AGO,Angola,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
AGO,Angola,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M15
AGO,Angola,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
AGO,Angola,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M2
AGO,Angola,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M4
AGO,Angola,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M6
AGO,Angola,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
AGO,Angola,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
AGO,Angola,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
AGO,Angola,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
AGO,Angola,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
AGO,Angola,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
AGO,Angola,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
AGO,Angola,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
AGO,Angola,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
AGO,Angola,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
AGO,Angola,AFRO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,ADULTS,Adults,NATIONAL,Y15-Y49
AGO,Angola,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
AGO,Angola,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M9
AGO,Angola,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
AIA,Anguilla,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
AIA,Anguilla,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
AIA,Anguilla,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y5
AIA,Anguilla,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
AIA,Anguilla,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
AIA,Anguilla,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
AIA,Anguilla,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
AIA,Anguilla,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
AIA,Anguilla,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
AIA,Anguilla,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
AIA,Anguilla,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
AIA,Anguilla,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
AIA,Anguilla,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
AIA,Anguilla,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,CATCHUP_A,Catch-up adults,NATIONAL,<Y25
AIA,Anguilla,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,<Y25
AIA,Anguilla,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9-15
AIA,Anguilla,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>Y18
AIA,Anguilla,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
AIA,Anguilla,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
AIA,Anguilla,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
AIA,Anguilla,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
AIA,Anguilla,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
AIA,Anguilla,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
AIA,Anguilla,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,Y1
AIA,Anguilla,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y2
AIA,Anguilla,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
AIA,Anguilla,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
AIA,Anguilla,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4-Y5
AIA,Anguilla,AMRO,2023,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,Y15
AIA,Anguilla,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
AIA,Anguilla,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
AIA,Anguilla,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
AIA,Anguilla,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M18
AIA,Anguilla,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y15
AIA,Anguilla,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
AIA,Anguilla,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+W4
AIA,Anguilla,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6-Y1
AIA,Anguilla,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,>Y4
AIA,Anguilla,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,TRAVELLERS,Travellers,NATIONAL,
AIA,Anguilla,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M15
AIA,Anguilla,AMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y4-Y5
AIA,Anguilla,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
ALB,Albania,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
ALB,Albania,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y6
ALB,Albania,EURO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_F,General/routine,NATIONAL,Y2
ALB,Albania,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
ALB,Albania,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
ALB,Albania,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
ALB,Albania,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
ALB,Albania,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y13
ALB,Albania,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
ALB,Albania,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
ALB,Albania,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
ALB,Albania,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ALB,Albania,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>Y9
ALB,Albania,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y9
ALB,Albania,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ALB,Albania,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
ALB,Albania,EURO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
ALB,Albania,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,Y1
ALB,Albania,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y5
ALB,Albania,EURO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
ALB,Albania,EURO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,Y2
ALB,Albania,EURO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y6
ALB,Albania,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
ALB,Albania,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
ALB,Albania,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
ALB,Albania,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
ALB,Albania,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
ALB,Albania,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M6
ALB,Albania,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y18
ALB,Albania,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y13
AND,Andorra,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
AND,Andorra,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
AND,Andorra,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M12
AND,Andorra,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y12
AND,Andorra,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
AND,Andorra,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
AND,Andorra,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
AND,Andorra,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
AND,Andorra,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
AND,Andorra,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
AND,Andorra,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,M15
AND,Andorra,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,,General/routine,NATIONAL,Y12
AND,Andorra,EURO,2023,MEN_B,Meningococcal B vaccine,1.0,,General/routine,NATIONAL,M2
AND,Andorra,EURO,2023,MEN_B,Meningococcal B vaccine,2.0,,General/routine,NATIONAL,M4
AND,Andorra,EURO,2023,MEN_B,Meningococcal B vaccine,3.0,,General/routine,NATIONAL,M13
AND,Andorra,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,,General/routine,NATIONAL,M4
AND,Andorra,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
AND,Andorra,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y3
AND,Andorra,EURO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,HW,Health workers,NATIONAL,1st contact
AND,Andorra,EURO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
AND,Andorra,EURO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
AND,Andorra,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M3
AND,Andorra,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M5
AND,Andorra,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M13
AND,Andorra,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
AND,Andorra,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M3
AND,Andorra,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
AND,Andorra,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",4.0,B_CHILD_W,General/routine,NATIONAL,Y5
AND,Andorra,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y15
AND,Andorra,EURO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M15
AND,Andorra,EURO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y3
ARE,United Arab Emirates,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
ARE,United Arab Emirates,EMRO,2023,CHOLERA,Cholera vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ARE,United Arab Emirates,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
ARE,United Arab Emirates,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
ARE,United Arab Emirates,EMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
ARE,United Arab Emirates,EMRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5-Y6
ARE,United Arab Emirates,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
ARE,United Arab Emirates,EMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARE,United Arab Emirates,EMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ARE,United Arab Emirates,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
ARE,United Arab Emirates,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
ARE,United Arab Emirates,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
ARE,United Arab Emirates,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,TRAVELLERS,Travellers,NATIONAL,+M6
ARE,United Arab Emirates,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+M1
ARE,United Arab Emirates,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
ARE,United Arab Emirates,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
ARE,United Arab Emirates,EMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARE,United Arab Emirates,EMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y13
ARE,United Arab Emirates,EMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
ARE,United Arab Emirates,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
ARE,United Arab Emirates,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
ARE,United Arab Emirates,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
ARE,United Arab Emirates,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARE,United Arab Emirates,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
ARE,United Arab Emirates,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=M6
ARE,United Arab Emirates,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARE,United Arab Emirates,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARE,United Arab Emirates,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,TRAVELLERS,Travellers,NATIONAL,
ARE,United Arab Emirates,EMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,Y15-Y16
ARE,United Arab Emirates,EMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ARE,United Arab Emirates,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
ARE,United Arab Emirates,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
ARE,United Arab Emirates,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
ARE,United Arab Emirates,EMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
ARE,United Arab Emirates,EMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y5-Y6
ARE,United Arab Emirates,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
ARE,United Arab Emirates,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
ARE,United Arab Emirates,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
ARE,United Arab Emirates,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARE,United Arab Emirates,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ARE,United Arab Emirates,EMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARE,United Arab Emirates,EMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ARE,United Arab Emirates,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
ARE,United Arab Emirates,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
ARE,United Arab Emirates,EMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,ADULTS,Adults,NATIONAL,
ARE,United Arab Emirates,EMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y15-Y16
ARE,United Arab Emirates,EMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARE,United Arab Emirates,EMRO,2023,TYPHOID_CONJ,Typhoid conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARE,United Arab Emirates,EMRO,2023,TYPHOID_CONJ,Typhoid conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ARE,United Arab Emirates,EMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12
ARE,United Arab Emirates,EMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y5-Y6
ARE,United Arab Emirates,EMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ARE,United Arab Emirates,EMRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y50
ARE,United Arab Emirates,EMRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M6
ARG,Argentina,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
ARG,Argentina,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
ARG,Argentina,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
ARG,Argentina,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
ARG,Argentina,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5
ARG,Argentina,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
ARG,Argentina,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
ARG,Argentina,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
ARG,Argentina,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15-M18
ARG,Argentina,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
ARG,Argentina,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
ARG,Argentina,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M12
ARG,Argentina,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
ARG,Argentina,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
ARG,Argentina,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
ARG,Argentina,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
ARG,Argentina,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
ARG,Argentina,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M2
ARG,Argentina,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y11
ARG,Argentina,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
ARG,Argentina,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
ARG,Argentina,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
ARG,Argentina,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
ARG,Argentina,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARG,Argentina,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M24
ARG,Argentina,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARG,Argentina,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
ARG,Argentina,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
ARG,Argentina,AMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
ARG,Argentina,AMRO,2023,IPV,IPV (Inactivated polio vaccine),5.0,,General/routine,NATIONAL,Y5
ARG,Argentina,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,M3
ARG,Argentina,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,,General/routine,NATIONAL,M5
ARG,Argentina,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,3.0,,General/routine,NATIONAL,M15
ARG,Argentina,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,4.0,,General/routine,NATIONAL,Y11
ARG,Argentina,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,Y1
ARG,Argentina,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y5
ARG,Argentina,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
ARG,Argentina,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
ARG,Argentina,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
ARG,Argentina,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
ARG,Argentina,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
ARG,Argentina,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>Y65
ARG,Argentina,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
ARG,Argentina,AMRO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
ARG,Argentina,AMRO,2023,RABIES,Rabies vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+D7
ARG,Argentina,AMRO,2023,RABIES,Rabies vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+D21
ARG,Argentina,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
ARG,Argentina,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
ARG,Argentina,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,
ARG,Argentina,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
ARG,Argentina,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6-M12
ARG,Argentina,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
ARG,Argentina,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y11
ARG,Argentina,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,HW,Health workers,NATIONAL,1st contact
ARG,Argentina,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",2.0,HW,Health workers,NATIONAL,+Y5
ARG,Argentina,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,1st contact
ARG,Argentina,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M15
ARG,Argentina,AMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y5
ARG,Argentina,AMRO,2023,VARICELLA,Varicella vaccine,1.0,HW,Health workers,NATIONAL,1st contact
ARG,Argentina,AMRO,2023,VARICELLA,Varicella vaccine,2.0,HW,Health workers,NATIONAL,+M1
ARG,Argentina,AMRO,2023,VARICELLA,Varicella vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
ARG,Argentina,AMRO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
ARG,Argentina,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,SUBNATIONAL,M18
ARG,Argentina,AMRO,2023,YF,YF (Yellow fever) vaccine,2.0,,General/routine,SUBNATIONAL,Y11
ARG,Argentina,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st Contact
ARM,Armenia,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
ARM,Armenia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,W6
ARM,Armenia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,W12
ARM,Armenia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,W18
ARM,Armenia,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
ARM,Armenia,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y6
ARM,Armenia,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,,General/routine,NATIONAL,Y15-Y16
ARM,Armenia,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,,General/routine,NATIONAL,+M6
ARM,Armenia,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
ARM,Armenia,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
ARM,Armenia,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
ARM,Armenia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
ARM,Armenia,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y14
ARM,Armenia,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
ARM,Armenia,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M2
ARM,Armenia,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
ARM,Armenia,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y15-Y45
ARM,Armenia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
ARM,Armenia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
ARM,Armenia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
ARM,Armenia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARM,Armenia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y2
ARM,Armenia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,Y3-Y5
ARM,Armenia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARM,Armenia,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,Y15-Y16
ARM,Armenia,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARM,Armenia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y4-Y6
ARM,Armenia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",3.0,,General/routine,NATIONAL,Y15-Y16
ARM,Armenia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,Y1
ARM,Armenia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARM,Armenia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
ARM,Armenia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W12
ARM,Armenia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W18
ARM,Armenia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,Y15-Y16
ARM,Armenia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARM,Armenia,EURO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ARM,Armenia,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
ARM,Armenia,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W16
ARM,Armenia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y26-Y30
ARM,Armenia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,Y36-Y40
ARM,Armenia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,Y46-Y50
ARM,Armenia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,Y56-Y60
ARM,Armenia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,Y66-Y70
ARM,Armenia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,ADULTS,Adults,NATIONAL,Y76-Y80
ARM,Armenia,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y15-Y16
ARM,Armenia,EURO,2023,TULAREMIA,Tularemia vaccine,1.0,,General/routine,NATIONAL,Y17
ARM,Armenia,EURO,2023,TULAREMIA,Tularemia vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y7
ATG,Antigua and Barbuda,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y5
ATG,Antigua and Barbuda,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
ATG,Antigua and Barbuda,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
ATG,Antigua and Barbuda,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
ATG,Antigua and Barbuda,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
ATG,Antigua and Barbuda,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
ATG,Antigua and Barbuda,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
ATG,Antigua and Barbuda,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
ATG,Antigua and Barbuda,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
ATG,Antigua and Barbuda,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
ATG,Antigua and Barbuda,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
ATG,Antigua and Barbuda,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
ATG,Antigua and Barbuda,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9-Y13
ATG,Antigua and Barbuda,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
ATG,Antigua and Barbuda,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,3.0,BOTH,HPV administered to females and males,NATIONAL,+Y1
ATG,Antigua and Barbuda,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
ATG,Antigua and Barbuda,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
ATG,Antigua and Barbuda,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
ATG,Antigua and Barbuda,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ATG,Antigua and Barbuda,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M35
ATG,Antigua and Barbuda,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=Y3
ATG,Antigua and Barbuda,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ATG,Antigua and Barbuda,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
ATG,Antigua and Barbuda,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
ATG,Antigua and Barbuda,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
ATG,Antigua and Barbuda,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
ATG,Antigua and Barbuda,AMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M6
ATG,Antigua and Barbuda,AMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M18
ATG,Antigua and Barbuda,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,Y5
ATG,Antigua and Barbuda,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,Y15
ATG,Antigua and Barbuda,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
ATG,Antigua and Barbuda,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
ATG,Antigua and Barbuda,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
ATG,Antigua and Barbuda,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y2
ATG,Antigua and Barbuda,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y25
ATG,Antigua and Barbuda,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y15
ATG,Antigua and Barbuda,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,
ATG,Antigua and Barbuda,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,Y3-Y5
ATG,Antigua and Barbuda,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
AUS,Australia,WPRO,2023,DTAP,DTaP (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
AUS,Australia,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
AUS,Australia,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
AUS,Australia,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
AUS,Australia,WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
AUS,Australia,WPRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,M18
AUS,Australia,WPRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,RISKGROUPS,Risk group(s),SUBNATIONAL,Y4
AUS,Australia,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y19
AUS,Australia,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
AUS,Australia,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,4.0,,General/routine,NATIONAL,M18
AUS,Australia,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y12-Y13
AUS,Australia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
AUS,Australia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
AUS,Australia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
AUS,Australia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
AUS,Australia,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y5
AUS,Australia,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
AUS,Australia,WPRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,M12
AUS,Australia,WPRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,,General/routine,NATIONAL,Y14-Y16
AUS,Australia,WPRO,2023,MEN_B,Meningococcal B vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,M2
AUS,Australia,WPRO,2023,MEN_B,Meningococcal B vaccine,2.0,RISKGROUPS,Risk group(s),SUBNATIONAL,M4
AUS,Australia,WPRO,2023,MEN_B,Meningococcal B vaccine,3.0,RISKGROUPS,Risk group(s),SUBNATIONAL,M6
AUS,Australia,WPRO,2023,MEN_B,Meningococcal B vaccine,4.0,RISKGROUPS,Risk group(s),SUBNATIONAL,M12
AUS,Australia,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
AUS,Australia,WPRO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",2.0,,General/routine,NATIONAL,M18
AUS,Australia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y70
AUS,Australia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
AUS,Australia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
AUS,Australia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
AUS,Australia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
AUS,Australia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
AUS,Australia,WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y50
AUS,Australia,WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,,General/routine,SUBNATIONAL,Y4
AUS,Australia,WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y4
AUS,Australia,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
AUS,Australia,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
AUS,Australia,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y12-Y13
AUS,Australia,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
AUS,Australia,WPRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y70-Y79
AUS,Australia,WPRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,2.0,CATCHUP_A,Catch-up adults,NATIONAL,Y71-Y79
AUT,Austria,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
AUT,Austria,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
AUT,Austria,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M10-M11
AUT,Austria,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,Y7-Y15
AUT,Austria,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,CATCHUP_A,Catch-up adults,NATIONAL,<Y21
AUT,Austria,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,<Y21
AUT,Austria,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9
AUT,Austria,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
AUT,Austria,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
AUT,Austria,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
AUT,Austria,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
AUT,Austria,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
AUT,Austria,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
AUT,Austria,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=M6
AUT,Austria,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
AUT,Austria,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,Y10-Y13
AUT,Austria,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,CATCHUP_A,Catch-up adults,NATIONAL,
AUT,Austria,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,CATCHUP_C,Catch-up children,NATIONAL,
AUT,Austria,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,+M3
AUT,Austria,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M9
AUT,Austria,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
AUT,Austria,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
AUT,Austria,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12-M14
AUT,Austria,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
AUT,Austria,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M2
AUT,Austria,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",4.0,B_CHILD_W,General/routine,NATIONAL,Y6-Y8
AZE,Azerbaijan,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
AZE,Azerbaijan,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y6
AZE,Azerbaijan,EURO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
AZE,Azerbaijan,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
AZE,Azerbaijan,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3
AZE,Azerbaijan,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M4
AZE,Azerbaijan,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
AZE,Azerbaijan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
AZE,Azerbaijan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
AZE,Azerbaijan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
AZE,Azerbaijan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
AZE,Azerbaijan,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y18
AZE,Azerbaijan,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
AZE,Azerbaijan,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M3
AZE,Azerbaijan,EURO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M6
AZE,Azerbaijan,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
AZE,Azerbaijan,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
AZE,Azerbaijan,EURO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M2
AZE,Azerbaijan,EURO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M3
AZE,Azerbaijan,EURO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M4
AZE,Azerbaijan,EURO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
AZE,Azerbaijan,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
AZE,Azerbaijan,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
AZE,Azerbaijan,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
AZE,Azerbaijan,EURO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M12
AZE,Azerbaijan,EURO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M18
BDI,Burundi,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
BDI,Burundi,AFRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
BDI,Burundi,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
BDI,Burundi,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
BDI,Burundi,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
BDI,Burundi,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
BDI,Burundi,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
BDI,Burundi,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
BDI,Burundi,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
BDI,Burundi,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
BDI,Burundi,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
BDI,Burundi,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
BDI,Burundi,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
BDI,Burundi,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
BDI,Burundi,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
BDI,Burundi,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
BDI,Burundi,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
BDI,Burundi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
BDI,Burundi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
BDI,Burundi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
BDI,Burundi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
BDI,Burundi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
BDI,Burundi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
BDI,Burundi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
BDI,Burundi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
BDI,Burundi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
BDI,Burundi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
BDI,Burundi,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
BDI,Burundi,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
BDI,Burundi,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
BDI,Burundi,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
BDI,Burundi,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
BDI,Burundi,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
BDI,Burundi,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BEL,Belgium,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,W8
BEL,Belgium,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,W12
BEL,Belgium,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,W16
BEL,Belgium,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15
BEL,Belgium,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5-Y6
BEL,Belgium,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,1st contact
BEL,Belgium,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,CATCHUP_C,Catch-up children,NATIONAL,+M1
BEL,Belgium,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,CATCHUP_C,Catch-up children,NATIONAL,+M6
BEL,Belgium,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
BEL,Belgium,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
BEL,Belgium,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
BEL,Belgium,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
BEL,Belgium,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y12-Y14
BEL,Belgium,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
BEL,Belgium,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
BEL,Belgium,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
BEL,Belgium,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
BEL,Belgium,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BEL,Belgium,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BEL,Belgium,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,CATCHUP_C,Catch-up children,NATIONAL,<M18
BEL,Belgium,EURO,2023,IPV,IPV (Inactivated polio vaccine),2.0,CATCHUP_C,Catch-up children,NATIONAL,+M1
BEL,Belgium,EURO,2023,IPV,IPV (Inactivated polio vaccine),3.0,CATCHUP_C,Catch-up children,NATIONAL,+M1
BEL,Belgium,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
BEL,Belgium,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,M15
BEL,Belgium,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,,General/routine,NATIONAL,Y15
BEL,Belgium,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,,General/routine,NATIONAL,M15
BEL,Belgium,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
BEL,Belgium,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y7-Y12
BEL,Belgium,EURO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,1st contact
BEL,Belgium,EURO,2023,PCV_15_VALENT,PCV-15 (Pneumococcal conjugate vaccine 15-valent) vaccine,1.0,,General/routine,NATIONAL,W8
BEL,Belgium,EURO,2023,PCV_15_VALENT,PCV-15 (Pneumococcal conjugate vaccine 15-valent) vaccine,2.0,,General/routine,NATIONAL,W16
BEL,Belgium,EURO,2023,PCV_15_VALENT,PCV-15 (Pneumococcal conjugate vaccine 15-valent) vaccine,3.0,,General/routine,NATIONAL,M12
BEL,Belgium,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W8
BEL,Belgium,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W16
BEL,Belgium,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
BEL,Belgium,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BEL,Belgium,EURO,2023,PCV20,PCV-20 (Pneumococcal conjugate vaccine 20-valent) vaccine,1.0,ADULTS,Adults,NATIONAL,Y65
BEL,Belgium,EURO,2023,PCV20,PCV-20 (Pneumococcal conjugate vaccine 20-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BEL,Belgium,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,Y65
BEL,Belgium,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BEL,Belgium,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W8
BEL,Belgium,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W12
BEL,Belgium,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,W8
BEL,Belgium,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,W12
BEL,Belgium,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,W16
BEL,Belgium,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,ADULTS,Adults,NATIONAL,Y25
BEL,Belgium,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",2.0,ADULTS,Adults,NATIONAL,+Y10
BEL,Belgium,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",3.0,ADULTS,Adults,NATIONAL,+Y10
BEL,Belgium,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",4.0,ADULTS,Adults,NATIONAL,+Y10
BEL,Belgium,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,ADULTS,Adults,NATIONAL,+Y10
BEL,Belgium,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,ADULTS,Adults,NATIONAL,+Y10
BEL,Belgium,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y14-Y16
BEL,Belgium,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
BEN,Benin,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
BEN,Benin,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
BEN,Benin,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
BEN,Benin,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
BEN,Benin,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
BEN,Benin,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
BEN,Benin,AFRO,2023,MEN_A_CONJ,Meningococcal A conjugate vaccine,1.0,,General/routine,NATIONAL,M9
BEN,Benin,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
BEN,Benin,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
BEN,Benin,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
BEN,Benin,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
BEN,Benin,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
BEN,Benin,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
BEN,Benin,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
BEN,Benin,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
BEN,Benin,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
BEN,Benin,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
BEN,Benin,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,3.0,,General/routine,NATIONAL,W14
BEN,Benin,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
BEN,Benin,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
BEN,Benin,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
BEN,Benin,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
BEN,Benin,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
BEN,Benin,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
BFA,Burkina Faso,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
BFA,Burkina Faso,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W8
BFA,Burkina Faso,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W12
BFA,Burkina Faso,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W16
BFA,Burkina Faso,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
BFA,Burkina Faso,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
BFA,Burkina Faso,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W16
BFA,Burkina Faso,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
BFA,Burkina Faso,AFRO,2023,MEN_A_CONJ,Meningococcal A conjugate vaccine,1.0,,General/routine,NATIONAL,M15
BFA,Burkina Faso,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
BFA,Burkina Faso,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M15
BFA,Burkina Faso,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
BFA,Burkina Faso,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W8
BFA,Burkina Faso,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W12
BFA,Burkina Faso,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W16
BFA,Burkina Faso,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W8
BFA,Burkina Faso,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W16
BFA,Burkina Faso,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M9
BFA,Burkina Faso,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,W8
BFA,Burkina Faso,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,W12
BFA,Burkina Faso,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,W16
BFA,Burkina Faso,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
BFA,Burkina Faso,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
BFA,Burkina Faso,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
BFA,Burkina Faso,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y2
BFA,Burkina Faso,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
BFA,Burkina Faso,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
BFA,Burkina Faso,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y2
BFA,Burkina Faso,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
BFA,Burkina Faso,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
BFA,Burkina Faso,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,1st contact
BFA,Burkina Faso,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
BFA,Burkina Faso,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
BFA,Burkina Faso,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
BFA,Burkina Faso,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
BFA,Burkina Faso,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y2
BFA,Burkina Faso,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
BFA,Burkina Faso,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
BFA,Burkina Faso,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
BGD,Bangladesh,SEARO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
BGD,Bangladesh,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
BGD,Bangladesh,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
BGD,Bangladesh,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
BGD,Bangladesh,SEARO,2023,IPV_FRAC,IPVf (Inactivated polio vaccine fractional dose),1.0,,General/routine,NATIONAL,W6
BGD,Bangladesh,SEARO,2023,IPV_FRAC,IPVf (Inactivated polio vaccine fractional dose),3.0,,General/routine,NATIONAL,W14
BGD,Bangladesh,SEARO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,W38
BGD,Bangladesh,SEARO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M15
BGD,Bangladesh,SEARO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
BGD,Bangladesh,SEARO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
BGD,Bangladesh,SEARO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
BGD,Bangladesh,SEARO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,W6
BGD,Bangladesh,SEARO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,W10
BGD,Bangladesh,SEARO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,W14
BGD,Bangladesh,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
BGD,Bangladesh,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
BGD,Bangladesh,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
BGD,Bangladesh,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y15-Y49
BGD,Bangladesh,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
BGD,Bangladesh,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,Y15-Y49
BGD,Bangladesh,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
BGD,Bangladesh,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
BGD,Bangladesh,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
BGD,Bangladesh,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
BGD,Bangladesh,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
BGD,Bangladesh,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
BGD,Bangladesh,SEARO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6-M59
BGR,Bulgaria,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
BGR,Bulgaria,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,2.0,,General/routine,NATIONAL,M7
BGR,Bulgaria,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,3.0,,General/routine,NATIONAL,Y7
BGR,Bulgaria,EURO,2023,CCHF,CCHF (Crimean-Congo Hemorrhagic Fever) vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,
BGR,Bulgaria,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
BGR,Bulgaria,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M3
BGR,Bulgaria,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M4
BGR,Bulgaria,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
BGR,Bulgaria,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M3
BGR,Bulgaria,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M4
BGR,Bulgaria,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M16
BGR,Bulgaria,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y6
BGR,Bulgaria,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
BGR,Bulgaria,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M1
BGR,Bulgaria,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
BGR,Bulgaria,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10-Y13
BGR,Bulgaria,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
BGR,Bulgaria,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
BGR,Bulgaria,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
BGR,Bulgaria,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BGR,Bulgaria,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
BGR,Bulgaria,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BGR,Bulgaria,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M13
BGR,Bulgaria,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y12
BGR,Bulgaria,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
BGR,Bulgaria,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
BGR,Bulgaria,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12
BGR,Bulgaria,EURO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BGR,Bulgaria,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
BGR,Bulgaria,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10-W24
BGR,Bulgaria,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,W6
BGR,Bulgaria,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,W10-W24
BGR,Bulgaria,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,W20-W32
BGR,Bulgaria,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,Y25
BGR,Bulgaria,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,Y35
BGR,Bulgaria,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,Y45
BGR,Bulgaria,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,Y55
BGR,Bulgaria,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,ADULTS,Adults,NATIONAL,Y65
BGR,Bulgaria,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,Y17
BGR,Bulgaria,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y12
BHR,Bahrain,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
BHR,Bahrain,EMRO,2023,CHOLERA,Cholera vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BHR,Bahrain,EMRO,2023,CHOLERA,Cholera vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
BHR,Bahrain,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
BHR,Bahrain,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
BHR,Bahrain,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
BHR,Bahrain,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
BHR,Bahrain,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,RISKGROUPS,Risk group(s),NATIONAL,Y4
BHR,Bahrain,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
BHR,Bahrain,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
BHR,Bahrain,EMRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y5
BHR,Bahrain,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
BHR,Bahrain,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
BHR,Bahrain,EMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BHR,Bahrain,EMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
BHR,Bahrain,EMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,Y12
BHR,Bahrain,EMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,CATCHUP_C,Catch-up children,NATIONAL,Y13
BHR,Bahrain,EMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M15
BHR,Bahrain,EMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,Y2
BHR,Bahrain,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
BHR,Bahrain,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BHR,Bahrain,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
BHR,Bahrain,EMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,5.0,RISKGROUPS,Risk group(s),NATIONAL,Y5
BHR,Bahrain,EMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y12-Y13
BHR,Bahrain,EMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6-M12
BHR,Bahrain,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y50
BHR,Bahrain,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
BHR,Bahrain,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
BHR,Bahrain,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BHR,Bahrain,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,Y10-Y19
BHR,Bahrain,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,<=Y9
BHR,Bahrain,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BHR,Bahrain,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
BHR,Bahrain,EMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
BHR,Bahrain,EMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
BHR,Bahrain,EMRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
BHR,Bahrain,EMRO,2023,IPV,IPV (Inactivated polio vaccine),5.0,RISKGROUPS,Risk group(s),NATIONAL,Y5
BHR,Bahrain,EMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,Y2
BHR,Bahrain,EMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,HW,Health workers,NATIONAL,
BHR,Bahrain,EMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BHR,Bahrain,EMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
BHR,Bahrain,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
BHR,Bahrain,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
BHR,Bahrain,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,HW,Health workers,NATIONAL,
BHR,Bahrain,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
BHR,Bahrain,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,TRAVELLERS,Travellers,NATIONAL,
BHR,Bahrain,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M4
BHR,Bahrain,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
BHR,Bahrain,EMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
BHR,Bahrain,EMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y5
BHR,Bahrain,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,TRAVELLERS,Travellers,NATIONAL,
BHR,Bahrain,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y50
BHR,Bahrain,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
BHR,Bahrain,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M15
BHR,Bahrain,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
BHR,Bahrain,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y5-Y50
BHR,Bahrain,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
BHR,Bahrain,EMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
BHR,Bahrain,EMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y2
BHR,Bahrain,EMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+Y5
BHR,Bahrain,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
BHR,Bahrain,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
BHR,Bahrain,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,,General/routine,NATIONAL,>=Y7
BHR,Bahrain,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,
BHR,Bahrain,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BHR,Bahrain,EMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,ADULTS,Adults,NATIONAL,>Y65
BHR,Bahrain,EMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y13
BHR,Bahrain,EMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
BHR,Bahrain,EMRO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y2
BHR,Bahrain,EMRO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,>=Y2
BHR,Bahrain,EMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,Y1
BHR,Bahrain,EMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y3
BHR,Bahrain,EMRO,2023,VARICELLA,Varicella vaccine,1.0,HW,Health workers,NATIONAL,
BHR,Bahrain,EMRO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BHR,Bahrain,EMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
BHS,Bahamas,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y5
BHS,Bahamas,AMRO,2023,DTWPHIB,DTwP-Hib (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15
BHS,Bahamas,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
BHS,Bahamas,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
BHS,Bahamas,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
BHS,Bahamas,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BHS,Bahamas,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+M6
BHS,Bahamas,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BHS,Bahamas,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+M6
BHS,Bahamas,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
BHS,Bahamas,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
BHS,Bahamas,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,ADULTS,Adults,NATIONAL,+M5
BHS,Bahamas,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9-Y12
BHS,Bahamas,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
BHS,Bahamas,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
BHS,Bahamas,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
BHS,Bahamas,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
BHS,Bahamas,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BHS,Bahamas,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
BHS,Bahamas,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=M6
BHS,Bahamas,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BHS,Bahamas,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
BHS,Bahamas,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
BHS,Bahamas,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,Y16
BHS,Bahamas,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
BHS,Bahamas,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M15
BHS,Bahamas,AMRO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,HW,Health workers,NATIONAL,
BHS,Bahamas,AMRO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BHS,Bahamas,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
BHS,Bahamas,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,Y4-Y5
BHS,Bahamas,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
BHS,Bahamas,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
BHS,Bahamas,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
BHS,Bahamas,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M15
BHS,Bahamas,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,SUBNATIONAL,1st contact
BHS,Bahamas,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,1st contact
BHS,Bahamas,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
BHS,Bahamas,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
BHS,Bahamas,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,+Y10
BHS,Bahamas,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,>Y10
BHS,Bahamas,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y12
BHS,Bahamas,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
BHS,Bahamas,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12
BHS,Bahamas,AMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y4-Y5
BHS,Bahamas,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BIH,Bosnia and Herzegovina,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
BIH,Bosnia and Herzegovina,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
BIH,Bosnia and Herzegovina,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M3-M4
BIH,Bosnia and Herzegovina,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M4-M6
BIH,Bosnia and Herzegovina,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18-Y2
BIH,Bosnia and Herzegovina,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5-Y7
BIH,Bosnia and Herzegovina,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
BIH,Bosnia and Herzegovina,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
BIH,Bosnia and Herzegovina,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BIH,Bosnia and Herzegovina,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
BIH,Bosnia and Herzegovina,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M1
BIH,Bosnia and Herzegovina,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
BIH,Bosnia and Herzegovina,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,,General/routine,,Y9-Y14
BIH,Bosnia and Herzegovina,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
BIH,Bosnia and Herzegovina,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
BIH,Bosnia and Herzegovina,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
BIH,Bosnia and Herzegovina,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BIH,Bosnia and Herzegovina,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BIH,Bosnia and Herzegovina,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
BIH,Bosnia and Herzegovina,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
BIH,Bosnia and Herzegovina,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,Y1
BIH,Bosnia and Herzegovina,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,TRAVELLERS,Travellers,NATIONAL,
BIH,Bosnia and Herzegovina,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BIH,Bosnia and Herzegovina,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y14-Y18
BIH,Bosnia and Herzegovina,EURO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
BLR,Belarus,EURO,2023,ANTHRAX,Anthrax vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BLR,Belarus,EURO,2023,AP,aP (acellular pertussis) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2-M18
BLR,Belarus,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,D3-D5
BLR,Belarus,EURO,2023,D_S,Diphtheria vaccine for older children and adults,1.0,,General/routine,NATIONAL,Y11
BLR,Belarus,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,B_CHILD_W,General/routine,NATIONAL,Y6
BLR,Belarus,EURO,2023,DTAP,DTaP (acellular) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M18
BLR,Belarus,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
BLR,Belarus,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M3
BLR,Belarus,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M4
BLR,Belarus,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2-M18
BLR,Belarus,EURO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
BLR,Belarus,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
BLR,Belarus,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3
BLR,Belarus,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M4
BLR,Belarus,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BLR,Belarus,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BLR,Belarus,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BLR,Belarus,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
BLR,Belarus,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y1-Y4
BLR,Belarus,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
BLR,Belarus,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
BLR,Belarus,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
BLR,Belarus,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BLR,Belarus,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>Y3
BLR,Belarus,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y3
BLR,Belarus,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BLR,Belarus,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
BLR,Belarus,EURO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M3
BLR,Belarus,EURO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M4
BLR,Belarus,EURO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,Y7
BLR,Belarus,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,Y1
BLR,Belarus,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
BLR,Belarus,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
BLR,Belarus,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M12
BLR,Belarus,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
BLR,Belarus,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
BLR,Belarus,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
BLR,Belarus,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M12
BLR,Belarus,EURO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BLR,Belarus,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BLR,Belarus,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BLR,Belarus,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y6
BLR,Belarus,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_F,General/routine,NATIONAL,Y16
BLR,Belarus,EURO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BLR,Belarus,EURO,2023,TULAREMIA,Tularemia vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BLR,Belarus,EURO,2023,YF,YF (Yellow fever) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BLZ,Belize,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
BLZ,Belize,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
BLZ,Belize,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
BLZ,Belize,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
BLZ,Belize,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
BLZ,Belize,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,RISKGROUPS,Risk group(s),NATIONAL,Y4
BLZ,Belize,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",6.0,RISKGROUPS,Risk group(s),NATIONAL,Y12
BLZ,Belize,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
BLZ,Belize,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
BLZ,Belize,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
BLZ,Belize,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
BLZ,Belize,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
BLZ,Belize,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
BLZ,Belize,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BLZ,Belize,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
BLZ,Belize,AMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9
BLZ,Belize,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
BLZ,Belize,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
BLZ,Belize,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
BLZ,Belize,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BLZ,Belize,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M11
BLZ,Belize,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,M12-M23
BLZ,Belize,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
BLZ,Belize,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
BLZ,Belize,AMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
BLZ,Belize,AMRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
BLZ,Belize,AMRO,2023,IPV,IPV (Inactivated polio vaccine),5.0,RISKGROUPS,Risk group(s),NATIONAL,Y4
BLZ,Belize,AMRO,2023,IPV,IPV (Inactivated polio vaccine),6.0,RISKGROUPS,Risk group(s),NATIONAL,Y12
BLZ,Belize,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
BLZ,Belize,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
BLZ,Belize,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
BLZ,Belize,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
BLZ,Belize,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4
BLZ,Belize,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
BLZ,Belize,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
BLZ,Belize,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M6
BLZ,Belize,AMRO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
BLZ,Belize,AMRO,2023,RABIES,Rabies vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+D3
BLZ,Belize,AMRO,2023,RABIES,Rabies vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+D7
BLZ,Belize,AMRO,2023,RABIES,Rabies vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,+D14
BLZ,Belize,AMRO,2023,RABIES,Rabies vaccine,5.0,RISKGROUPS,Risk group(s),NATIONAL,+D28
BLZ,Belize,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y12
BLZ,Belize,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,
BLZ,Belize,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,
BLZ,Belize,AMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
BLZ,Belize,AMRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
BLZ,Belize,AMRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
BLZ,Belize,AMRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
BLZ,Belize,AMRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
BLZ,Belize,AMRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
BLZ,Belize,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
BMU,Bermuda,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,CHOLERA,Cholera vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,CHOLERA,Cholera vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+W2
BMU,Bermuda,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
BMU,Bermuda,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
BMU,Bermuda,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
BMU,Bermuda,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
BMU,Bermuda,AMRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y6
BMU,Bermuda,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+M6-M12
BMU,Bermuda,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+M6-M12
BMU,Bermuda,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
BMU,Bermuda,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
BMU,Bermuda,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
BMU,Bermuda,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
BMU,Bermuda,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,TRAVELLERS,Travellers,NATIONAL,+M6
BMU,Bermuda,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+M1
BMU,Bermuda,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,M6
BMU,Bermuda,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M7
BMU,Bermuda,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M12
BMU,Bermuda,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y11
BMU,Bermuda,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6-M12
BMU,Bermuda,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
BMU,Bermuda,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
BMU,Bermuda,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
BMU,Bermuda,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BMU,Bermuda,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y18
BMU,Bermuda,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BMU,Bermuda,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+D28
BMU,Bermuda,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M15
BMU,Bermuda,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y4-Y6
BMU,Bermuda,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
BMU,Bermuda,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
BMU,Bermuda,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
BMU,Bermuda,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M18
BMU,Bermuda,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,RABIES,Rabies vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,RABIES,Rabies vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+D7
BMU,Bermuda,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
BMU,Bermuda,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
BMU,Bermuda,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y19
BMU,Bermuda,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+Y10
BMU,Bermuda,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+Y10
BMU,Bermuda,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y19
BMU,Bermuda,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,>=Y19
BMU,Bermuda,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+Y10
BMU,Bermuda,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y11-Y18
BMU,Bermuda,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,TYPHOID_CONJ,Typhoid conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,TYPHOID_CONJ,Typhoid conjugate vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+Y3
BMU,Bermuda,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M24
BMU,Bermuda,AMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y4-Y6
BMU,Bermuda,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BMU,Bermuda,AMRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y50
BMU,Bermuda,AMRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M2
BOL,Bolivia (Plurinational State of),AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
BOL,Bolivia (Plurinational State of),AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
BOL,Bolivia (Plurinational State of),AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
BOL,Bolivia (Plurinational State of),AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
BOL,Bolivia (Plurinational State of),AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18-M23
BOL,Bolivia (Plurinational State of),AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
BOL,Bolivia (Plurinational State of),AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
BOL,Bolivia (Plurinational State of),AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
BOL,Bolivia (Plurinational State of),AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
BOL,Bolivia (Plurinational State of),AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
BOL,Bolivia (Plurinational State of),AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
BOL,Bolivia (Plurinational State of),AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
BOL,Bolivia (Plurinational State of),AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10
BOL,Bolivia (Plurinational State of),AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y60
BOL,Bolivia (Plurinational State of),AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
BOL,Bolivia (Plurinational State of),AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
BOL,Bolivia (Plurinational State of),AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BOL,Bolivia (Plurinational State of),AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,<Y1
BOL,Bolivia (Plurinational State of),AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,Y1
BOL,Bolivia (Plurinational State of),AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
BOL,Bolivia (Plurinational State of),AMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
BOL,Bolivia (Plurinational State of),AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
BOL,Bolivia (Plurinational State of),AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18-M23
BOL,Bolivia (Plurinational State of),AMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M4
BOL,Bolivia (Plurinational State of),AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18-M23
BOL,Bolivia (Plurinational State of),AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4
BOL,Bolivia (Plurinational State of),AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
BOL,Bolivia (Plurinational State of),AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
BOL,Bolivia (Plurinational State of),AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
BOL,Bolivia (Plurinational State of),AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
BOL,Bolivia (Plurinational State of),AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
BOL,Bolivia (Plurinational State of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
BOL,Bolivia (Plurinational State of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
BOL,Bolivia (Plurinational State of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
BOL,Bolivia (Plurinational State of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
BOL,Bolivia (Plurinational State of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
BOL,Bolivia (Plurinational State of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
BOL,Bolivia (Plurinational State of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
BOL,Bolivia (Plurinational State of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
BOL,Bolivia (Plurinational State of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
BOL,Bolivia (Plurinational State of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,Y7-Y49
BOL,Bolivia (Plurinational State of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
BOL,Bolivia (Plurinational State of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
BOL,Bolivia (Plurinational State of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
BOL,Bolivia (Plurinational State of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
BOL,Bolivia (Plurinational State of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
BOL,Bolivia (Plurinational State of),AMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
BOL,Bolivia (Plurinational State of),AMRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
BOL,Bolivia (Plurinational State of),AMRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
BOL,Bolivia (Plurinational State of),AMRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
BOL,Bolivia (Plurinational State of),AMRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
BOL,Bolivia (Plurinational State of),AMRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
BOL,Bolivia (Plurinational State of),AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M12-M23
BRA,Brazil,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
BRA,Brazil,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BRA,Brazil,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
BRA,Brazil,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
BRA,Brazil,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
BRA,Brazil,AMRO,2023,DTAP,DTaP (acellular) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
BRA,Brazil,AMRO,2023,DTAP,DTaP (acellular) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
BRA,Brazil,AMRO,2023,DTAP,DTaP (acellular) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
BRA,Brazil,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15
BRA,Brazil,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
BRA,Brazil,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
BRA,Brazil,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
BRA,Brazil,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
BRA,Brazil,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y19
BRA,Brazil,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M15
BRA,Brazil,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,ADULTS,Adults,NATIONAL,>=Y7
BRA,Brazil,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,ADULTS,Adults,NATIONAL,>=Y7
BRA,Brazil,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y7
BRA,Brazil,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,,General/routine,NATIONAL,>=Y7
BRA,Brazil,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,,General/routine,NATIONAL,>=Y7
BRA,Brazil,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,,General/routine,NATIONAL,>=Y7
BRA,Brazil,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
BRA,Brazil,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y19
BRA,Brazil,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9-Y14
BRA,Brazil,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
BRA,Brazil,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y9-Y26
BRA,Brazil,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M2
BRA,Brazil,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
BRA,Brazil,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
BRA,Brazil,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
BRA,Brazil,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
BRA,Brazil,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BRA,Brazil,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y6
BRA,Brazil,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
BRA,Brazil,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
BRA,Brazil,AMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
BRA,Brazil,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
BRA,Brazil,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M6-M9
BRA,Brazil,AMRO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,,General/routine,NATIONAL,M3
BRA,Brazil,AMRO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,2.0,,General/routine,NATIONAL,M5
BRA,Brazil,AMRO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,3.0,,General/routine,NATIONAL,M12
BRA,Brazil,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,ADULTS,Adults,NATIONAL,
BRA,Brazil,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
BRA,Brazil,AMRO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",2.0,,General/routine,NATIONAL,M15
BRA,Brazil,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M15
BRA,Brazil,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4
BRA,Brazil,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
BRA,Brazil,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
BRA,Brazil,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12
BRA,Brazil,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
BRA,Brazil,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
BRA,Brazil,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y7
BRA,Brazil,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,>=Y7
BRA,Brazil,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,>=Y7
BRA,Brazil,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,>=Y7
BRA,Brazil,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,>=Y7
BRA,Brazil,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,>=Y7
BRA,Brazil,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,ADULTS,Adults,NATIONAL,
BRA,Brazil,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,Y4
BRA,Brazil,AMRO,2023,VARICELLA,Varicella vaccine,1.0,HW,Health workers,NATIONAL,
BRA,Brazil,AMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6-M11
BRA,Brazil,AMRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12-M18
BRA,Brazil,AMRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M19-M25
BRA,Brazil,AMRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M26-M32
BRA,Brazil,AMRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M33-M39
BRA,Brazil,AMRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M40-M46
BRA,Brazil,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
BRA,Brazil,AMRO,2023,YF,YF (Yellow fever) vaccine,2.0,,General/routine,NATIONAL,Y4
BRB,Barbados,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M9
BRB,Barbados,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,CATCHUP_C,Catch-up children,NATIONAL,Y5-Y7
BRB,Barbados,AMRO,2023,DTAP,DTaP (acellular) vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
BRB,Barbados,AMRO,2023,DTAP,DTaP (acellular) vaccine,5.0,RISKGROUPS,Risk group(s),NATIONAL,Y4.5
BRB,Barbados,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
BRB,Barbados,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
BRB,Barbados,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
BRB,Barbados,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
BRB,Barbados,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4.5
BRB,Barbados,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
BRB,Barbados,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
BRB,Barbados,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
BRB,Barbados,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
BRB,Barbados,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BRB,Barbados,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
BRB,Barbados,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
BRB,Barbados,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
BRB,Barbados,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
BRB,Barbados,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
BRB,Barbados,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
BRB,Barbados,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,TRAVELLERS,Travellers,NATIONAL,+M6
BRB,Barbados,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BRB,Barbados,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+M1
BRB,Barbados,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y10-Y11
BRB,Barbados,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
BRB,Barbados,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
BRB,Barbados,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
BRB,Barbados,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BRB,Barbados,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BRB,Barbados,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
BRB,Barbados,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
BRB,Barbados,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
BRB,Barbados,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
BRB,Barbados,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
BRB,Barbados,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,Y1.5
BRB,Barbados,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4.5
BRB,Barbados,AMRO,2023,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,Y10-Y11
BRB,Barbados,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
BRB,Barbados,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
BRB,Barbados,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
BRB,Barbados,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y10-Y11
BRB,Barbados,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,
BRB,Barbados,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12
BRB,Barbados,AMRO,2023,VARICELLA,Varicella vaccine,1.0,HW,Health workers,NATIONAL,1st contact
BRB,Barbados,AMRO,2023,VARICELLA,Varicella vaccine,2.0,HW,Health workers,NATIONAL,+W6
BRB,Barbados,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BRN,Brunei Darussalam,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
BRN,Brunei Darussalam,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
BRN,Brunei Darussalam,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
BRN,Brunei Darussalam,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
BRN,Brunei Darussalam,WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y5
BRN,Brunei Darussalam,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
BRN,Brunei Darussalam,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,4.0,,General/routine,NATIONAL,Y1
BRN,Brunei Darussalam,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y13
BRN,Brunei Darussalam,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
BRN,Brunei Darussalam,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
BRN,Brunei Darussalam,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
BRN,Brunei Darussalam,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
BRN,Brunei Darussalam,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BRN,Brunei Darussalam,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=M6
BRN,Brunei Darussalam,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
BRN,Brunei Darussalam,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BRN,Brunei Darussalam,WPRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
BRN,Brunei Darussalam,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
BRN,Brunei Darussalam,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
BRN,Brunei Darussalam,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BRN,Brunei Darussalam,WPRO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,PW,Pregnant women,NATIONAL,
BRN,Brunei Darussalam,WPRO,2023,TT,TT (Tetanus toxoid) vaccine,2.0,PW,Pregnant women,NATIONAL,
BTN,Bhutan,SEARO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
BTN,Bhutan,SEARO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_F,General/routine,NATIONAL,M24
BTN,Bhutan,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
BTN,Bhutan,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
BTN,Bhutan,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
BTN,Bhutan,SEARO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
BTN,Bhutan,SEARO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y12
BTN,Bhutan,SEARO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,3.0,BOTH,HPV administered to females and males,NATIONAL,+M6
BTN,Bhutan,SEARO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
BTN,Bhutan,SEARO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
BTN,Bhutan,SEARO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
BTN,Bhutan,SEARO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BTN,Bhutan,SEARO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M24
BTN,Bhutan,SEARO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
BTN,Bhutan,SEARO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
BTN,Bhutan,SEARO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,W32
BTN,Bhutan,SEARO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M9
BTN,Bhutan,SEARO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M24
BTN,Bhutan,SEARO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
BTN,Bhutan,SEARO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
BTN,Bhutan,SEARO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
BTN,Bhutan,SEARO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
BTN,Bhutan,SEARO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
BTN,Bhutan,SEARO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
BTN,Bhutan,SEARO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M9
BTN,Bhutan,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y6
BTN,Bhutan,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y12
BTN,Bhutan,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
BTN,Bhutan,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
BTN,Bhutan,SEARO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
BTN,Bhutan,SEARO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
BTN,Bhutan,SEARO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
BTN,Bhutan,SEARO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
BTN,Bhutan,SEARO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
BTN,Bhutan,SEARO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
BWA,Botswana,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
BWA,Botswana,AFRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",4.0,,General/routine,NATIONAL,M18
BWA,Botswana,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
BWA,Botswana,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3
BWA,Botswana,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M4
BWA,Botswana,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
BWA,Botswana,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9-Y13
BWA,Botswana,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
BWA,Botswana,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M4
BWA,Botswana,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
BWA,Botswana,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
BWA,Botswana,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M2
BWA,Botswana,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M3
BWA,Botswana,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M4
BWA,Botswana,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
BWA,Botswana,AFRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y7
BWA,Botswana,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
BWA,Botswana,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M3
BWA,Botswana,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M4
BWA,Botswana,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
BWA,Botswana,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M3
BWA,Botswana,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,3.0,,General/routine,NATIONAL,M4
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+W4
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y7
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y13
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+W4
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,1st contact
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+W4
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
BWA,Botswana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
BWA,Botswana,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
BWA,Botswana,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
BWA,Botswana,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
BWA,Botswana,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
BWA,Botswana,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
BWA,Botswana,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
BWA,Botswana,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
BWA,Botswana,AFRO,2023,YF,YF (Yellow fever) vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+Y10
CAF,Central African Republic,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
CAF,Central African Republic,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
CAF,Central African Republic,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
CAF,Central African Republic,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
CAF,Central African Republic,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
CAF,Central African Republic,AFRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
CAF,Central African Republic,AFRO,2023,MEN_A_CONJ,Meningococcal A conjugate vaccine,1.0,,General/routine,NATIONAL,M9
CAF,Central African Republic,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
CAF,Central African Republic,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
CAF,Central African Republic,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
CAF,Central African Republic,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
CAF,Central African Republic,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
CAF,Central African Republic,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
CAF,Central African Republic,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
CAF,Central African Republic,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
CAF,Central African Republic,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
CAF,Central African Republic,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
CAF,Central African Republic,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
CAF,Central African Republic,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
CAF,Central African Republic,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
CAF,Central African Republic,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
CAN,Canada,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,SUBNATIONAL,M1
CAN,Canada,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,SUBNATIONAL,M2
CAN,Canada,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,SUBNATIONAL,M4
CAN,Canada,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,SUBNATIONAL,M6
CAN,Canada,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
CAN,Canada,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
CAN,Canada,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6-M12
CAN,Canada,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
CAN,Canada,AMRO,2023,HEPA_HEPB,"Hepatitis A, Hepatitis B vaccine",1.0,CATCHUP_C,Catch-up children,SUBNATIONAL,
CAN,Canada,AMRO,2023,HEPA_HEPB,"Hepatitis A, Hepatitis B vaccine",1.0,,General/routine,SUBNATIONAL,M18
CAN,Canada,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,CATCHUP_C,Catch-up children,SUBNATIONAL,
CAN,Canada,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,CATCHUP_C,Catch-up children,SUBNATIONAL,
CAN,Canada,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,SUBNATIONAL,M1-Y12
CAN,Canada,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,SUBNATIONAL,M6-M9
CAN,Canada,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,SUBNATIONAL,B-Y12
CAN,Canada,AMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,3.0,CATCHUP_C,Catch-up children,SUBNATIONAL,
CAN,Canada,AMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9-Y13
CAN,Canada,AMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,Y11-Y16
CAN,Canada,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y18
CAN,Canada,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
CAN,Canada,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
CAN,Canada,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CAN,Canada,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,M6-Y4
CAN,Canada,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y17
CAN,Canada,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CAN,Canada,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,SUBNATIONAL,Y9-Y17
CAN,Canada,AMRO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,CATCHUP_C,Catch-up children,SUBNATIONAL,
CAN,Canada,AMRO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,2.0,,General/routine,SUBNATIONAL,M12
CAN,Canada,AMRO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,,General/routine,NATIONAL,M2-M18
CAN,Canada,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,SUBNATIONAL,M12
CAN,Canada,AMRO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",1.0,CATCHUP_C,Catch-up children,SUBNATIONAL,
CAN,Canada,AMRO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",1.0,,General/routine,SUBNATIONAL,M12
CAN,Canada,AMRO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",2.0,,General/routine,NATIONAL,M18-Y6
CAN,Canada,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,SUBNATIONAL,M2
CAN,Canada,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,SUBNATIONAL,M4
CAN,Canada,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2-M12
CAN,Canada,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
CAN,Canada,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6-M12
CAN,Canada,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M15-M18
CAN,Canada,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y50
CAN,Canada,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,,General/routine,SUBNATIONAL,Y2-Y3
CAN,Canada,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,
CAN,Canada,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,SUBNATIONAL,M2
CAN,Canada,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,SUBNATIONAL,M4
CAN,Canada,AMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,SUBNATIONAL,M2
CAN,Canada,AMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,SUBNATIONAL,M4
CAN,Canada,AMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,SUBNATIONAL,M6
CAN,Canada,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,SUBNATIONAL,1st contact
CAN,Canada,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,SUBNATIONAL,+Y10
CAN,Canada,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_ADO_W,General/routine,SUBNATIONAL,Y15
CAN,Canada,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",2.0,ADULTS,Adults,SUBNATIONAL,+Y10
CAN,Canada,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,ADULTS,Adults,SUBNATIONAL,1st contact
CAN,Canada,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,B_ADO_W,General/routine,SUBNATIONAL,Y11-Y16
CAN,Canada,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
CAN,Canada,AMRO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",1.0,CATCHUP_C,Catch-up children,SUBNATIONAL,
CAN,Canada,AMRO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",1.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y6
CAN,Canada,AMRO,2023,VARICELLA,Varicella vaccine,1.0,CATCHUP_C,Catch-up children,SUBNATIONAL,
CAN,Canada,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,SUBNATIONAL,M12-M15
CAN,Canada,AMRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,ADULTS,Adults,SUBNATIONAL,>=Y60
CAN,Canada,AMRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,2.0,ADULTS,Adults,SUBNATIONAL,>=Y60
CHE,Switzerland,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
CHE,Switzerland,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
CHE,Switzerland,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M12
CHE,Switzerland,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y7
CHE,Switzerland,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,,General/routine,NATIONAL,Y11-Y15
CHE,Switzerland,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,,General/routine,NATIONAL,+M6
CHE,Switzerland,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
CHE,Switzerland,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y11-Y14
CHE,Switzerland,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
CHE,Switzerland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
CHE,Switzerland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
CHE,Switzerland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
CHE,Switzerland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CHE,Switzerland,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CHE,Switzerland,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,M24
CHE,Switzerland,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,,General/routine,NATIONAL,Y11-Y15
CHE,Switzerland,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M9
CHE,Switzerland,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M12
CHE,Switzerland,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
CHE,Switzerland,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
CHE,Switzerland,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
CHE,Switzerland,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,1st contact
CHE,Switzerland,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,2.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+M1
CHE,Switzerland,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,3.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+M6-M10
CHE,Switzerland,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,Y6
CHE,Switzerland,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,2.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+M1
CHE,Switzerland,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,3.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+M6-M10
CHE,Switzerland,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y25
CHE,Switzerland,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,Y45
CHE,Switzerland,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,Y65
CHE,Switzerland,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y11-Y15
CHE,Switzerland,EURO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M9
CHE,Switzerland,EURO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,M12
CHE,Switzerland,EURO,2023,VARICELLA,Varicella vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,Y11-Y14
CHE,Switzerland,EURO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y11-Y14
CHE,Switzerland,EURO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
CHE,Switzerland,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M2
CHE,Switzerland,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y65
CHE,Switzerland,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M2
CHE,Switzerland,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
CHL,Chile,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
CHL,Chile,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
CHL,Chile,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
CHL,Chile,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
CHL,Chile,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
CHL,Chile,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M18
CHL,Chile,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
CHL,Chile,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
CHL,Chile,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
CHL,Chile,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
CHL,Chile,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
CHL,Chile,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
CHL,Chile,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
CHL,Chile,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9
CHL,Chile,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,Y10
CHL,Chile,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
CHL,Chile,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
CHL,Chile,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
CHL,Chile,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CHL,Chile,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y5
CHL,Chile,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,Y5-Y10
CHL,Chile,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,Y1
CHL,Chile,AMRO,2023,MEN_B,Meningococcal B vaccine,1.0,,General/routine,NATIONAL,M2
CHL,Chile,AMRO,2023,MEN_B,Meningococcal B vaccine,2.0,,General/routine,NATIONAL,M4
CHL,Chile,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,Y1
CHL,Chile,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M36
CHL,Chile,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
CHL,Chile,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
CHL,Chile,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
CHL,Chile,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
CHL,Chile,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
CHL,Chile,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y6
CHL,Chile,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y13
CHL,Chile,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
CHL,Chile,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M18
CHL,Chile,AMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,M36
CHL,Chile,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,SUBNATIONAL,M18
CHN,China,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
CHN,China,WPRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y6
CHN,China,WPRO,2023,DTAP,DTaP (acellular) vaccine,1.0,,General/routine,NATIONAL,M3
CHN,China,WPRO,2023,DTAP,DTaP (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
CHN,China,WPRO,2023,DTAP,DTaP (acellular) vaccine,3.0,,General/routine,NATIONAL,M5
CHN,China,WPRO,2023,DTAP,DTaP (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
CHN,China,WPRO,2023,HEPA_INACTD,Hepatitis A inactivted,1.0,,General/routine,SUBNATIONAL,M18
CHN,China,WPRO,2023,HEPA_INACTD,Hepatitis A inactivted,2.0,,General/routine,SUBNATIONAL,Y2
CHN,China,WPRO,2023,HEPA_LIVEATD,Hepatitis A live attenuated,1.0,,General/routine,NATIONAL,M18
CHN,China,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
CHN,China,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M1
CHN,China,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
CHN,China,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
CHN,China,WPRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M3
CHN,China,WPRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,1.0,,General/routine,SUBNATIONAL,M8
CHN,China,WPRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,2.0,,General/routine,SUBNATIONAL,M8
CHN,China,WPRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,3.0,,General/routine,SUBNATIONAL,Y2
CHN,China,WPRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,4.0,,General/routine,SUBNATIONAL,Y6
CHN,China,WPRO,2023,JE_LIVEATD,JE-Livatd (Japanese Encephalitis live-attenuated) vaccine,1.0,,General/routine,NATIONAL,M8
CHN,China,WPRO,2023,JE_LIVEATD,JE-Livatd (Japanese Encephalitis live-attenuated) vaccine,2.0,,General/routine,NATIONAL,Y2
CHN,China,WPRO,2023,MEN_A_PS,Meningococcal A polysaccharide vaccine,1.0,,General/routine,NATIONAL,M6
CHN,China,WPRO,2023,MEN_A_PS,Meningococcal A polysaccharide vaccine,2.0,,General/routine,NATIONAL,M9
CHN,China,WPRO,2023,MEN_AC_PS,Meningococcal AC polysaccharide vaccine,1.0,,General/routine,NATIONAL,Y3
CHN,China,WPRO,2023,MEN_AC_PS,Meningococcal AC polysaccharide vaccine,2.0,,General/routine,NATIONAL,Y6
CHN,China,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M8
CHN,China,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
CHN,China,WPRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M4
CHN,China,WPRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,Y4
CIV,Côte d'Ivoire,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
CIV,Côte d'Ivoire,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
CIV,Côte d'Ivoire,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
CIV,Côte d'Ivoire,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
CIV,Côte d'Ivoire,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
CIV,Côte d'Ivoire,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
CIV,Côte d'Ivoire,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
CIV,Côte d'Ivoire,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
CIV,Côte d'Ivoire,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
CIV,Côte d'Ivoire,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W6
CIV,Côte d'Ivoire,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,W14
CIV,Côte d'Ivoire,AFRO,2023,MEN_A_CONJ,Meningococcal A conjugate vaccine,1.0,,General/routine,NATIONAL,M9
CIV,Côte d'Ivoire,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
CIV,Côte d'Ivoire,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M15
CIV,Côte d'Ivoire,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
CIV,Côte d'Ivoire,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
CIV,Côte d'Ivoire,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
CIV,Côte d'Ivoire,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
CIV,Côte d'Ivoire,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
CIV,Côte d'Ivoire,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
CIV,Côte d'Ivoire,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
CIV,Côte d'Ivoire,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
CIV,Côte d'Ivoire,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
CIV,Côte d'Ivoire,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
CIV,Côte d'Ivoire,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
CIV,Côte d'Ivoire,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
CIV,Côte d'Ivoire,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
CIV,Côte d'Ivoire,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
CIV,Côte d'Ivoire,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,SUBNATIONAL,M6
CIV,Côte d'Ivoire,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,SUBNATIONAL,M12
CIV,Côte d'Ivoire,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,SUBNATIONAL,M18
CIV,Côte d'Ivoire,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,SUBNATIONAL,M24
CIV,Côte d'Ivoire,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,SUBNATIONAL,M30
CIV,Côte d'Ivoire,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,SUBNATIONAL,M36
CIV,Côte d'Ivoire,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
CMR,Cameroon,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
CMR,Cameroon,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
CMR,Cameroon,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
CMR,Cameroon,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
CMR,Cameroon,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9
CMR,Cameroon,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
CMR,Cameroon,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
CMR,Cameroon,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M15
CMR,Cameroon,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
CMR,Cameroon,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
CMR,Cameroon,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
CMR,Cameroon,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
CMR,Cameroon,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
CMR,Cameroon,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
CMR,Cameroon,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
CMR,Cameroon,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
CMR,Cameroon,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
CMR,Cameroon,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
CMR,Cameroon,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,3.0,,General/routine,NATIONAL,W14
CMR,Cameroon,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
CMR,Cameroon,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
CMR,Cameroon,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
CMR,Cameroon,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+M12
CMR,Cameroon,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+M12
CMR,Cameroon,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
CMR,Cameroon,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
CMR,Cameroon,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
CMR,Cameroon,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
CMR,Cameroon,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
CMR,Cameroon,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
CMR,Cameroon,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,PW,Pregnant women,NATIONAL,
CMR,Cameroon,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,,M9
COD,Democratic Republic of the Congo,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
COD,Democratic Republic of the Congo,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
COD,Democratic Republic of the Congo,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
COD,Democratic Republic of the Congo,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
COD,Democratic Republic of the Congo,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
COD,Democratic Republic of the Congo,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
COD,Democratic Republic of the Congo,AFRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
COD,Democratic Republic of the Congo,AFRO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,M15
COD,Democratic Republic of the Congo,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
COD,Democratic Republic of the Congo,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
COD,Democratic Republic of the Congo,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
COD,Democratic Republic of the Congo,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
COD,Democratic Republic of the Congo,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
COD,Democratic Republic of the Congo,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
COD,Democratic Republic of the Congo,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
COD,Democratic Republic of the Congo,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,W6
COD,Democratic Republic of the Congo,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,W10
COD,Democratic Republic of the Congo,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,W14
COD,Democratic Republic of the Congo,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
COD,Democratic Republic of the Congo,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
COD,Democratic Republic of the Congo,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
COD,Democratic Republic of the Congo,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
COD,Democratic Republic of the Congo,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
COD,Democratic Republic of the Congo,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
COD,Democratic Republic of the Congo,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
COD,Democratic Republic of the Congo,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
COD,Democratic Republic of the Congo,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
COD,Democratic Republic of the Congo,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
COD,Democratic Republic of the Congo,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
COD,Democratic Republic of the Congo,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
COG,Congo,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
COG,Congo,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W8
COG,Congo,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W12
COG,Congo,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W16
COG,Congo,AFRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,W16
COG,Congo,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,W36
COG,Congo,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,W60
COG,Congo,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
COG,Congo,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W8
COG,Congo,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W12
COG,Congo,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W16
COG,Congo,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W8
COG,Congo,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W12
COG,Congo,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W16
COG,Congo,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,W8
COG,Congo,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,W12
COG,Congo,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,W16
COG,Congo,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
COG,Congo,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
COG,Congo,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
COG,Congo,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
COG,Congo,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
COG,Congo,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,W36
COG,Congo,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,W60
COG,Congo,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,W36
COK,Cook Islands,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
COK,Cook Islands,WPRO,2023,DTAP,DTaP (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y4
COK,Cook Islands,WPRO,2023,DTAPHIBHEPB,DTaP-Hib-HepB (acellular) vaccine,1.0,,General/routine,NATIONAL,W6
COK,Cook Islands,WPRO,2023,DTAPHIBHEPB,DTaP-Hib-HepB (acellular) vaccine,2.0,,General/routine,NATIONAL,M3
COK,Cook Islands,WPRO,2023,DTAPHIBHEPB,DTaP-Hib-HepB (acellular) vaccine,3.0,,General/routine,NATIONAL,M5
COK,Cook Islands,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
COK,Cook Islands,WPRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
COK,Cook Islands,WPRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
COK,Cook Islands,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M5
COK,Cook Islands,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
COK,Cook Islands,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
COK,Cook Islands,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,HW,Health workers,NATIONAL,
COK,Cook Islands,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M6-M12
COK,Cook Islands,WPRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
COK,Cook Islands,WPRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M3
COK,Cook Islands,WPRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M5
COK,Cook Islands,WPRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,Y4
COK,Cook Islands,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,,W6
COK,Cook Islands,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,,M3
COK,Cook Islands,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,,M8
COK,Cook Islands,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,,W6
COK,Cook Islands,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,,M3
COK,Cook Islands,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_ADO_W,General/routine,NATIONAL,Y11
COL,Colombia,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
COL,Colombia,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
COL,Colombia,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
COL,Colombia,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
COL,Colombia,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
COL,Colombia,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,RISKGROUPS,Risk group(s),NATIONAL,Y5
COL,Colombia,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,A5
COL,Colombia,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
COL,Colombia,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
COL,Colombia,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
COL,Colombia,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
COL,Colombia,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,Y1
COL,Colombia,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
COL,Colombia,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
COL,Colombia,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
COL,Colombia,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
COL,Colombia,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9-Y17
COL,Colombia,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
COL,Colombia,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
COL,Colombia,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
COL,Colombia,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
COL,Colombia,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
COL,Colombia,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M11
COL,Colombia,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,
COL,Colombia,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
COL,Colombia,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
COL,Colombia,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
COL,Colombia,AMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
COL,Colombia,AMRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,M18
COL,Colombia,AMRO,2023,IPV,IPV (Inactivated polio vaccine),5.0,,General/routine,NATIONAL,Y5
COL,Colombia,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
COL,Colombia,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,
COL,Colombia,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,
COL,Colombia,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,Y1
COL,Colombia,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y5
COL,Colombia,AMRO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,1st contact
COL,Colombia,AMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,HW,Health workers,NATIONAL,
COL,Colombia,AMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M6-Y59
COL,Colombia,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
COL,Colombia,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
COL,Colombia,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12
COL,Colombia,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
COL,Colombia,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
COL,Colombia,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
COL,Colombia,AMRO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
COL,Colombia,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
COL,Colombia,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
COL,Colombia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,HW,Health workers,NATIONAL,1st contact
COL,Colombia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,HW,Health workers,NATIONAL,+M1
COL,Colombia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,HW,Health workers,NATIONAL,+M6
COL,Colombia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,HW,Health workers,NATIONAL,+Y1
COL,Colombia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,HW,Health workers,NATIONAL,+Y1
COL,Colombia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
COL,Colombia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
COL,Colombia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
COL,Colombia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
COL,Colombia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
COL,Colombia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
COL,Colombia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
COL,Colombia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,+Y1
COL,Colombia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,RISKGROUPS,Risk group(s),NATIONAL,+Y1
COL,Colombia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
COL,Colombia,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
COL,Colombia,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y7
COL,Colombia,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,Y1
COL,Colombia,AMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y5
COL,Colombia,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M12-M18
COM,Comoros,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
COM,Comoros,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
COM,Comoros,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
COM,Comoros,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
COM,Comoros,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
COM,Comoros,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
COM,Comoros,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
COM,Comoros,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
COM,Comoros,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
COM,Comoros,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
COM,Comoros,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
COM,Comoros,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
COM,Comoros,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
COM,Comoros,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
COM,Comoros,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
COM,Comoros,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
COM,Comoros,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
COM,Comoros,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
COM,Comoros,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
COM,Comoros,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
COM,Comoros,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
COM,Comoros,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
CPV,Cabo Verde,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
CPV,Cabo Verde,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
CPV,Cabo Verde,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
CPV,Cabo Verde,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
CPV,Cabo Verde,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
CPV,Cabo Verde,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
CPV,Cabo Verde,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M2
CPV,Cabo Verde,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M4
CPV,Cabo Verde,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,4.0,,General/routine,NATIONAL,M6
CPV,Cabo Verde,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,5.0,,General/routine,NATIONAL,M18
CPV,Cabo Verde,AFRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10
CPV,Cabo Verde,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M4
CPV,Cabo Verde,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
CPV,Cabo Verde,AFRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M9
CPV,Cabo Verde,AFRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M15
CPV,Cabo Verde,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
CPV,Cabo Verde,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M2
CPV,Cabo Verde,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M4
CPV,Cabo Verde,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M6
CPV,Cabo Verde,AFRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,M18
CPV,Cabo Verde,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
CPV,Cabo Verde,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
CPV,Cabo Verde,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
CPV,Cabo Verde,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
CPV,Cabo Verde,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
CPV,Cabo Verde,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
CPV,Cabo Verde,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
CPV,Cabo Verde,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
CPV,Cabo Verde,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
CPV,Cabo Verde,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
CPV,Cabo Verde,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M12
CRI,Costa Rica,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
CRI,Costa Rica,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
CRI,Costa Rica,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
CRI,Costa Rica,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
CRI,Costa Rica,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15
CRI,Costa Rica,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
CRI,Costa Rica,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M2
CRI,Costa Rica,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
CRI,Costa Rica,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
CRI,Costa Rica,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M2
CRI,Costa Rica,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
CRI,Costa Rica,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10
CRI,Costa Rica,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
CRI,Costa Rica,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y58
CRI,Costa Rica,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
CRI,Costa Rica,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
CRI,Costa Rica,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CRI,Costa Rica,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y6
CRI,Costa Rica,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M15
CRI,Costa Rica,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y4
CRI,Costa Rica,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
CRI,Costa Rica,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
CRI,Costa Rica,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M15
CRI,Costa Rica,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,HW,Health workers,NATIONAL,
CRI,Costa Rica,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
CRI,Costa Rica,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
CRI,Costa Rica,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
CRI,Costa Rica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,ADULTS,Adults,NATIONAL,+Y10
CRI,Costa Rica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y20
CRI,Costa Rica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+Y10
CRI,Costa Rica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+Y10
CRI,Costa Rica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y10
CRI,Costa Rica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y10
CRI,Costa Rica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y10
CRI,Costa Rica,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,HW,Health workers,NATIONAL,
CRI,Costa Rica,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
CRI,Costa Rica,AMRO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y4
CRI,Costa Rica,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M15
CUB,Cuba,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
CUB,Cuba,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y6
CUB,Cuba,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
CUB,Cuba,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
CUB,Cuba,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
CUB,Cuba,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
CUB,Cuba,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
CUB,Cuba,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
CUB,Cuba,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
CUB,Cuba,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
CUB,Cuba,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
CUB,Cuba,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
CUB,Cuba,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
CUB,Cuba,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
CUB,Cuba,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M2
CUB,Cuba,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,Y1
CUB,Cuba,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M1
CUB,Cuba,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
CUB,Cuba,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
CUB,Cuba,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
CUB,Cuba,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
CUB,Cuba,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
CUB,Cuba,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
CUB,Cuba,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
CUB,Cuba,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CUB,Cuba,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y2
CUB,Cuba,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,Y2-Y5
CUB,Cuba,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CUB,Cuba,AMRO,2023,IPV_FRAC,IPVf (Inactivated polio vaccine fractional dose),1.0,,General/routine,NATIONAL,M4
CUB,Cuba,AMRO,2023,IPV_FRAC,IPVf (Inactivated polio vaccine fractional dose),2.0,,General/routine,NATIONAL,M8
CUB,Cuba,AMRO,2023,LEPTOSPIROSIS,Leptospirosis,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CUB,Cuba,AMRO,2023,MEN_BC,Meningococcal BC vaccine,1.0,,General/routine,NATIONAL,M3
CUB,Cuba,AMRO,2023,MEN_BC,Meningococcal BC vaccine,2.0,,General/routine,NATIONAL,M5
CUB,Cuba,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,Y1
CUB,Cuba,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
CUB,Cuba,AMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,<Y1
CUB,Cuba,AMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,Y1
CUB,Cuba,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,Y2
CUB,Cuba,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,Y9
CUB,Cuba,AMRO,2023,TT,TT (Tetanus toxoid) vaccine,2.0,ADULTS,Adults,NATIONAL,Y25
CUB,Cuba,AMRO,2023,TT,TT (Tetanus toxoid) vaccine,3.0,ADULTS,Adults,NATIONAL,Y35
CUB,Cuba,AMRO,2023,TT,TT (Tetanus toxoid) vaccine,4.0,ADULTS,Adults,NATIONAL,Y45
CUB,Cuba,AMRO,2023,TT,TT (Tetanus toxoid) vaccine,5.0,ADULTS,Adults,NATIONAL,Y45
CUB,Cuba,AMRO,2023,TT,TT (Tetanus toxoid) vaccine,6.0,ADULTS,Adults,NATIONAL,Y65
CUB,Cuba,AMRO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,,General/routine,NATIONAL,Y14
CUB,Cuba,AMRO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,,General/routine,NATIONAL,Y10
CUB,Cuba,AMRO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,2.0,,General/routine,NATIONAL,Y13
CUB,Cuba,AMRO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,3.0,,General/routine,NATIONAL,Y16
CUB,Cuba,AMRO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CUW,Curaçao,AMRO,2019,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y4
CUW,Curaçao,AMRO,2019,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3.5
CUW,Curaçao,AMRO,2019,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15
CUW,Curaçao,AMRO,2019,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M5.5
CUW,Curaçao,AMRO,2019,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
CUW,Curaçao,AMRO,2019,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
CUW,Curaçao,AMRO,2019,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
CUW,Curaçao,AMRO,2019,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
CUW,Curaçao,AMRO,2019,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
CUW,Curaçao,AMRO,2019,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
CUW,Curaçao,AMRO,2019,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
CUW,Curaçao,AMRO,2019,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
CUW,Curaçao,AMRO,2019,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
CUW,Curaçao,AMRO,2019,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
CUW,Curaçao,AMRO,2019,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M15
CUW,Curaçao,AMRO,2019,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M15
CUW,Curaçao,AMRO,2019,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4
CUW,Curaçao,AMRO,2019,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M3.5
CUW,Curaçao,AMRO,2019,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M5.5
CUW,Curaçao,AMRO,2019,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M3.5
CUW,Curaçao,AMRO,2019,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12
CUW,Curaçao,AMRO,2019,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M5.5
CUW,Curaçao,AMRO,2019,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y10
CUW,Curaçao,AMRO,2019,YF,YF (Yellow fever) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
CYM,Cayman Islands,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,W6
CYM,Cayman Islands,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
CYM,Cayman Islands,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
CYM,Cayman Islands,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
CYM,Cayman Islands,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15
CYM,Cayman Islands,AMRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y6
CYM,Cayman Islands,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
CYM,Cayman Islands,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+M6-M12
CYM,Cayman Islands,AMRO,2023,HEPA_HEPB,"Hepatitis A, Hepatitis B vaccine",1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
CYM,Cayman Islands,AMRO,2023,HEPA_HEPB,"Hepatitis A, Hepatitis B vaccine",2.0,TRAVELLERS,Travellers,NATIONAL,+M1
CYM,Cayman Islands,AMRO,2023,HEPA_HEPB,"Hepatitis A, Hepatitis B vaccine",3.0,TRAVELLERS,Travellers,NATIONAL,+M6-M12
CYM,Cayman Islands,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=M12
CYM,Cayman Islands,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M6-M18
CYM,Cayman Islands,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,>=M12
CYM,Cayman Islands,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+M6-M18
CYM,Cayman Islands,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
CYM,Cayman Islands,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
CYM,Cayman Islands,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+W4
CYM,Cayman Islands,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
CYM,Cayman Islands,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+W4
CYM,Cayman Islands,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
CYM,Cayman Islands,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
CYM,Cayman Islands,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,W6
CYM,Cayman Islands,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M9
CYM,Cayman Islands,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y11-Y12
CYM,Cayman Islands,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
CYM,Cayman Islands,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
CYM,Cayman Islands,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
CYM,Cayman Islands,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
CYM,Cayman Islands,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CYM,Cayman Islands,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
CYM,Cayman Islands,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=M6
CYM,Cayman Islands,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CYM,Cayman Islands,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
CYM,Cayman Islands,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
CYM,Cayman Islands,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M15
CYM,Cayman Islands,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
CYM,Cayman Islands,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
CYM,Cayman Islands,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
CYM,Cayman Islands,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
CYM,Cayman Islands,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M12
CYM,Cayman Islands,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CYM,Cayman Islands,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
CYM,Cayman Islands,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
CYM,Cayman Islands,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,
CYM,Cayman Islands,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+W6
CYM,Cayman Islands,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
CYM,Cayman Islands,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
CYM,Cayman Islands,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y14-Y16
CYM,Cayman Islands,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
CYM,Cayman Islands,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12
CYM,Cayman Islands,AMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y3-Y4
CYM,Cayman Islands,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
CYM,Cayman Islands,AMRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M2-M6
CYM,Cayman Islands,AMRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
CYM,Cayman Islands,AMRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M2-M6
CYM,Cayman Islands,AMRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
CYP,Cyprus,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CYP,Cyprus,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2-M3
CYP,Cyprus,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4-M5
CYP,Cyprus,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6-M8
CYP,Cyprus,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18-M20
CYP,Cyprus,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y6
CYP,Cyprus,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CYP,Cyprus,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M24
CYP,Cyprus,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,M30
CYP,Cyprus,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CYP,Cyprus,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,M2-M3
CYP,Cyprus,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M4-M5
CYP,Cyprus,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6-M8
CYP,Cyprus,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,,General/routine,NATIONAL,M2-M3
CYP,Cyprus,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,,General/routine,NATIONAL,M4-M5
CYP,Cyprus,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,,General/routine,NATIONAL,M6-M8
CYP,Cyprus,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,4.0,,General/routine,NATIONAL,M18-M20
CYP,Cyprus,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y11-Y12
CYP,Cyprus,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
CYP,Cyprus,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y65
CYP,Cyprus,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
CYP,Cyprus,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
CYP,Cyprus,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CYP,Cyprus,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y15
CYP,Cyprus,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CYP,Cyprus,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,TRAVELLERS,Travellers,NATIONAL,
CYP,Cyprus,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,M12
CYP,Cyprus,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12-M15
CYP,Cyprus,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y4-Y6
CYP,Cyprus,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M3
CYP,Cyprus,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M5
CYP,Cyprus,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12-M15
CYP,Cyprus,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M3
CYP,Cyprus,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M5
CYP,Cyprus,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12-M15
CYP,Cyprus,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CYP,Cyprus,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
CYP,Cyprus,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+Y10
CYP,Cyprus,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+Y10
CYP,Cyprus,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y10
CYP,Cyprus,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y10
CYP,Cyprus,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,ADULTS,Adults,NATIONAL,+Y10
CYP,Cyprus,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,ADULTS,Adults,NATIONAL,
CYP,Cyprus,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y11-Y12
CYP,Cyprus,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
CYP,Cyprus,EURO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
CYP,Cyprus,EURO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12-M15
CYP,Cyprus,EURO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y4-Y6
CYP,Cyprus,EURO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
CZE,Czechia,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M1
CZE,Czechia,EURO,2023,DTAP,DTaP (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y5
CZE,Czechia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M3
CZE,Czechia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M5
CZE,Czechia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M11
CZE,Czechia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
CZE,Czechia,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y13
CZE,Czechia,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M5-M13
CZE,Czechia,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y13
CZE,Czechia,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
CZE,Czechia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
CZE,Czechia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
CZE,Czechia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
CZE,Czechia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CZE,Czechia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
CZE,Czechia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M13
CZE,Czechia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y5
CZE,Czechia,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y10
CZE,Czechia,EURO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,ADULTS,Adults,NATIONAL,
CZE,Czechia,EURO,2023,TT,TT (Tetanus toxoid) vaccine,6.0,ADULTS,Adults,NATIONAL,Y25
DEU,Germany,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,<=Y4
DEU,Germany,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
DEU,Germany,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M11
DEU,Germany,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
DEU,Germany,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M3
DEU,Germany,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,HW,Health workers,NATIONAL,
DEU,Germany,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DEU,Germany,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DEU,Germany,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
DEU,Germany,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DEU,Germany,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
DEU,Germany,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DEU,Germany,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,Y15-Y17
DEU,Germany,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M5
DEU,Germany,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9-Y14
DEU,Germany,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,Y15-Y17
DEU,Germany,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M5
DEU,Germany,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9-Y14
DEU,Germany,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,Y15-Y17
DEU,Germany,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M5
DEU,Germany,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9-Y14
DEU,Germany,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
DEU,Germany,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
DEU,Germany,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
DEU,Germany,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DEU,Germany,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DEU,Germany,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DEU,Germany,EURO,2023,MEN_B,Meningococcal B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DEU,Germany,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,<=Y17
DEU,Germany,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,,General/routine,NATIONAL,M12
DEU,Germany,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,ADULTS,Adults,NATIONAL,
DEU,Germany,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,CATCHUP_C,Catch-up children,NATIONAL,<=Y17
DEU,Germany,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M11
DEU,Germany,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,HW,Health workers,NATIONAL,
DEU,Germany,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
DEU,Germany,EURO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",1.0,CATCHUP_C,Catch-up children,NATIONAL,<=Y17
DEU,Germany,EURO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",2.0,,General/routine,NATIONAL,M15
DEU,Germany,EURO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y18
DEU,Germany,EURO,2023,MPOX,Mpox (monkeypox) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y18
DEU,Germany,EURO,2023,PCV_15_VALENT,PCV-15 (Pneumococcal conjugate vaccine 15-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y2-Y17
DEU,Germany,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,<=Y4
DEU,Germany,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
DEU,Germany,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M11
DEU,Germany,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
DEU,Germany,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M3
DEU,Germany,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,<=Y4
DEU,Germany,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
DEU,Germany,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
DEU,Germany,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M11
DEU,Germany,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M3
DEU,Germany,EURO,2023,PCV20,PCV-20 (Pneumococcal conjugate vaccine 20-valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
DEU,Germany,EURO,2023,PCV20,PCV-20 (Pneumococcal conjugate vaccine 20-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DEU,Germany,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y2-Y17
DEU,Germany,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,W12-W32
DEU,Germany,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M3
DEU,Germany,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
DEU,Germany,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,W12-W32
DEU,Germany,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M3
DEU,Germany,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M4
DEU,Germany,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,W6
DEU,Germany,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,1.0,ADULTS,Adults,SUBNATIONAL,
DEU,Germany,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,
DEU,Germany,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,1.0,ADULTS,Adults,SUBNATIONAL,
DEU,Germany,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,
DEU,Germany,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y18
DEU,Germany,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",2.0,ADULTS,Adults,NATIONAL,+Y10
DEU,Germany,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,CATCHUP_C,Catch-up children,NATIONAL,<=Y8
DEU,Germany,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",4.0,B_CHILD_W,General/routine,NATIONAL,Y5-Y6
DEU,Germany,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
DEU,Germany,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",1.0,CATCHUP_C,Catch-up children,NATIONAL,<=Y17
DEU,Germany,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y9-Y16
DEU,Germany,EURO,2023,VARICELLA,Varicella vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,<=Y17
DEU,Germany,EURO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M11
DEU,Germany,EURO,2023,VARICELLA,Varicella vaccine,1.0,HW,Health workers,NATIONAL,
DEU,Germany,EURO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DEU,Germany,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
DEU,Germany,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,2.0,ADULTS,Adults,NATIONAL,>=Y60
DEU,Germany,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y50
DJI,Djibouti,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
DJI,Djibouti,EMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15
DJI,Djibouti,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
DJI,Djibouti,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
DJI,Djibouti,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
DJI,Djibouti,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
DJI,Djibouti,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
DJI,Djibouti,EMRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
DJI,Djibouti,EMRO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,M15
DJI,Djibouti,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
DJI,Djibouti,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
DJI,Djibouti,EMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
DJI,Djibouti,EMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,M15
DJI,Djibouti,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
DJI,Djibouti,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
DJI,Djibouti,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
DJI,Djibouti,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
DJI,Djibouti,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
DJI,Djibouti,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
DJI,Djibouti,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
DJI,Djibouti,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
DJI,Djibouti,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
DJI,Djibouti,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
DJI,Djibouti,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
DJI,Djibouti,EMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M9
DJI,Djibouti,EMRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M15
DMA,Dominica,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B-Y1
DMA,Dominica,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
DMA,Dominica,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
DMA,Dominica,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
DMA,Dominica,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
DMA,Dominica,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,RISKGROUPS,Risk group(s),NATIONAL,Y3
DMA,Dominica,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,1.0,B_2YL_W,General/routine,NATIONAL,M18
DMA,Dominica,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,2.0,B_CHILD_F,General/routine,NATIONAL,Y3
DMA,Dominica,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
DMA,Dominica,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
DMA,Dominica,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
DMA,Dominica,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
DMA,Dominica,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
DMA,Dominica,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M5
DMA,Dominica,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
DMA,Dominica,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M5
DMA,Dominica,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
DMA,Dominica,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
DMA,Dominica,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y10-Y12
DMA,Dominica,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
DMA,Dominica,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
DMA,Dominica,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
DMA,Dominica,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DMA,Dominica,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M35
DMA,Dominica,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>Y3
DMA,Dominica,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DMA,Dominica,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
DMA,Dominica,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
DMA,Dominica,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
DMA,Dominica,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
DMA,Dominica,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
DMA,Dominica,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
DMA,Dominica,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y3
DMA,Dominica,AMRO,2023,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,Y10-Y12
DMA,Dominica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
DMA,Dominica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
DMA,Dominica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M5
DMA,Dominica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+W4-W6
DMA,Dominica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
DMA,Dominica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y10-Y12
DMA,Dominica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,1st contact
DMA,Dominica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
DMA,Dominica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
DMA,Dominica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M5
DMA,Dominica,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
DNK,Denmark,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M3
DNK,Denmark,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M5
DNK,Denmark,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M12
DNK,Denmark,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y5
DNK,Denmark,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
DNK,Denmark,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
DNK,Denmark,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
DNK,Denmark,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
DNK,Denmark,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M1
DNK,Denmark,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M2
DNK,Denmark,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,M12
DNK,Denmark,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,<=Y18
DNK,Denmark,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M5-M13
DNK,Denmark,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y12-Y14
DNK,Denmark,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,Y65-Y84
DNK,Denmark,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
DNK,Denmark,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
DNK,Denmark,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DNK,Denmark,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,Y2-Y6
DNK,Denmark,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DNK,Denmark,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y4
DNK,Denmark,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M15
DNK,Denmark,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y18
DNK,Denmark,EURO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
DNK,Denmark,EURO,2023,MPOX,Mpox (monkeypox) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+D28
DNK,Denmark,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M3
DNK,Denmark,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M5
DNK,Denmark,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
DNK,Denmark,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
DNK,Denmark,EURO,2023,PCV20,PCV-20 (Pneumococcal conjugate vaccine 20-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
DNK,Denmark,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
DNK,Denmark,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+Y6
DNK,Denmark,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
DOM,Dominican Republic,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
DOM,Dominican Republic,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
DOM,Dominican Republic,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
DOM,Dominican Republic,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
DOM,Dominican Republic,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
DOM,Dominican Republic,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
DOM,Dominican Republic,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
DOM,Dominican Republic,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
DOM,Dominican Republic,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
DOM,Dominican Republic,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
DOM,Dominican Republic,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
DOM,Dominican Republic,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
DOM,Dominican Republic,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
DOM,Dominican Republic,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
DOM,Dominican Republic,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
DOM,Dominican Republic,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
DOM,Dominican Republic,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9-Y14
DOM,Dominican Republic,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
DOM,Dominican Republic,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
DOM,Dominican Republic,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
DOM,Dominican Republic,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DOM,Dominican Republic,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,M12-M23
DOM,Dominican Republic,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M11
DOM,Dominican Republic,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DOM,Dominican Republic,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
DOM,Dominican Republic,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
DOM,Dominican Republic,AMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
DOM,Dominican Republic,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,HW,Health workers,NATIONAL,
DOM,Dominican Republic,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DOM,Dominican Republic,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
DOM,Dominican Republic,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
DOM,Dominican Republic,AMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y2
DOM,Dominican Republic,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
DOM,Dominican Republic,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4
DOM,Dominican Republic,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
DOM,Dominican Republic,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
DOM,Dominican Republic,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
DOM,Dominican Republic,AMRO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
DOM,Dominican Republic,AMRO,2023,RABIES,Rabies vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+D3
DOM,Dominican Republic,AMRO,2023,RABIES,Rabies vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+D7
DOM,Dominican Republic,AMRO,2023,RABIES,Rabies vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,+D14
DOM,Dominican Republic,AMRO,2023,RABIES,Rabies vaccine,5.0,RISKGROUPS,Risk group(s),NATIONAL,+D28
DOM,Dominican Republic,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
DOM,Dominican Republic,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
DOM,Dominican Republic,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
DOM,Dominican Republic,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
DOM,Dominican Republic,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
DOM,Dominican Republic,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
DOM,Dominican Republic,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,ADULTS,Adults,NATIONAL,+Y10
DOM,Dominican Republic,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
DOM,Dominican Republic,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
DOM,Dominican Republic,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
DOM,Dominican Republic,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
DOM,Dominican Republic,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,+Y1
DOM,Dominican Republic,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
DOM,Dominican Republic,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,RISKGROUPS,Risk group(s),NATIONAL,+Y1
DOM,Dominican Republic,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y7
DOM,Dominican Republic,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
DOM,Dominican Republic,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,Y1-Y59
DZA,Algeria,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
DZA,Algeria,AFRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
DZA,Algeria,AFRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
DZA,Algeria,AFRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M12
DZA,Algeria,AFRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y6
DZA,Algeria,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
DZA,Algeria,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
DZA,Algeria,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
DZA,Algeria,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
DZA,Algeria,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DZA,Algeria,AFRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
DZA,Algeria,AFRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M11
DZA,Algeria,AFRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
DZA,Algeria,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M2
DZA,Algeria,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M4
DZA,Algeria,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M12
DZA,Algeria,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
DZA,Algeria,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
DZA,Algeria,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
DZA,Algeria,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_ADO_W,General/routine,NATIONAL,Y11-Y13
DZA,Algeria,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,,General/routine,NATIONAL,Y16-Y18
ECU,Ecuador,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,<Y1
ECU,Ecuador,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M12-M23
ECU,Ecuador,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5
ECU,Ecuador,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
ECU,Ecuador,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
ECU,Ecuador,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
ECU,Ecuador,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
ECU,Ecuador,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
ECU,Ecuador,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
ECU,Ecuador,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
ECU,Ecuador,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
ECU,Ecuador,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
ECU,Ecuador,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,Y1-Y5
ECU,Ecuador,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,CATCHUP_C,Catch-up children,NATIONAL,+M2
ECU,Ecuador,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,CATCHUP_C,Catch-up children,NATIONAL,+M6
ECU,Ecuador,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
ECU,Ecuador,AMRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
ECU,Ecuador,AMRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
ECU,Ecuador,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
ECU,Ecuador,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
ECU,Ecuador,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
ECU,Ecuador,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ECU,Ecuador,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M11
ECU,Ecuador,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>M12
ECU,Ecuador,AMRO,2023,IPV_FRAC,IPVf (Inactivated polio vaccine fractional dose),1.0,CATCHUP_C,Catch-up children,NATIONAL,Y1-Y5
ECU,Ecuador,AMRO,2023,IPV_FRAC,IPVf (Inactivated polio vaccine fractional dose),2.0,,General/routine,NATIONAL,M4
ECU,Ecuador,AMRO,2023,IPV_FRAC,IPVf (Inactivated polio vaccine fractional dose),1.0,,General/routine,NATIONAL,M2
ECU,Ecuador,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,CATCHUP_C,Catch-up children,NATIONAL,Y2-Y7
ECU,Ecuador,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,CATCHUP_C,Catch-up children,NATIONAL,+M1
ECU,Ecuador,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
ECU,Ecuador,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
ECU,Ecuador,AMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,Y8-Y49
ECU,Ecuador,AMRO,2023,OPV,OPV (Oral polio vaccine),1.0,CATCHUP_C,Catch-up children,NATIONAL,Y1-Y5
ECU,Ecuador,AMRO,2023,OPV,OPV (Oral polio vaccine),2.0,CATCHUP_C,Catch-up children,NATIONAL,Y1-Y5
ECU,Ecuador,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,CATCHUP_C,Catch-up children,NATIONAL,Y1-Y5
ECU,Ecuador,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
ECU,Ecuador,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M12-M23
ECU,Ecuador,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y5
ECU,Ecuador,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
ECU,Ecuador,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
ECU,Ecuador,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M6
ECU,Ecuador,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
ECU,Ecuador,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
ECU,Ecuador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
ECU,Ecuador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
ECU,Ecuador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
ECU,Ecuador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
ECU,Ecuador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
ECU,Ecuador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
ECU,Ecuador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y15
ECU,Ecuador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
ECU,Ecuador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
ECU,Ecuador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
ECU,Ecuador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,Y16-Y49
ECU,Ecuador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
ECU,Ecuador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
ECU,Ecuador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
ECU,Ecuador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
ECU,Ecuador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
ECU,Ecuador,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12-M23
ECU,Ecuador,AMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6-M11
ECU,Ecuador,AMRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12-M59
ECU,Ecuador,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M12-M23
EGY,Egypt,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
EGY,Egypt,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
EGY,Egypt,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
EGY,Egypt,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
EGY,Egypt,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
EGY,Egypt,EMRO,2023,DTWP,DTwP (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
EGY,Egypt,EMRO,2023,DTWP,DTwP (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
EGY,Egypt,EMRO,2023,DTWP,DTwP (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
EGY,Egypt,EMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
EGY,Egypt,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
EGY,Egypt,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
EGY,Egypt,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
EGY,Egypt,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
EGY,Egypt,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
EGY,Egypt,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
EGY,Egypt,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
EGY,Egypt,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M2
EGY,Egypt,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M4
EGY,Egypt,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,4.0,,General/routine,NATIONAL,M6
EGY,Egypt,EMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
EGY,Egypt,EMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
EGY,Egypt,EMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
EGY,Egypt,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
EGY,Egypt,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
EGY,Egypt,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
EGY,Egypt,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
EGY,Egypt,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=M6
EGY,Egypt,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
EGY,Egypt,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
EGY,Egypt,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
EGY,Egypt,EMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
EGY,Egypt,EMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
EGY,Egypt,EMRO,2023,MEN_AC_PS,Meningococcal AC polysaccharide vaccine,1.0,,General/routine,NATIONAL,Y4
EGY,Egypt,EMRO,2023,MEN_AC_PS,Meningococcal AC polysaccharide vaccine,2.0,,General/routine,NATIONAL,Y6
EGY,Egypt,EMRO,2023,MEN_AC_PS,Meningococcal AC polysaccharide vaccine,3.0,,General/routine,NATIONAL,Y12
EGY,Egypt,EMRO,2023,MEN_AC_PS,Meningococcal AC polysaccharide vaccine,4.0,,General/routine,NATIONAL,Y15
EGY,Egypt,EMRO,2023,MEN_ACYW_135PS,Meningococcal ACYW polysaccharide vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
EGY,Egypt,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
EGY,Egypt,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
EGY,Egypt,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
EGY,Egypt,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M2
EGY,Egypt,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M4
EGY,Egypt,EMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M6
EGY,Egypt,EMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,M9
EGY,Egypt,EMRO,2023,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,M12
EGY,Egypt,EMRO,2023,OPV,OPV (Oral polio vaccine),7.0,,General/routine,NATIONAL,M18
EGY,Egypt,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y7-Y8
EGY,Egypt,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y9-Y10
EGY,Egypt,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
EGY,Egypt,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
EGY,Egypt,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
EGY,Egypt,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
EGY,Egypt,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
EGY,Egypt,EMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
EGY,Egypt,EMRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
EGY,Egypt,EMRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
EGY,Egypt,EMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ERI,Eritrea,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
ERI,Eritrea,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
ERI,Eritrea,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
ERI,Eritrea,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
ERI,Eritrea,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
ERI,Eritrea,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
ERI,Eritrea,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
ERI,Eritrea,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
ERI,Eritrea,AFRO,2023,MEN_A_CONJ,Meningococcal A conjugate vaccine,1.0,,General/routine,NATIONAL,M18
ERI,Eritrea,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
ERI,Eritrea,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
ERI,Eritrea,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
ERI,Eritrea,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
ERI,Eritrea,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
ERI,Eritrea,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
ERI,Eritrea,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
ERI,Eritrea,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
ERI,Eritrea,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
ERI,Eritrea,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
ERI,Eritrea,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
ERI,Eritrea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
ERI,Eritrea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
ERI,Eritrea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
ERI,Eritrea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
ERI,Eritrea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
ERI,Eritrea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,>Y14
ERI,Eritrea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
ERI,Eritrea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
ERI,Eritrea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
ERI,Eritrea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
ERI,Eritrea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
ERI,Eritrea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
ERI,Eritrea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
ERI,Eritrea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
ERI,Eritrea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
ERI,Eritrea,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
ERI,Eritrea,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
ERI,Eritrea,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
ERI,Eritrea,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
ERI,Eritrea,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
ERI,Eritrea,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
ESP,Spain,EURO,2023,CHOLERA,Cholera vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ESP,Spain,EURO,2023,DTAPHEPBIPV,DTaP-HepB-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,SUBNATIONAL,Y6
ESP,Spain,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
ESP,Spain,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
ESP,Spain,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M11
ESP,Spain,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y6
ESP,Spain,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ESP,Spain,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,SUBNATIONAL,M24-Y6
ESP,Spain,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,SUBNATIONAL,M15
ESP,Spain,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ESP,Spain,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
ESP,Spain,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ESP,Spain,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
ESP,Spain,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ESP,Spain,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y12
ESP,Spain,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
ESP,Spain,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>Y26
ESP,Spain,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,>Y26
ESP,Spain,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,>Y26
ESP,Spain,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y12
ESP,Spain,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
ESP,Spain,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y12
ESP,Spain,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
ESP,Spain,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>Y26
ESP,Spain,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1-M2
ESP,Spain,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
ESP,Spain,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
ESP,Spain,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
ESP,Spain,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
ESP,Spain,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ESP,Spain,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ESP,Spain,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,TRAVELLERS,Travellers,NATIONAL,
ESP,Spain,EURO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ESP,Spain,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,3.0,,General/routine,NATIONAL,Y12
ESP,Spain,EURO,2023,MEN_B,Meningococcal B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ESP,Spain,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,,General/routine,NATIONAL,M4
ESP,Spain,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,2.0,,General/routine,SUBNATIONAL,M12
ESP,Spain,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,SUBNATIONAL,M12
ESP,Spain,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,SUBNATIONAL,Y3-Y4
ESP,Spain,EURO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",1.0,,General/routine,SUBNATIONAL,M12-M15
ESP,Spain,EURO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",2.0,,General/routine,SUBNATIONAL,Y3-Y4
ESP,Spain,EURO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>Y18
ESP,Spain,EURO,2023,MPOX,Mpox (monkeypox) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
ESP,Spain,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
ESP,Spain,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
ESP,Spain,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M11
ESP,Spain,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>Y64
ESP,Spain,EURO,2023,RABIES,Rabies vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ESP,Spain,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ESP,Spain,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
ESP,Spain,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_ADO_W,General/routine,NATIONAL,Y14
ESP,Spain,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ESP,Spain,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,HW,Health workers,NATIONAL,
ESP,Spain,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
ESP,Spain,EURO,2023,TYPHOID_CONJ,Typhoid conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ESP,Spain,EURO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ESP,Spain,EURO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,SUBNATIONAL,M15
ESP,Spain,EURO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,SUBNATIONAL,Y3-Y4
ESP,Spain,EURO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ESP,Spain,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y65-Y80
ESP,Spain,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M6
ESP,Spain,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,>=Y60
EST,Estonia,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,D1-D5
EST,Estonia,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
EST,Estonia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M3
EST,Estonia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4.5
EST,Estonia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
EST,Estonia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,4.0,B_2YL_F,General/routine,NATIONAL,Y2
EST,Estonia,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y6-Y7
EST,Estonia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
EST,Estonia,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
EST,Estonia,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,
EST,Estonia,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,Y12
EST,Estonia,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y12
EST,Estonia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
EST,Estonia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
EST,Estonia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
EST,Estonia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
EST,Estonia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
EST,Estonia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
EST,Estonia,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,RISKGROUPS,Risk group(s),NATIONAL,M3
EST,Estonia,EURO,2023,IPV,IPV (Inactivated polio vaccine),2.0,RISKGROUPS,Risk group(s),NATIONAL,M4.5
EST,Estonia,EURO,2023,IPV,IPV (Inactivated polio vaccine),3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
EST,Estonia,EURO,2023,IPV,IPV (Inactivated polio vaccine),4.0,RISKGROUPS,Risk group(s),NATIONAL,Y2
EST,Estonia,EURO,2023,IPV,IPV (Inactivated polio vaccine),5.0,RISKGROUPS,Risk group(s),NATIONAL,Y6-Y7
EST,Estonia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,Y1
EST,Estonia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y13
EST,Estonia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
EST,Estonia,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
EST,Estonia,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M3
EST,Estonia,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M4.5
EST,Estonia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y25
EST,Estonia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+Y10
EST,Estonia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+Y10
EST,Estonia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y10
EST,Estonia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y10
EST,Estonia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,ADULTS,Adults,NATIONAL,+Y10
EST,Estonia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y15-Y16
EST,Estonia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
EST,Estonia,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,ADULTS,Adults,NATIONAL,Y15-Y16
EST,Estonia,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y15-Y16
ETH,Ethiopia,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
ETH,Ethiopia,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
ETH,Ethiopia,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
ETH,Ethiopia,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
ETH,Ethiopia,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
ETH,Ethiopia,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
ETH,Ethiopia,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
ETH,Ethiopia,AFRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
ETH,Ethiopia,AFRO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,M15
ETH,Ethiopia,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
ETH,Ethiopia,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
ETH,Ethiopia,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
ETH,Ethiopia,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
ETH,Ethiopia,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
ETH,Ethiopia,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
ETH,Ethiopia,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
ETH,Ethiopia,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
ETH,Ethiopia,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
ETH,Ethiopia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
ETH,Ethiopia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
ETH,Ethiopia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
ETH,Ethiopia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
ETH,Ethiopia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+W4
ETH,Ethiopia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+W4
ETH,Ethiopia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,1st contact
ETH,Ethiopia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
ETH,Ethiopia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
ETH,Ethiopia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
ETH,Ethiopia,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
ETH,Ethiopia,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
ETH,Ethiopia,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
ETH,Ethiopia,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
ETH,Ethiopia,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
ETH,Ethiopia,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
FIN,Finland,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,<Y7
FIN,Finland,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M3
FIN,Finland,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M5
FIN,Finland,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M12
FIN,Finland,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y4
FIN,Finland,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
FIN,Finland,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
FIN,Finland,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
FIN,Finland,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
FIN,Finland,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,<Y18
FIN,Finland,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,Y10-Y12
FIN,Finland,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y10-Y12
FIN,Finland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
FIN,Finland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
FIN,Finland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
FIN,Finland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
FIN,Finland,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y7
FIN,Finland,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,RISKGROUPS,Risk group(s),NATIONAL,
FIN,Finland,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,TRAVELLERS,Travellers,NATIONAL,
FIN,Finland,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
FIN,Finland,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
FIN,Finland,EURO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",2.0,,General/routine,NATIONAL,Y6
FIN,Finland,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M3
FIN,Finland,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M5
FIN,Finland,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12
FIN,Finland,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
FIN,Finland,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,<Y5
FIN,Finland,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
FIN,Finland,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M3
FIN,Finland,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M5
FIN,Finland,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,1.0,,General/routine,SUBNATIONAL,>=Y3
FIN,Finland,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,1.0,,General/routine,SUBNATIONAL,>=Y3
FIN,Finland,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y45
FIN,Finland,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,Y65
FIN,Finland,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+Y10
FIN,Finland,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,ADULTS,Adults,NATIONAL,Y25
FIN,Finland,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y14-Y15
FIN,Finland,EURO,2023,VARICELLA,Varicella vaccine,2.0,CATCHUP_C,Catch-up children,NATIONAL,Y1.5-Y11
FIN,Finland,EURO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M18
FJI,Fiji,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,<M12
FJI,Fiji,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
FJI,Fiji,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,<Y8
FJI,Fiji,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
FJI,Fiji,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
FJI,Fiji,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
FJI,Fiji,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
FJI,Fiji,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+W6
FJI,Fiji,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+W14
FJI,Fiji,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
FJI,Fiji,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M12
FJI,Fiji,WPRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y8-Y13
FJI,Fiji,WPRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
FJI,Fiji,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
FJI,Fiji,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
FJI,Fiji,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
FJI,Fiji,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
FJI,Fiji,WPRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M12
FJI,Fiji,WPRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
FJI,Fiji,WPRO,2023,MR,MR (Measles and rubella) vaccine,3.0,,General/routine,NATIONAL,Y6
FJI,Fiji,WPRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
FJI,Fiji,WPRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
FJI,Fiji,WPRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
FJI,Fiji,WPRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
FJI,Fiji,WPRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,W6
FJI,Fiji,WPRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,W10
FJI,Fiji,WPRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,W14
FJI,Fiji,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,<Y2
FJI,Fiji,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
FJI,Fiji,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W14
FJI,Fiji,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y6
FJI,Fiji,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_ADO_W,General/routine,NATIONAL,Y11
FJI,Fiji,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,
FJI,Fiji,WPRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M12
FJI,Fiji,WPRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M18
FJI,Fiji,WPRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M24
FJI,Fiji,WPRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M30
FJI,Fiji,WPRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M36
FJI,Fiji,WPRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M42
FRA,France,EURO,2023,AP,aP (acellular pertussis) vaccine,1.0,PW,Pregnant women,NATIONAL,
FRA,France,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,SUBNATIONAL,M1-M2
FRA,France,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
FRA,France,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
FRA,France,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M11
FRA,France,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y6
FRA,France,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
FRA,France,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M6-M12
FRA,France,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
FRA,France,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
FRA,France,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
FRA,France,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
FRA,France,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
FRA,France,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
FRA,France,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
FRA,France,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y11-Y14
FRA,France,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
FRA,France,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
FRA,France,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
FRA,France,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
FRA,France,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
FRA,France,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
FRA,France,EURO,2023,MEN_B,Meningococcal B vaccine,1.0,,General/routine,NATIONAL,M3
FRA,France,EURO,2023,MEN_B,Meningococcal B vaccine,2.0,,General/routine,NATIONAL,M5
FRA,France,EURO,2023,MEN_B,Meningococcal B vaccine,3.0,,General/routine,NATIONAL,M12
FRA,France,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,,General/routine,NATIONAL,M5
FRA,France,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,2.0,,General/routine,NATIONAL,M12
FRA,France,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
FRA,France,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
FRA,France,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
FRA,France,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
FRA,France,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M11
FRA,France,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,Y65
FRA,France,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y2-Y65
FRA,France,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
FRA,France,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M3
FRA,France,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M4
FRA,France,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,ADULTS,Adults,NATIONAL,Y25
FRA,France,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y11-Y13
FRA,France,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",6.0,ADULTS,Adults,NATIONAL,Y25
FRA,France,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y13
FRA,France,EURO,2023,TDIPV_S,"Td-IPV (Tetanus, diphtheria for older children and adults and IPV) vaccine",1.0,ADULTS,Adults,NATIONAL,Y45
FRA,France,EURO,2023,TDIPV_S,"Td-IPV (Tetanus, diphtheria for older children and adults and IPV) vaccine",2.0,ADULTS,Adults,NATIONAL,Y65
FRA,France,EURO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,SUBNATIONAL,M9
FSM,Micronesia (Federated States of),WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
FSM,Micronesia (Federated States of),WPRO,2023,DTAP,DTaP (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M12
FSM,Micronesia (Federated States of),WPRO,2023,DTAP,DTaP (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,>=Y4
FSM,Micronesia (Federated States of),WPRO,2023,DTAPHEPBIPV,DTaP-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
FSM,Micronesia (Federated States of),WPRO,2023,DTAPHEPBIPV,DTaP-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
FSM,Micronesia (Federated States of),WPRO,2023,DTAPHEPBIPV,DTaP-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
FSM,Micronesia (Federated States of),WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
FSM,Micronesia (Federated States of),WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,,General/routine,NATIONAL,M2
FSM,Micronesia (Federated States of),WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,,General/routine,NATIONAL,M4
FSM,Micronesia (Federated States of),WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,,General/routine,NATIONAL,M12
FSM,Micronesia (Federated States of),WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10-Y11
FSM,Micronesia (Federated States of),WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
FSM,Micronesia (Federated States of),WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
FSM,Micronesia (Federated States of),WPRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
FSM,Micronesia (Federated States of),WPRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
FSM,Micronesia (Federated States of),WPRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,>=Y4
FSM,Micronesia (Federated States of),WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
FSM,Micronesia (Federated States of),WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,>=M13
FSM,Micronesia (Federated States of),WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
FSM,Micronesia (Federated States of),WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
FSM,Micronesia (Federated States of),WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
FSM,Micronesia (Federated States of),WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M13
FSM,Micronesia (Federated States of),WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
FSM,Micronesia (Federated States of),WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
FSM,Micronesia (Federated States of),WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M6
FSM,Micronesia (Federated States of),WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,>=Y11
FSM,Micronesia (Federated States of),WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y11-Y12
GAB,Gabon,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
GAB,Gabon,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
GAB,Gabon,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
GAB,Gabon,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
GAB,Gabon,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
GAB,Gabon,AFRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
GAB,Gabon,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
GAB,Gabon,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
GAB,Gabon,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
GAB,Gabon,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
GAB,Gabon,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
GAB,Gabon,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
GAB,Gabon,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
GAB,Gabon,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
GAB,Gabon,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
GAB,Gabon,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,D28
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,W8
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,W12
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,W16
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,1.0,B_2YL_F,General/routine,NATIONAL,M40
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y16
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y1-Y15
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,W4
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,Y1
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,HIB_MEN_C_CONJ,"Hib (Haemophilus influenzae type B), Meningococcal C conjugate vaccine",1.0,,General/routine,NATIONAL,Y1
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,ADULTS,Adults,NATIONAL,Y25-Y45
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,ADULTS,Adults,NATIONAL,Y25-Y45
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,Y25-Y24
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,CATCHUP_A,Catch-up adults,NATIONAL,<Y25
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,<Y25
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y12-Y13
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,Y2-Y14
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,Y2-Y14
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,CATCHUP_A,Catch-up adults,NATIONAL,<Y25
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,<Y25
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,Y14
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,MEN_B,Meningococcal B vaccine,1.0,,General/routine,NATIONAL,W8
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,MEN_B,Meningococcal B vaccine,2.0,,General/routine,NATIONAL,W16
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,MEN_B,Meningococcal B vaccine,3.0,,General/routine,NATIONAL,Y1
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,MEN_B,Meningococcal B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y2
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,Y1
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M40
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W12
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,Y1
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>Y65
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y2-Y65
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W8
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W12
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,TDIPV_S,"Td-IPV (Tetanus, diphtheria for older children and adults and IPV) vaccine",1.0,B_ADO_W,General/routine,NATIONAL,Y14
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,TDIPV_S,"Td-IPV (Tetanus, diphtheria for older children and adults and IPV) vaccine",1.0,PW,Pregnant women,NATIONAL,
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y65
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M6-M12
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y50
GBR,United Kingdom of Great Britain and Northern Ireland,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+W8
GEO,Georgia,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B-D5
GEO,Georgia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
GEO,Georgia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M3
GEO,Georgia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M4
GEO,Georgia,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
GEO,Georgia,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5
GEO,Georgia,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,>Y18
GEO,Georgia,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
GEO,Georgia,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M3-M6
GEO,Georgia,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M3-M6
GEO,Georgia,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
GEO,Georgia,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>Y18
GEO,Georgia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
GEO,Georgia,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y10-Y12
GEO,Georgia,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
GEO,Georgia,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y13-Y46
GEO,Georgia,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M2-M6
GEO,Georgia,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
GEO,Georgia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
GEO,Georgia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
GEO,Georgia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
GEO,Georgia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
GEO,Georgia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,Y5-Y18
GEO,Georgia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M59
GEO,Georgia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
GEO,Georgia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
GEO,Georgia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y5
GEO,Georgia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>Y65
GEO,Georgia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
GEO,Georgia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
GEO,Georgia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
GEO,Georgia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
GEO,Georgia,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
GEO,Georgia,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M3
GEO,Georgia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y14
GEO,Georgia,EURO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
GHA,Ghana,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
GHA,Ghana,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
GHA,Ghana,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
GHA,Ghana,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
GHA,Ghana,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
GHA,Ghana,AFRO,2023,MEN_A_CONJ,Meningococcal A conjugate vaccine,1.0,,General/routine,NATIONAL,M18
GHA,Ghana,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
GHA,Ghana,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
GHA,Ghana,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
GHA,Ghana,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
GHA,Ghana,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
GHA,Ghana,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
GHA,Ghana,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
GHA,Ghana,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
GHA,Ghana,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
GHA,Ghana,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
GHA,Ghana,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,3.0,,General/routine,NATIONAL,W14
GHA,Ghana,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
GHA,Ghana,AFRO,2023,RTS_S,Malaria vaccine,1.0,,General/routine,SUBNATIONAL,M6
GHA,Ghana,AFRO,2023,RTS_S,Malaria vaccine,2.0,,General/routine,SUBNATIONAL,M7
GHA,Ghana,AFRO,2023,RTS_S,Malaria vaccine,3.0,,General/routine,SUBNATIONAL,M9
GHA,Ghana,AFRO,2023,RTS_S,Malaria vaccine,4.0,,General/routine,SUBNATIONAL,M18
GHA,Ghana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
GHA,Ghana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
GHA,Ghana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
GHA,Ghana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
GHA,Ghana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
GHA,Ghana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
GHA,Ghana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
GHA,Ghana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,Y15-Y49
GHA,Ghana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
GHA,Ghana,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
GHA,Ghana,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
GHA,Ghana,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
GHA,Ghana,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
GHA,Ghana,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
GHA,Ghana,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
GHA,Ghana,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
GHA,Ghana,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
GIN,Guinea,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
GIN,Guinea,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
GIN,Guinea,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
GIN,Guinea,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
GIN,Guinea,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
GIN,Guinea,AFRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
GIN,Guinea,AFRO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,M18
GIN,Guinea,AFRO,2023,MEN_A_PS,Meningococcal A polysaccharide vaccine,1.0,,General/routine,NATIONAL,M15
GIN,Guinea,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
GIN,Guinea,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
GIN,Guinea,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
GIN,Guinea,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
GIN,Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
GIN,Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
GIN,Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
GIN,Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
GIN,Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
GIN,Guinea,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
GMB,Gambia,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
GMB,Gambia,AFRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
GMB,Gambia,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
GMB,Gambia,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3
GMB,Gambia,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M4
GMB,Gambia,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
GMB,Gambia,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9-Y14
GMB,Gambia,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+Y1
GMB,Gambia,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M4
GMB,Gambia,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
GMB,Gambia,AFRO,2023,MEN_A_CONJ,Meningococcal A conjugate vaccine,1.0,,General/routine,NATIONAL,M12
GMB,Gambia,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
GMB,Gambia,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
GMB,Gambia,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
GMB,Gambia,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M2
GMB,Gambia,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M3
GMB,Gambia,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M4
GMB,Gambia,AFRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,M9
GMB,Gambia,AFRO,2023,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,M18
GMB,Gambia,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
GMB,Gambia,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M3
GMB,Gambia,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M4
GMB,Gambia,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
GMB,Gambia,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M3
GMB,Gambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
GMB,Gambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
GMB,Gambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
GMB,Gambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
GMB,Gambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
GMB,Gambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
GMB,Gambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,1st contact
GMB,Gambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
GMB,Gambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
GMB,Gambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
GMB,Gambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
GMB,Gambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
GMB,Gambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
GMB,Gambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
GMB,Gambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
GMB,Gambia,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
GMB,Gambia,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
GMB,Gambia,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
GMB,Gambia,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
GMB,Gambia,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
GMB,Gambia,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
GMB,Gambia,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
GNB,Guinea-Bissau,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
GNB,Guinea-Bissau,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
GNB,Guinea-Bissau,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
GNB,Guinea-Bissau,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
GNB,Guinea-Bissau,AFRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,W14
GNB,Guinea-Bissau,AFRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
GNB,Guinea-Bissau,AFRO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,M15-M23
GNB,Guinea-Bissau,AFRO,2023,MEN_A_CONJ,Meningococcal A conjugate vaccine,1.0,,General/routine,NATIONAL,M9
GNB,Guinea-Bissau,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
GNB,Guinea-Bissau,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
GNB,Guinea-Bissau,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
GNB,Guinea-Bissau,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
GNB,Guinea-Bissau,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
GNB,Guinea-Bissau,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
GNB,Guinea-Bissau,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
GNB,Guinea-Bissau,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
GNB,Guinea-Bissau,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
GNB,Guinea-Bissau,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
GNB,Guinea-Bissau,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
GNB,Guinea-Bissau,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
GNB,Guinea-Bissau,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
GNB,Guinea-Bissau,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
GNB,Guinea-Bissau,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,M1
GNB,Guinea-Bissau,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,M2
GNB,Guinea-Bissau,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,M6
GNB,Guinea-Bissau,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,M12
GNB,Guinea-Bissau,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,M24
GNB,Guinea-Bissau,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
GNB,Guinea-Bissau,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
GNB,Guinea-Bissau,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
GNB,Guinea-Bissau,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
GNB,Guinea-Bissau,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
GNB,Guinea-Bissau,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
GNB,Guinea-Bissau,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M11
GNB,Guinea-Bissau,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
GNB,Guinea-Bissau,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M23-M59
GNB,Guinea-Bissau,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
GNQ,Equatorial Guinea,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
GNQ,Equatorial Guinea,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
GNQ,Equatorial Guinea,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
GNQ,Equatorial Guinea,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
GNQ,Equatorial Guinea,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
GNQ,Equatorial Guinea,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,,B
GNQ,Equatorial Guinea,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
GNQ,Equatorial Guinea,AFRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
GNQ,Equatorial Guinea,AFRO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,M18
GNQ,Equatorial Guinea,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
GNQ,Equatorial Guinea,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
GNQ,Equatorial Guinea,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
GNQ,Equatorial Guinea,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
GNQ,Equatorial Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
GNQ,Equatorial Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
GNQ,Equatorial Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
GNQ,Equatorial Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
GNQ,Equatorial Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
GNQ,Equatorial Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,1st contact
GNQ,Equatorial Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
GNQ,Equatorial Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
GNQ,Equatorial Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
GNQ,Equatorial Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
GNQ,Equatorial Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
GNQ,Equatorial Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
GNQ,Equatorial Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
GNQ,Equatorial Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
GNQ,Equatorial Guinea,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
GNQ,Equatorial Guinea,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,,M12
GNQ,Equatorial Guinea,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,,M6
GNQ,Equatorial Guinea,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
GRC,Greece,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
GRC,Greece,EURO,2023,DTAP,DTaP (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
GRC,Greece,EURO,2023,DTAP,DTaP (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
GRC,Greece,EURO,2023,DTAP,DTaP (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
GRC,Greece,EURO,2023,DTAP,DTaP (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15-M18
GRC,Greece,EURO,2023,DTAP,DTaP (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y6
GRC,Greece,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y18
GRC,Greece,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
GRC,Greece,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M24
GRC,Greece,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,M30
GRC,Greece,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
GRC,Greece,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
GRC,Greece,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
GRC,Greece,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
GRC,Greece,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
GRC,Greece,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y18
GRC,Greece,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
GRC,Greece,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,TRAVELLERS,Travellers,NATIONAL,+M6
GRC,Greece,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+M1
GRC,Greece,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,M2
GRC,Greece,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M4
GRC,Greece,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6-M18
GRC,Greece,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
GRC,Greece,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,,General/routine,NATIONAL,M2
GRC,Greece,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,,General/routine,NATIONAL,M4
GRC,Greece,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,,General/routine,NATIONAL,M6
GRC,Greece,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,4.0,,General/routine,NATIONAL,M15-M18
GRC,Greece,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9-Y11
GRC,Greece,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
GRC,Greece,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
GRC,Greece,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y18-Y26
GRC,Greece,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
GRC,Greece,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
GRC,Greece,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
GRC,Greece,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
GRC,Greece,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
GRC,Greece,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>M6
GRC,Greece,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
GRC,Greece,EURO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
GRC,Greece,EURO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6-M18
GRC,Greece,EURO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,Y4-Y6
GRC,Greece,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,Y11-Y12
GRC,Greece,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,,General/routine,NATIONAL,M12
GRC,Greece,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12-M15
GRC,Greece,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M24-M47
GRC,Greece,EURO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",1.0,,General/routine,NATIONAL,M12-M15
GRC,Greece,EURO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",2.0,,General/routine,NATIONAL,M24-M47
GRC,Greece,EURO,2023,PCV_15_VALENT,PCV-15 (Pneumococcal conjugate vaccine 15-valent) vaccine,1.0,,General/routine,NATIONAL,M2
GRC,Greece,EURO,2023,PCV_15_VALENT,PCV-15 (Pneumococcal conjugate vaccine 15-valent) vaccine,2.0,,General/routine,NATIONAL,M4
GRC,Greece,EURO,2023,PCV_15_VALENT,PCV-15 (Pneumococcal conjugate vaccine 15-valent) vaccine,3.0,,General/routine,NATIONAL,M12
GRC,Greece,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
GRC,Greece,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
GRC,Greece,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
GRC,Greece,EURO,2023,PCV20,PCV-20 (Pneumococcal conjugate vaccine 20-valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
GRC,Greece,EURO,2023,PCV20,PCV-20 (Pneumococcal conjugate vaccine 20-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y19-Y64
GRC,Greece,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y2-Y18
GRC,Greece,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
GRC,Greece,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
GRC,Greece,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
GRC,Greece,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
GRC,Greece,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M6
GRC,Greece,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+Y10
GRC,Greece,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+Y10
GRC,Greece,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y10
GRC,Greece,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y10
GRC,Greece,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,ADULTS,Adults,NATIONAL,+Y10
GRC,Greece,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,ADULTS,Adults,NATIONAL,Y18-Y25
GRC,Greece,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",2.0,ADULTS,Adults,NATIONAL,+Y10
GRC,Greece,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",3.0,ADULTS,Adults,NATIONAL,+Y10
GRC,Greece,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",4.0,ADULTS,Adults,NATIONAL,+Y10
GRC,Greece,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,ADULTS,Adults,NATIONAL,+Y10
GRC,Greece,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,ADULTS,Adults,NATIONAL,+Y10
GRC,Greece,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y11-Y12
GRC,Greece,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",1.0,ADULTS,Adults,NATIONAL,Y18-Y25
GRC,Greece,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y11-Y12
GRC,Greece,EURO,2023,TDIPV_S,"Td-IPV (Tetanus, diphtheria for older children and adults and IPV) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y11-Y12
GRC,Greece,EURO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12-M15
GRC,Greece,EURO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,M24-M47
GRC,Greece,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y60-Y75
GRC,Greece,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y18
GRD,Grenada,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y4
GRD,Grenada,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
GRD,Grenada,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
GRD,Grenada,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
GRD,Grenada,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
GRD,Grenada,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
GRD,Grenada,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
GRD,Grenada,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
GRD,Grenada,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
GRD,Grenada,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
GRD,Grenada,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
GRD,Grenada,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
GRD,Grenada,AMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
GRD,Grenada,AMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
GRD,Grenada,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
GRD,Grenada,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
GRD,Grenada,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
GRD,Grenada,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
GRD,Grenada,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=M6
GRD,Grenada,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
GRD,Grenada,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
GRD,Grenada,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W6
GRD,Grenada,AMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
GRD,Grenada,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
GRD,Grenada,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
GRD,Grenada,AMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M4
GRD,Grenada,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
GRD,Grenada,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4-Y5
GRD,Grenada,AMRO,2023,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,Y14-Y15
GRD,Grenada,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y14-Y15
GRD,Grenada,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
GRD,Grenada,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
GRD,Grenada,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
GRD,Grenada,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
GRD,Grenada,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
GRD,Grenada,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
GRD,Grenada,AMRO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
GRD,Grenada,AMRO,2023,VARICELLA,Varicella vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
GRD,Grenada,AMRO,2023,VARICELLA,Varicella vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
GRD,Grenada,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,>Y1
GTM,Guatemala,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
GTM,Guatemala,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
GTM,Guatemala,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
GTM,Guatemala,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
GTM,Guatemala,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
GTM,Guatemala,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
GTM,Guatemala,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+W4
GTM,Guatemala,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
GTM,Guatemala,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
GTM,Guatemala,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
GTM,Guatemala,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+W4
GTM,Guatemala,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
GTM,Guatemala,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
GTM,Guatemala,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
GTM,Guatemala,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
GTM,Guatemala,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
GTM,Guatemala,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
GTM,Guatemala,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
GTM,Guatemala,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
GTM,Guatemala,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M11
GTM,Guatemala,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,M12-M35
GTM,Guatemala,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
GTM,Guatemala,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,CATCHUP_C,Catch-up children,NATIONAL,Y7-Y15
GTM,Guatemala,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
GTM,Guatemala,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
GTM,Guatemala,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,CATCHUP_C,Catch-up children,NATIONAL,Y7-Y10
GTM,Guatemala,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
GTM,Guatemala,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
GTM,Guatemala,AMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,HW,Health workers,NATIONAL,1st contact
GTM,Guatemala,AMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
GTM,Guatemala,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
GTM,Guatemala,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
GTM,Guatemala,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4
GTM,Guatemala,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
GTM,Guatemala,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
GTM,Guatemala,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
GTM,Guatemala,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y2
GTM,Guatemala,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y2
GTM,Guatemala,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
GTM,Guatemala,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
GTM,Guatemala,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y10
GTM,Guatemala,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,
GTM,Guatemala,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
GTM,Guatemala,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
GTM,Guatemala,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
GTM,Guatemala,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,HW,Health workers,NATIONAL,1st contact
GTM,Guatemala,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,1st contact
GTM,Guatemala,AMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
GTM,Guatemala,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,M6-Y59
GUM,Guam,WPRO,2023,DTAP,DTaP (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
GUM,Guam,WPRO,2023,DTAP,DTaP (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
GUM,Guam,WPRO,2023,DTAP,DTaP (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
GUM,Guam,WPRO,2023,DTAP,DTaP (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15-M18
GUM,Guam,WPRO,2023,DTAP,DTaP (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y6
GUM,Guam,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
GUM,Guam,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
GUM,Guam,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
GUM,Guam,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M12-M15
GUM,Guam,WPRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,ADULTS,Adults,NATIONAL,Y19
GUM,Guam,WPRO,2023,HEPA_HEPB,"Hepatitis A, Hepatitis B vaccine",1.0,ADULTS,Adults,NATIONAL,Y19
GUM,Guam,WPRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M12
GUM,Guam,WPRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,M18
GUM,Guam,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,ADULTS,Adults,NATIONAL,Y19
GUM,Guam,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,ADULTS,Adults,NATIONAL,+W4
GUM,Guam,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
GUM,Guam,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
GUM,Guam,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
GUM,Guam,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M1-M2
GUM,Guam,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6-M18
GUM,Guam,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,,General/routine,NATIONAL,M2
GUM,Guam,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,,General/routine,NATIONAL,M4
GUM,Guam,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,,General/routine,NATIONAL,M6
GUM,Guam,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,4.0,,General/routine,NATIONAL,M12-M15
GUM,Guam,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,ADULTS,Adults,NATIONAL,Y19-Y26
GUM,Guam,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1-M2
GUM,Guam,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
GUM,Guam,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,,General/routine,NATIONAL,+M6
GUM,Guam,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,,General/routine,NATIONAL,Y11-Y12
GUM,Guam,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
GUM,Guam,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
GUM,Guam,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
GUM,Guam,WPRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
GUM,Guam,WPRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6-M18
GUM,Guam,WPRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,Y4-Y6
GUM,Guam,WPRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,Y11-Y12
GUM,Guam,WPRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,,General/routine,NATIONAL,Y16
GUM,Guam,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,ADULTS,Adults,NATIONAL,Y19
GUM,Guam,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,ADULTS,Adults,NATIONAL,+M1
GUM,Guam,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y4-Y6
GUM,Guam,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12-M15
GUM,Guam,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,ADULTS,Adults,NATIONAL,Y65
GUM,Guam,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
GUM,Guam,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
GUM,Guam,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
GUM,Guam,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M12-M15
GUM,Guam,WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,Y65
GUM,Guam,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
GUM,Guam,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
GUM,Guam,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M6
GUM,Guam,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y19
GUM,Guam,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+Y10
GUM,Guam,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_CHILD_W,General/routine,NATIONAL,Y7
GUM,Guam,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,ADULTS,Adults,NATIONAL,Y19
GUM,Guam,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",2.0,ADULTS,Adults,NATIONAL,+Y10
GUM,Guam,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y11
GUM,Guam,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
GUM,Guam,WPRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y50
GUM,Guam,WPRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
GUY,Guyana,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B-W6
GUY,Guyana,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
GUY,Guyana,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
GUY,Guyana,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
GUY,Guyana,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,SUBNATIONAL,+M6
GUY,Guyana,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,SUBNATIONAL,1st contact
GUY,Guyana,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,SUBNATIONAL,+M1
GUY,Guyana,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+M6
GUY,Guyana,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+M1
GUY,Guyana,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,1st contact
GUY,Guyana,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
GUY,Guyana,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9-Y16
GUY,Guyana,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
GUY,Guyana,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
GUY,Guyana,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
GUY,Guyana,AMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
GUY,Guyana,AMRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
GUY,Guyana,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y19
GUY,Guyana,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
GUY,Guyana,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
GUY,Guyana,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
GUY,Guyana,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
GUY,Guyana,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,M45
GUY,Guyana,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
GUY,Guyana,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
GUY,Guyana,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
GUY,Guyana,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y19
GUY,Guyana,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
GUY,Guyana,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
GUY,Guyana,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
GUY,Guyana,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
GUY,Guyana,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+W4
GUY,Guyana,AMRO,2023,VARICELLA,Varicella vaccine,1.0,ADULTS,Adults,SUBNATIONAL,Y18
GUY,Guyana,AMRO,2023,VARICELLA,Varicella vaccine,2.0,ADULTS,Adults,SUBNATIONAL,+M1
GUY,Guyana,AMRO,2023,VARICELLA,Varicella vaccine,2.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+M1
GUY,Guyana,AMRO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,1st contact
GUY,Guyana,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M12
HKG,"China, Hong Kong SAR",WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
HKG,"China, Hong Kong SAR",WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
HKG,"China, Hong Kong SAR",WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
HKG,"China, Hong Kong SAR",WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
HKG,"China, Hong Kong SAR",WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
HKG,"China, Hong Kong SAR",WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y6
HKG,"China, Hong Kong SAR",WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,,General/routine,NATIONAL,>=Y16
HKG,"China, Hong Kong SAR",WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
HKG,"China, Hong Kong SAR",WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
HKG,"China, Hong Kong SAR",WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
HKG,"China, Hong Kong SAR",WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M1
HKG,"China, Hong Kong SAR",WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
HKG,"China, Hong Kong SAR",WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10
HKG,"China, Hong Kong SAR",WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,Y11
HKG,"China, Hong Kong SAR",WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y50
HKG,"China, Hong Kong SAR",WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
HKG,"China, Hong Kong SAR",WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
HKG,"China, Hong Kong SAR",WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
HKG,"China, Hong Kong SAR",WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y17
HKG,"China, Hong Kong SAR",WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
HKG,"China, Hong Kong SAR",WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
HKG,"China, Hong Kong SAR",WPRO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",2.0,,General/routine,NATIONAL,M18-Y6
HKG,"China, Hong Kong SAR",WPRO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,HW,Health workers,NATIONAL,
HKG,"China, Hong Kong SAR",WPRO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
HKG,"China, Hong Kong SAR",WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
HKG,"China, Hong Kong SAR",WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
HKG,"China, Hong Kong SAR",WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
HKG,"China, Hong Kong SAR",WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y65
HKG,"China, Hong Kong SAR",WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y65
HKG,"China, Hong Kong SAR",WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
HKG,"China, Hong Kong SAR",WPRO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y11
HKG,"China, Hong Kong SAR",WPRO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",1.0,PW,Pregnant women,NATIONAL,
HKG,"China, Hong Kong SAR",WPRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12
HND,Honduras,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
HND,Honduras,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
HND,Honduras,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
HND,Honduras,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
HND,Honduras,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,RISKGROUPS,Risk group(s),NATIONAL,Y4
HND,Honduras,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
HND,Honduras,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
HND,Honduras,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
HND,Honduras,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
HND,Honduras,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
HND,Honduras,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,HW,Health workers,NATIONAL,1st contact
HND,Honduras,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,HW,Health workers,NATIONAL,+M6
HND,Honduras,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,Y1
HND,Honduras,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
HND,Honduras,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
HND,Honduras,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
HND,Honduras,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,4.0,HW,Health workers,NATIONAL,+Y1
HND,Honduras,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
HND,Honduras,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
HND,Honduras,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,+Y1
HND,Honduras,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
HND,Honduras,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
HND,Honduras,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y11
HND,Honduras,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
HND,Honduras,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
HND,Honduras,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
HND,Honduras,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
HND,Honduras,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
HND,Honduras,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,
HND,Honduras,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,M12-M23
HND,Honduras,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
HND,Honduras,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
HND,Honduras,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
HND,Honduras,AMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
HND,Honduras,AMRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
HND,Honduras,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
HND,Honduras,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
HND,Honduras,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,>Y5
HND,Honduras,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
HND,Honduras,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
HND,Honduras,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
HND,Honduras,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
HND,Honduras,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
HND,Honduras,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
HND,Honduras,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
HND,Honduras,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_ADO_W,General/routine,NATIONAL,Y11
HND,Honduras,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
HND,Honduras,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
HND,Honduras,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
HND,Honduras,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+M24
HND,Honduras,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+M36
HND,Honduras,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+Y10
HND,Honduras,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
HND,Honduras,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,HW,Health workers,SUBNATIONAL,1st contact
HND,Honduras,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,SUBNATIONAL,1st contact
HND,Honduras,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,1st contact
HND,Honduras,AMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
HND,Honduras,AMRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
HND,Honduras,AMRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
HND,Honduras,AMRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
HND,Honduras,AMRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
HND,Honduras,AMRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
HND,Honduras,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,Y1
HRV,Croatia,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,D2
HRV,Croatia,EURO,2023,DTAP,DTaP (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y6
HRV,Croatia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
HRV,Croatia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
HRV,Croatia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
HRV,Croatia,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
HRV,Croatia,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y14
HRV,Croatia,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6-M12
HRV,Croatia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
HRV,Croatia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
HRV,Croatia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
HRV,Croatia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
HRV,Croatia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
HRV,Croatia,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,Y7
HRV,Croatia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
HRV,Croatia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y7
HRV,Croatia,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
HRV,Croatia,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
HRV,Croatia,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12
HRV,Croatia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y24
HRV,Croatia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,Y60
HRV,Croatia,EURO,2023,TDIPV_S,"Td-IPV (Tetanus, diphtheria for older children and adults and IPV) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y14
HTI,Haiti,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
HTI,Haiti,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15
HTI,Haiti,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
HTI,Haiti,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
HTI,Haiti,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
HTI,Haiti,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W6
HTI,Haiti,AMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
HTI,Haiti,AMRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M12-M23
HTI,Haiti,AMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W0
HTI,Haiti,AMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
HTI,Haiti,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
HTI,Haiti,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M9
HTI,Haiti,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
HTI,Haiti,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
HTI,Haiti,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
HTI,Haiti,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
HTI,Haiti,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
HTI,Haiti,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
HTI,Haiti,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
HTI,Haiti,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
HTI,Haiti,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
HTI,Haiti,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
HUN,Hungary,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
HUN,Hungary,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
HUN,Hungary,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M3
HUN,Hungary,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M4
HUN,Hungary,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
HUN,Hungary,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y6
HUN,Hungary,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,,General/routine,NATIONAL,Y12
HUN,Hungary,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,,General/routine,NATIONAL,+M6
HUN,Hungary,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y12
HUN,Hungary,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
HUN,Hungary,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y60
HUN,Hungary,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
HUN,Hungary,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
HUN,Hungary,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
HUN,Hungary,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
HUN,Hungary,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M15
HUN,Hungary,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y11
HUN,Hungary,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
HUN,Hungary,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
HUN,Hungary,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
HUN,Hungary,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y11
HUN,Hungary,EURO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M13
HUN,Hungary,EURO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,M16
IDN,Indonesia,SEARO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B-M1
IDN,Indonesia,SEARO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y7
IDN,Indonesia,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
IDN,Indonesia,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3
IDN,Indonesia,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M4
IDN,Indonesia,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
IDN,Indonesia,SEARO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
IDN,Indonesia,SEARO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y11
IDN,Indonesia,SEARO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,Y12
IDN,Indonesia,SEARO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M4
IDN,Indonesia,SEARO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
IDN,Indonesia,SEARO,2023,JE_LIVEATD,JE-Livatd (Japanese Encephalitis live-attenuated) vaccine,1.0,,General/routine,SUBNATIONAL,M10
IDN,Indonesia,SEARO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
IDN,Indonesia,SEARO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
IDN,Indonesia,SEARO,2023,MR,MR (Measles and rubella) vaccine,3.0,,General/routine,NATIONAL,Y7
IDN,Indonesia,SEARO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M1
IDN,Indonesia,SEARO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M2
IDN,Indonesia,SEARO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M3
IDN,Indonesia,SEARO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M4
IDN,Indonesia,SEARO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
IDN,Indonesia,SEARO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M3
IDN,Indonesia,SEARO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
IDN,Indonesia,SEARO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
IDN,Indonesia,SEARO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M3
IDN,Indonesia,SEARO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,3.0,,General/routine,NATIONAL,M4
IDN,Indonesia,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y15-Y39
IDN,Indonesia,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,Y15-Y39
IDN,Indonesia,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,Y15-Y39
IDN,Indonesia,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,Y15-Y39
IDN,Indonesia,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,Y15-Y39
IDN,Indonesia,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,Y15-Y39
IDN,Indonesia,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,Y15-Y39
IDN,Indonesia,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,Y15-Y39
IDN,Indonesia,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,B_ADO_W,General/routine,NATIONAL,Y9-Y10
IDN,Indonesia,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,Y15-Y39
IDN,Indonesia,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_CHILD_W,General/routine,NATIONAL,Y7-Y8
IDN,Indonesia,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,Y15-Y39
IDN,Indonesia,SEARO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6-M11
IDN,Indonesia,SEARO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12-M59
IND,India,SEARO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
IND,India,SEARO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M16-M24
IND,India,SEARO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5-Y6
IND,India,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
IND,India,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
IND,India,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
IND,India,SEARO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
IND,India,SEARO,2023,IPV_FRAC,IPVf (Inactivated polio vaccine fractional dose),1.0,,General/routine,NATIONAL,W6
IND,India,SEARO,2023,IPV_FRAC,IPVf (Inactivated polio vaccine fractional dose),2.0,,General/routine,NATIONAL,W14
IND,India,SEARO,2023,IPV_FRAC,IPVf (Inactivated polio vaccine fractional dose),3.0,,General/routine,NATIONAL,M9
IND,India,SEARO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,1.0,,General/routine,SUBNATIONAL,M9-M12
IND,India,SEARO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,2.0,,General/routine,SUBNATIONAL,M16-M24
IND,India,SEARO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9-M12
IND,India,SEARO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M16-M24
IND,India,SEARO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
IND,India,SEARO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
IND,India,SEARO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
IND,India,SEARO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
IND,India,SEARO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,M16-M24
IND,India,SEARO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,W6
IND,India,SEARO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,W14
IND,India,SEARO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M9
IND,India,SEARO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
IND,India,SEARO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
IND,India,SEARO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,3.0,,General/routine,NATIONAL,W14
IND,India,SEARO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,W14
IND,India,SEARO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,W6
IND,India,SEARO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,W10
IND,India,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_ADO_W,General/routine,NATIONAL,Y10
IND,India,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,Y16
IND,India,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
IND,India,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+W4
IND,India,SEARO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M9
IND,India,SEARO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M18
IND,India,SEARO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M24
IND,India,SEARO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M30
IND,India,SEARO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M36
IND,India,SEARO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M42
IRL,Ireland,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRL,Ireland,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
IRL,Ireland,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
IRL,Ireland,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
IRL,Ireland,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y4
IRL,Ireland,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M5
IRL,Ireland,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
IRL,Ireland,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
IRL,Ireland,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
IRL,Ireland,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
IRL,Ireland,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M5
IRL,Ireland,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
IRL,Ireland,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
IRL,Ireland,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M5
IRL,Ireland,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,4.0,,General/routine,NATIONAL,M13
IRL,Ireland,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRL,Ireland,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y12
IRL,Ireland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
IRL,Ireland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
IRL,Ireland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
IRL,Ireland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRL,Ireland,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,Y2-Y17
IRL,Ireland,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRL,Ireland,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,Y12
IRL,Ireland,EURO,2023,MEN_B,Meningococcal B vaccine,1.0,,General/routine,NATIONAL,M2
IRL,Ireland,EURO,2023,MEN_B,Meningococcal B vaccine,2.0,,General/routine,NATIONAL,M4
IRL,Ireland,EURO,2023,MEN_B,Meningococcal B vaccine,3.0,,General/routine,NATIONAL,M12
IRL,Ireland,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,,General/routine,NATIONAL,M6
IRL,Ireland,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,2.0,,General/routine,NATIONAL,M13
IRL,Ireland,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y4-Y5
IRL,Ireland,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
IRL,Ireland,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,HW,Health workers,NATIONAL,
IRL,Ireland,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRL,Ireland,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
IRL,Ireland,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M6
IRL,Ireland,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M13
IRL,Ireland,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
IRL,Ireland,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y2
IRL,Ireland,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
IRL,Ireland,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
IRL,Ireland,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y12-Y13
IRL,Ireland,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
IRL,Ireland,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRN,Iran (Islamic Republic of),EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
IRN,Iran (Islamic Republic of),EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
IRN,Iran (Islamic Republic of),EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
IRN,Iran (Islamic Republic of),EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
IRN,Iran (Islamic Republic of),EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,RISKGROUPS,Risk group(s),NATIONAL,M18
IRN,Iran (Islamic Republic of),EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",6.0,RISKGROUPS,Risk group(s),NATIONAL,Y6
IRN,Iran (Islamic Republic of),EMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
IRN,Iran (Islamic Republic of),EMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y6
IRN,Iran (Islamic Republic of),EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
IRN,Iran (Islamic Republic of),EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
IRN,Iran (Islamic Republic of),EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
IRN,Iran (Islamic Republic of),EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
IRN,Iran (Islamic Republic of),EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M2
IRN,Iran (Islamic Republic of),EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
IRN,Iran (Islamic Republic of),EMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
IRN,Iran (Islamic Republic of),EMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
IRN,Iran (Islamic Republic of),EMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
IRN,Iran (Islamic Republic of),EMRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,<Y25
IRN,Iran (Islamic Republic of),EMRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,<Y25
IRN,Iran (Islamic Republic of),EMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,<Y25
IRN,Iran (Islamic Republic of),EMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,<Y25
IRN,Iran (Islamic Republic of),EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y65
IRN,Iran (Islamic Republic of),EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
IRN,Iran (Islamic Republic of),EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
IRN,Iran (Islamic Republic of),EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRN,Iran (Islamic Republic of),EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M59
IRN,Iran (Islamic Republic of),EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRN,Iran (Islamic Republic of),EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M4
IRN,Iran (Islamic Republic of),EMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M6
IRN,Iran (Islamic Republic of),EMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRN,Iran (Islamic Republic of),EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
IRN,Iran (Islamic Republic of),EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
IRN,Iran (Islamic Republic of),EMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRN,Iran (Islamic Republic of),EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
IRN,Iran (Islamic Republic of),EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M2
IRN,Iran (Islamic Republic of),EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M4
IRN,Iran (Islamic Republic of),EMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M6
IRN,Iran (Islamic Republic of),EMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,M18
IRN,Iran (Islamic Republic of),EMRO,2023,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,Y6
IRN,Iran (Islamic Republic of),EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRN,Iran (Islamic Republic of),EMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRN,Iran (Islamic Republic of),EMRO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRN,Iran (Islamic Republic of),EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,Y25
IRN,Iran (Islamic Republic of),EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+Y10
IRN,Iran (Islamic Republic of),EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_ADO_W,General/routine,NATIONAL,Y15
IRN,Iran (Islamic Republic of),EMRO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRN,Iran (Islamic Republic of),EMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
IRQ,Iraq,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
IRQ,Iraq,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRQ,Iraq,EMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
IRQ,Iraq,EMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y6
IRQ,Iraq,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
IRQ,Iraq,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
IRQ,Iraq,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
IRQ,Iraq,EMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRQ,Iraq,EMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRQ,Iraq,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRQ,Iraq,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
IRQ,Iraq,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
IRQ,Iraq,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
IRQ,Iraq,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
IRQ,Iraq,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRQ,Iraq,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
IRQ,Iraq,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=M6
IRQ,Iraq,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRQ,Iraq,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M4
IRQ,Iraq,EMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M6
IRQ,Iraq,EMRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
IRQ,Iraq,EMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRQ,Iraq,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
IRQ,Iraq,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
IRQ,Iraq,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
IRQ,Iraq,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M2
IRQ,Iraq,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M4
IRQ,Iraq,EMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M6
IRQ,Iraq,EMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,M18
IRQ,Iraq,EMRO,2023,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,Y4-Y6
IRQ,Iraq,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
IRQ,Iraq,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
IRQ,Iraq,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
IRQ,Iraq,EMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRQ,Iraq,EMRO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
IRQ,Iraq,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
IRQ,Iraq,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
IRQ,Iraq,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
IRQ,Iraq,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
IRQ,Iraq,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
IRQ,Iraq,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
IRQ,Iraq,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
IRQ,Iraq,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,>Y7
IRQ,Iraq,EMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M9
IRQ,Iraq,EMRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M18
IRQ,Iraq,EMRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,Y4-Y6
IRQ,Iraq,EMRO,2023,YF,YF (Yellow fever) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISL,Iceland,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M3
ISL,Iceland,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M5
ISL,Iceland,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M12
ISL,Iceland,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
ISL,Iceland,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISL,Iceland,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y12
ISL,Iceland,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
ISL,Iceland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
ISL,Iceland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
ISL,Iceland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
ISL,Iceland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISL,Iceland,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M36
ISL,Iceland,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,Y3-Y17
ISL,Iceland,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISL,Iceland,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,M12
ISL,Iceland,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,,General/routine,NATIONAL,M6
ISL,Iceland,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,2.0,,General/routine,NATIONAL,M8
ISL,Iceland,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M18
ISL,Iceland,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y12
ISL,Iceland,EURO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,HW,Health workers,,
ISL,Iceland,EURO,2023,MPOX,Mpox (monkeypox) vaccine,2.0,HW,Health workers,,
ISL,Iceland,EURO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,RISKGROUPS,Risk group(s),,
ISL,Iceland,EURO,2023,MPOX,Mpox (monkeypox) vaccine,2.0,RISKGROUPS,Risk group(s),,
ISL,Iceland,EURO,2023,PCV_15_VALENT,PCV-15 (Pneumococcal conjugate vaccine 15-valent) vaccine,1.0,,General/routine,NATIONAL,M3
ISL,Iceland,EURO,2023,PCV_15_VALENT,PCV-15 (Pneumococcal conjugate vaccine 15-valent) vaccine,2.0,,General/routine,NATIONAL,M5
ISL,Iceland,EURO,2023,PCV_15_VALENT,PCV-15 (Pneumococcal conjugate vaccine 15-valent) vaccine,3.0,,General/routine,NATIONAL,M12
ISL,Iceland,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",4.0,B_CHILD_W,General/routine,NATIONAL,Y4
ISL,Iceland,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
ISL,Iceland,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y14
ISL,Iceland,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",1.0,PW,Pregnant women,NATIONAL,
ISL,Iceland,EURO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M18
ISL,Iceland,EURO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,M30
ISR,Israel,EURO,2022,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISR,Israel,EURO,2022,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
ISR,Israel,EURO,2022,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
ISR,Israel,EURO,2022,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
ISR,Israel,EURO,2022,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",4.0,RISKGROUPS,Risk group(s),NATIONAL,M12
ISR,Israel,EURO,2022,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
ISR,Israel,EURO,2022,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
ISR,Israel,EURO,2022,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
ISR,Israel,EURO,2022,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M12
ISR,Israel,EURO,2022,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISR,Israel,EURO,2022,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ISR,Israel,EURO,2022,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M18
ISR,Israel,EURO,2022,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,M24
ISR,Israel,EURO,2022,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISR,Israel,EURO,2022,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ISR,Israel,EURO,2022,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
ISR,Israel,EURO,2022,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M1
ISR,Israel,EURO,2022,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
ISR,Israel,EURO,2022,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISR,Israel,EURO,2022,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y13
ISR,Israel,EURO,2022,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
ISR,Israel,EURO,2022,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
ISR,Israel,EURO,2022,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
ISR,Israel,EURO,2022,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
ISR,Israel,EURO,2022,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISR,Israel,EURO,2022,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,Y5-Y18
ISR,Israel,EURO,2022,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M59
ISR,Israel,EURO,2022,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISR,Israel,EURO,2022,IPV,IPV (Inactivated polio vaccine),1.0,CATCHUP_A,Catch-up adults,NATIONAL,
ISR,Israel,EURO,2022,IPV,IPV (Inactivated polio vaccine),1.0,CATCHUP_C,Catch-up children,NATIONAL,
ISR,Israel,EURO,2022,IPV,IPV (Inactivated polio vaccine),1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISR,Israel,EURO,2022,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ISR,Israel,EURO,2022,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISR,Israel,EURO,2022,MEN_B,Meningococcal B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISR,Israel,EURO,2022,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",1.0,,General/routine,NATIONAL,M12
ISR,Israel,EURO,2022,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",2.0,,General/routine,NATIONAL,Y6
ISR,Israel,EURO,2022,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M6
ISR,Israel,EURO,2022,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M18
ISR,Israel,EURO,2022,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
ISR,Israel,EURO,2022,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
ISR,Israel,EURO,2022,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
ISR,Israel,EURO,2022,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
ISR,Israel,EURO,2022,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
ISR,Israel,EURO,2022,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISR,Israel,EURO,2022,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
ISR,Israel,EURO,2022,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
ISR,Israel,EURO,2022,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M6
ISR,Israel,EURO,2022,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ISR,Israel,EURO,2022,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ISR,Israel,EURO,2022,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,
ISR,Israel,EURO,2022,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
ISR,Israel,EURO,2022,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+Y5
ISR,Israel,EURO,2022,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y13
ISR,Israel,EURO,2022,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
ISR,Israel,EURO,2022,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISR,Israel,EURO,2022,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y7
ISR,Israel,EURO,2022,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISR,Israel,EURO,2022,TT,TT (Tetanus toxoid) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISR,Israel,EURO,2022,TYPHOID_CONJ,Typhoid conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ISR,Israel,EURO,2022,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ISR,Israel,EURO,2022,TYPHOIDHEPA,Typhoid and Hepatitis A,1.0,TRAVELLERS,Travellers,NATIONAL,
ISR,Israel,EURO,2022,VARICELLA,Varicella vaccine,1.0,CATCHUP_A,Catch-up adults,NATIONAL,
ISR,Israel,EURO,2022,VARICELLA,Varicella vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,
ISR,Israel,EURO,2022,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ISR,Israel,EURO,2022,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
ISR,Israel,EURO,2022,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
ISR,Israel,EURO,2022,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y18
ITA,Italy,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,HW,Health workers,NATIONAL,
ITA,Italy,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M3
ITA,Italy,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M5
ITA,Italy,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M11
ITA,Italy,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y6
ITA,Italy,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ITA,Italy,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,SUBNATIONAL,M13-M14
ITA,Italy,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,SUBNATIONAL,M24
ITA,Italy,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ITA,Italy,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y11
ITA,Italy,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
ITA,Italy,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ITA,Italy,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,M13-M15
ITA,Italy,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,,General/routine,NATIONAL,Y12-Y18
ITA,Italy,EURO,2023,MEN_B,Meningococcal B vaccine,1.0,,General/routine,NATIONAL,M3
ITA,Italy,EURO,2023,MEN_B,Meningococcal B vaccine,2.0,,General/routine,NATIONAL,M5-M6
ITA,Italy,EURO,2023,MEN_B,Meningococcal B vaccine,3.0,,General/routine,NATIONAL,M12-M15
ITA,Italy,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,,General/routine,NATIONAL,M13-M15
ITA,Italy,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ITA,Italy,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M13-M15
ITA,Italy,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y5-Y6
ITA,Italy,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,HW,Health workers,NATIONAL,
ITA,Italy,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
ITA,Italy,EURO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",2.0,,General/routine,NATIONAL,Y5-Y6
ITA,Italy,EURO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",1.0,,General/routine,NATIONAL,M13-M15
ITA,Italy,EURO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",1.0,HW,Health workers,NATIONAL,
ITA,Italy,EURO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
ITA,Italy,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
ITA,Italy,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M5
ITA,Italy,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M11
ITA,Italy,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M3
ITA,Italy,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ITA,Italy,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
ITA,Italy,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M3
ITA,Italy,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M5
ITA,Italy,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M3
ITA,Italy,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M5
ITA,Italy,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M7
ITA,Italy,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,ADULTS,Adults,NATIONAL,1st contact
ITA,Italy,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",2.0,ADULTS,Adults,NATIONAL,+Y10
ITA,Italy,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",3.0,ADULTS,Adults,NATIONAL,+Y10
ITA,Italy,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",4.0,ADULTS,Adults,NATIONAL,+Y10
ITA,Italy,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,ADULTS,Adults,NATIONAL,+Y10
ITA,Italy,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,ADULTS,Adults,NATIONAL,+Y10
ITA,Italy,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
ITA,Italy,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y12-Y18
ITA,Italy,EURO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y5-Y6
ITA,Italy,EURO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M13-M15
ITA,Italy,EURO,2023,VARICELLA,Varicella vaccine,1.0,HW,Health workers,NATIONAL,
ITA,Italy,EURO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ITA,Italy,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y65
JAM,Jamaica,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
JAM,Jamaica,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,W6
JAM,Jamaica,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M3
JAM,Jamaica,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
JAM,Jamaica,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
JAM,Jamaica,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,RISKGROUPS,Risk group(s),NATIONAL,Y4-Y6
JAM,Jamaica,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
JAM,Jamaica,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y6
JAM,Jamaica,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
JAM,Jamaica,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3
JAM,Jamaica,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
JAM,Jamaica,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
JAM,Jamaica,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+W4
JAM,Jamaica,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
JAM,Jamaica,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
JAM,Jamaica,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+W4
JAM,Jamaica,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
JAM,Jamaica,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
JAM,Jamaica,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M3
JAM,Jamaica,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
JAM,Jamaica,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,W6
JAM,Jamaica,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,W6
JAM,Jamaica,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M3
JAM,Jamaica,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
JAM,Jamaica,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y11-Y12
JAM,Jamaica,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
JAM,Jamaica,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
JAM,Jamaica,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
JAM,Jamaica,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
JAM,Jamaica,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
JAM,Jamaica,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
JAM,Jamaica,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
JAM,Jamaica,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
JAM,Jamaica,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,M36-Y17
JAM,Jamaica,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M35
JAM,Jamaica,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
JAM,Jamaica,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W6
JAM,Jamaica,AMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
JAM,Jamaica,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
JAM,Jamaica,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
JAM,Jamaica,AMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M3
JAM,Jamaica,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
JAM,Jamaica,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4-Y6
JAM,Jamaica,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,W6
JAM,Jamaica,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M3
JAM,Jamaica,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
JAM,Jamaica,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,M15
JAM,Jamaica,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y4
JAM,Jamaica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
JAM,Jamaica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
JAM,Jamaica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
JAM,Jamaica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
JAM,Jamaica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
JAM,Jamaica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y11-Y12
JAM,Jamaica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
JAM,Jamaica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
JAM,Jamaica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
JAM,Jamaica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
JAM,Jamaica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
JAM,Jamaica,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,RISKGROUPS,Risk group(s),NATIONAL,+Y10
JAM,Jamaica,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,>M12
JOR,Jordan,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
JOR,Jordan,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M3
JOR,Jordan,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
JOR,Jordan,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M5
JOR,Jordan,EMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
JOR,Jordan,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,,General/routine,NATIONAL,Y15
JOR,Jordan,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,,General/routine,NATIONAL,+M6
JOR,Jordan,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,,General/routine,NATIONAL,+M1
JOR,Jordan,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
JOR,Jordan,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
JOR,Jordan,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
JOR,Jordan,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
JOR,Jordan,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
JOR,Jordan,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
JOR,Jordan,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
JOR,Jordan,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=M6
JOR,Jordan,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
JOR,Jordan,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
JOR,Jordan,EMRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
JOR,Jordan,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
JOR,Jordan,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
JOR,Jordan,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M4
JOR,Jordan,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M5
JOR,Jordan,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M9
JOR,Jordan,EMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
JOR,Jordan,EMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y6
JOR,Jordan,EMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M3
JOR,Jordan,EMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
JOR,Jordan,EMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M5
JOR,Jordan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_CHILD_W,General/routine,NATIONAL,Y6
JOR,Jordan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,B_ADO_F,General/routine,NATIONAL,Y16
JOR,Jordan,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
JOR,Jordan,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
JOR,Jordan,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
JOR,Jordan,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
JOR,Jordan,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
JOR,Jordan,EMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M9
JOR,Jordan,EMRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M18
JPN,Japan,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,Y1
JPN,Japan,WPRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,,General/routine,NATIONAL,Y11
JPN,Japan,WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M3
JPN,Japan,WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4.5
JPN,Japan,WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
JPN,Japan,WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
JPN,Japan,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,M2
JPN,Japan,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M3
JPN,Japan,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M7
JPN,Japan,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,,General/routine,NATIONAL,M2
JPN,Japan,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,,General/routine,NATIONAL,M3
JPN,Japan,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,,General/routine,NATIONAL,M4
JPN,Japan,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,4.0,,General/routine,NATIONAL,Y1
JPN,Japan,WPRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y13
JPN,Japan,WPRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,Y13
JPN,Japan,WPRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,3.0,FEMALE,HPV for females only,NATIONAL,Y13
JPN,Japan,WPRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y13
JPN,Japan,WPRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,Y13
JPN,Japan,WPRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,3.0,FEMALE,HPV for females only,NATIONAL,Y13
JPN,Japan,WPRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,1.0,,General/routine,NATIONAL,M36
JPN,Japan,WPRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,2.0,,General/routine,NATIONAL,M37
JPN,Japan,WPRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,3.0,,General/routine,NATIONAL,Y4
JPN,Japan,WPRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,4.0,,General/routine,NATIONAL,Y9
JPN,Japan,WPRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,Y1
JPN,Japan,WPRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,Y5
JPN,Japan,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
JPN,Japan,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M3
JPN,Japan,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M4
JPN,Japan,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,Y1
JPN,Japan,WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,Y65
JPN,Japan,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
JPN,Japan,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M3
JPN,Japan,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
JPN,Japan,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M3
JPN,Japan,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M4
JPN,Japan,WPRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12
JPN,Japan,WPRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,M18
KAZ,Kazakhstan,EURO,2023,ANTHRAX,Anthrax vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KAZ,Kazakhstan,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
KAZ,Kazakhstan,EURO,2023,DTAP,DTaP (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y6
KAZ,Kazakhstan,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
KAZ,Kazakhstan,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M4
KAZ,Kazakhstan,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M3
KAZ,Kazakhstan,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
KAZ,Kazakhstan,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,Y2
KAZ,Kazakhstan,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,Y2.5
KAZ,Kazakhstan,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
KAZ,Kazakhstan,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KAZ,Kazakhstan,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
KAZ,Kazakhstan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
KAZ,Kazakhstan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
KAZ,Kazakhstan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
KAZ,Kazakhstan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KAZ,Kazakhstan,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
KAZ,Kazakhstan,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=M6
KAZ,Kazakhstan,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KAZ,Kazakhstan,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,Y1
KAZ,Kazakhstan,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
KAZ,Kazakhstan,EURO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,Y1
KAZ,Kazakhstan,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
KAZ,Kazakhstan,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
KAZ,Kazakhstan,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
KAZ,Kazakhstan,EURO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KAZ,Kazakhstan,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,1.0,,General/routine,SUBNATIONAL,
KAZ,Kazakhstan,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y26
KAZ,Kazakhstan,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,Y36
KAZ,Kazakhstan,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,Y46
KAZ,Kazakhstan,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,Y56
KAZ,Kazakhstan,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,Y66
KAZ,Kazakhstan,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_F,General/routine,NATIONAL,Y16
KAZ,Kazakhstan,EURO,2023,TULAREMIA,Tularemia vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,
KAZ,Kazakhstan,EURO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KEN,Kenya,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
KEN,Kenya,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
KEN,Kenya,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
KEN,Kenya,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
KEN,Kenya,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10-Y14
KEN,Kenya,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
KEN,Kenya,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
KEN,Kenya,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
KEN,Kenya,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
KEN,Kenya,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KEN,Kenya,AFRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
KEN,Kenya,AFRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=M6
KEN,Kenya,AFRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KEN,Kenya,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
KEN,Kenya,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
KEN,Kenya,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
KEN,Kenya,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
KEN,Kenya,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
KEN,Kenya,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
KEN,Kenya,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
KEN,Kenya,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,W6
KEN,Kenya,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,W10
KEN,Kenya,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,W14
KEN,Kenya,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
KEN,Kenya,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
KEN,Kenya,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,3.0,,General/routine,NATIONAL,W14
KEN,Kenya,AFRO,2023,RTS_S,Malaria vaccine,1.0,,General/routine,SUBNATIONAL,M6
KEN,Kenya,AFRO,2023,RTS_S,Malaria vaccine,2.0,,General/routine,SUBNATIONAL,M7
KEN,Kenya,AFRO,2023,RTS_S,Malaria vaccine,3.0,,General/routine,SUBNATIONAL,M9
KEN,Kenya,AFRO,2023,RTS_S,Malaria vaccine,4.0,,General/routine,SUBNATIONAL,M24
KEN,Kenya,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
KEN,Kenya,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
KEN,Kenya,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
KEN,Kenya,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
KEN,Kenya,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
KEN,Kenya,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
KEN,Kenya,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
KEN,Kenya,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
KEN,Kenya,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
KEN,Kenya,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
KEN,Kenya,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
KEN,Kenya,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,SUBNATIONAL,M9
KGZ,Kyrgyzstan,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
KGZ,Kyrgyzstan,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,B_CHILD_W,General/routine,NATIONAL,Y6
KGZ,Kyrgyzstan,EURO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_F,General/routine,NATIONAL,Y2
KGZ,Kyrgyzstan,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
KGZ,Kyrgyzstan,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3.5
KGZ,Kyrgyzstan,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M5
KGZ,Kyrgyzstan,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
KGZ,Kyrgyzstan,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y11
KGZ,Kyrgyzstan,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,Y11
KGZ,Kyrgyzstan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
KGZ,Kyrgyzstan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
KGZ,Kyrgyzstan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
KGZ,Kyrgyzstan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KGZ,Kyrgyzstan,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,
KGZ,Kyrgyzstan,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,
KGZ,Kyrgyzstan,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KGZ,Kyrgyzstan,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M3.5
KGZ,Kyrgyzstan,EURO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
KGZ,Kyrgyzstan,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
KGZ,Kyrgyzstan,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
KGZ,Kyrgyzstan,EURO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M2
KGZ,Kyrgyzstan,EURO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M3.5
KGZ,Kyrgyzstan,EURO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M5
KGZ,Kyrgyzstan,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
KGZ,Kyrgyzstan,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M5
KGZ,Kyrgyzstan,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12
KGZ,Kyrgyzstan,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
KGZ,Kyrgyzstan,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M3.5
KGZ,Kyrgyzstan,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M5
KGZ,Kyrgyzstan,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_ADO_W,General/routine,NATIONAL,Y11
KGZ,Kyrgyzstan,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,Y16
KHM,Cambodia,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
KHM,Cambodia,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
KHM,Cambodia,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
KHM,Cambodia,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
KHM,Cambodia,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
KHM,Cambodia,WPRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
KHM,Cambodia,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
KHM,Cambodia,WPRO,2023,JE_LIVEATD,JE-Livatd (Japanese Encephalitis live-attenuated) vaccine,1.0,,General/routine,NATIONAL,M9
KHM,Cambodia,WPRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
KHM,Cambodia,WPRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
KHM,Cambodia,WPRO,2023,MR,MR (Measles and rubella) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M6
KHM,Cambodia,WPRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
KHM,Cambodia,WPRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
KHM,Cambodia,WPRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
KHM,Cambodia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
KHM,Cambodia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
KHM,Cambodia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
KHM,Cambodia,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
KHM,Cambodia,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
KHM,Cambodia,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
KHM,Cambodia,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
KHM,Cambodia,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
KHM,Cambodia,WPRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6-M59
KHM,Cambodia,WPRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M6-M59
KIR,Kiribati,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B-Y1
KIR,Kiribati,WPRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y6
KIR,Kiribati,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
KIR,Kiribati,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
KIR,Kiribati,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
KIR,Kiribati,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B-W2
KIR,Kiribati,WPRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
KIR,Kiribati,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
KIR,Kiribati,WPRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M12
KIR,Kiribati,WPRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,Y6
KIR,Kiribati,WPRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
KIR,Kiribati,WPRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
KIR,Kiribati,WPRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
KIR,Kiribati,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
KIR,Kiribati,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
KIR,Kiribati,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
KIR,Kiribati,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
KIR,Kiribati,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
KIR,Kiribati,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
KIR,Kiribati,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+W4
KIR,Kiribati,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
KIR,Kiribati,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
KIR,Kiribati,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
KIR,Kiribati,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
KIR,Kiribati,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
KIR,Kiribati,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+W4
KIR,Kiribati,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,Y15
KIR,Kiribati,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
KIR,Kiribati,WPRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
KIR,Kiribati,WPRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
KNA,Saint Kitts and Nevis,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B-M11
KNA,Saint Kitts and Nevis,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y6
KNA,Saint Kitts and Nevis,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",6.0,,General/routine,NATIONAL,Y16
KNA,Saint Kitts and Nevis,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
KNA,Saint Kitts and Nevis,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4.5-Y5
KNA,Saint Kitts and Nevis,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
KNA,Saint Kitts and Nevis,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
KNA,Saint Kitts and Nevis,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
KNA,Saint Kitts and Nevis,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KNA,Saint Kitts and Nevis,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
KNA,Saint Kitts and Nevis,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y11
KNA,Saint Kitts and Nevis,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
KNA,Saint Kitts and Nevis,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
KNA,Saint Kitts and Nevis,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
KNA,Saint Kitts and Nevis,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KNA,Saint Kitts and Nevis,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
KNA,Saint Kitts and Nevis,AMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
KNA,Saint Kitts and Nevis,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
KNA,Saint Kitts and Nevis,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
KNA,Saint Kitts and Nevis,AMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M4
KNA,Saint Kitts and Nevis,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
KNA,Saint Kitts and Nevis,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4.5-Y5
KNA,Saint Kitts and Nevis,AMRO,2023,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,Y16
KNA,Saint Kitts and Nevis,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_F,General/routine,NATIONAL,Y16
KNA,Saint Kitts and Nevis,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
KOR,Republic of Korea,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B-M1
KOR,Republic of Korea,WPRO,2023,DTAP,DTaP (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
KOR,Republic of Korea,WPRO,2023,DTAP,DTaP (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
KOR,Republic of Korea,WPRO,2023,DTAP,DTaP (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
KOR,Republic of Korea,WPRO,2023,DTAP,DTaP (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15-M18
KOR,Republic of Korea,WPRO,2023,DTAP,DTaP (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y6
KOR,Republic of Korea,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
KOR,Republic of Korea,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
KOR,Republic of Korea,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
KOR,Republic of Korea,WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
KOR,Republic of Korea,WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
KOR,Republic of Korea,WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
KOR,Republic of Korea,WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y6
KOR,Republic of Korea,WPRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M12-M23
KOR,Republic of Korea,WPRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,+M6-M18
KOR,Republic of Korea,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,ADULTS,Adults,NATIONAL,
KOR,Republic of Korea,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,,General/routine,NATIONAL,
KOR,Republic of Korea,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B-M1
KOR,Republic of Korea,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M1
KOR,Republic of Korea,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
KOR,Republic of Korea,WPRO,2023,HFRS,Hemorrhagic fever with renal syndrome vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
KOR,Republic of Korea,WPRO,2023,HFRS,Hemorrhagic fever with renal syndrome vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
KOR,Republic of Korea,WPRO,2023,HFRS,Hemorrhagic fever with renal syndrome vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M12
KOR,Republic of Korea,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,,General/routine,NATIONAL,M2
KOR,Republic of Korea,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,,General/routine,NATIONAL,M4
KOR,Republic of Korea,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,,General/routine,NATIONAL,M6
KOR,Republic of Korea,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,4.0,,General/routine,NATIONAL,M12-M15
KOR,Republic of Korea,WPRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y12
KOR,Republic of Korea,WPRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
KOR,Republic of Korea,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y65
KOR,Republic of Korea,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
KOR,Republic of Korea,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
KOR,Republic of Korea,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KOR,Republic of Korea,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y9
KOR,Republic of Korea,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,M6-Y13
KOR,Republic of Korea,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KOR,Republic of Korea,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
KOR,Republic of Korea,WPRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
KOR,Republic of Korea,WPRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6-M18
KOR,Republic of Korea,WPRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,Y4-Y6
KOR,Republic of Korea,WPRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,1.0,,General/routine,NATIONAL,M12-M23
KOR,Republic of Korea,WPRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,2.0,,General/routine,NATIONAL,+D7-D30
KOR,Republic of Korea,WPRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,3.0,,General/routine,NATIONAL,+M12
KOR,Republic of Korea,WPRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,4.0,,General/routine,NATIONAL,Y6
KOR,Republic of Korea,WPRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,5.0,,General/routine,NATIONAL,Y12
KOR,Republic of Korea,WPRO,2023,JE_LIVEATD,JE-Livatd (Japanese Encephalitis live-attenuated) vaccine,1.0,,General/routine,NATIONAL,M12-M23
KOR,Republic of Korea,WPRO,2023,JE_LIVEATD,JE-Livatd (Japanese Encephalitis live-attenuated) vaccine,2.0,,General/routine,NATIONAL,+M12
KOR,Republic of Korea,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12-M15
KOR,Republic of Korea,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y4-Y6
KOR,Republic of Korea,WPRO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y18
KOR,Republic of Korea,WPRO,2023,MPOX,Mpox (monkeypox) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y18
KOR,Republic of Korea,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
KOR,Republic of Korea,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
KOR,Republic of Korea,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
KOR,Republic of Korea,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M12-M15
KOR,Republic of Korea,WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
KOR,Republic of Korea,WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
KOR,Republic of Korea,WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+Y5
KOR,Republic of Korea,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y11-Y12
KOR,Republic of Korea,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y11-Y12
KOR,Republic of Korea,WPRO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
KOR,Republic of Korea,WPRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12-M15
KWT,Kuwait,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,M3
KWT,Kuwait,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,
KWT,Kuwait,EMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_F,General/routine,NATIONAL,Y3.6
KWT,Kuwait,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
KWT,Kuwait,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
KWT,Kuwait,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
KWT,Kuwait,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
KWT,Kuwait,EMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,ADULTS,Adults,NATIONAL,
KWT,Kuwait,EMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,HW,Health workers,NATIONAL,
KWT,Kuwait,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,ADULTS,Adults,SUBNATIONAL,
KWT,Kuwait,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,SUBNATIONAL,
KWT,Kuwait,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
KWT,Kuwait,EMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y9-Y45
KWT,Kuwait,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
KWT,Kuwait,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
KWT,Kuwait,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
KWT,Kuwait,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KWT,Kuwait,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y5
KWT,Kuwait,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,Y5-Y18
KWT,Kuwait,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KWT,Kuwait,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
KWT,Kuwait,EMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
KWT,Kuwait,EMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
KWT,Kuwait,EMRO,2023,MEN_AC_CONJ,Meningococcal AC conjugate vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,
KWT,Kuwait,EMRO,2023,MEN_ACYW_135PS,Meningococcal ACYW polysaccharide vaccine,1.0,,General/routine,NATIONAL,Y2
KWT,Kuwait,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
KWT,Kuwait,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M24
KWT,Kuwait,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",3.0,,General/routine,NATIONAL,Y10-Y12
KWT,Kuwait,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M12
KWT,Kuwait,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M18
KWT,Kuwait,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,Y3.5
KWT,Kuwait,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
KWT,Kuwait,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
KWT,Kuwait,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M18
KWT,Kuwait,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
KWT,Kuwait,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
KWT,Kuwait,EMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,
KWT,Kuwait,EMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
KWT,Kuwait,EMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
KWT,Kuwait,EMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M6
KWT,Kuwait,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y10-Y12
KWT,Kuwait,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,7.0,,General/routine,NATIONAL,Y16-Y18
KWT,Kuwait,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,
KWT,Kuwait,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,HW,Health workers,SUBNATIONAL,
KWT,Kuwait,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,
KWT,Kuwait,EMRO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,
KWT,Kuwait,EMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y2
KWT,Kuwait,EMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,Y1
KWT,Kuwait,EMRO,2023,VARICELLA,Varicella vaccine,1.0,HW,Health workers,NATIONAL,
KWT,Kuwait,EMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,SUBNATIONAL,
LAO,Lao People's Democratic Republic,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
LAO,Lao People's Democratic Republic,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
LAO,Lao People's Democratic Republic,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
LAO,Lao People's Democratic Republic,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
LAO,Lao People's Democratic Republic,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
LAO,Lao People's Democratic Republic,WPRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10
LAO,Lao People's Democratic Republic,WPRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,Y11-Y15
LAO,Lao People's Democratic Republic,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
LAO,Lao People's Democratic Republic,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
LAO,Lao People's Democratic Republic,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
LAO,Lao People's Democratic Republic,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LAO,Lao People's Democratic Republic,WPRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,W14
LAO,Lao People's Democratic Republic,WPRO,2023,JE_LIVEATD,JE-Livatd (Japanese Encephalitis live-attenuated) vaccine,1.0,,General/routine,NATIONAL,M9
LAO,Lao People's Democratic Republic,WPRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
LAO,Lao People's Democratic Republic,WPRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M12
LAO,Lao People's Democratic Republic,WPRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
LAO,Lao People's Democratic Republic,WPRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
LAO,Lao People's Democratic Republic,WPRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
LAO,Lao People's Democratic Republic,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
LAO,Lao People's Democratic Republic,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
LAO,Lao People's Democratic Republic,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
LAO,Lao People's Democratic Republic,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
LAO,Lao People's Democratic Republic,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
LAO,Lao People's Democratic Republic,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
LAO,Lao People's Democratic Republic,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
LAO,Lao People's Democratic Republic,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
LAO,Lao People's Democratic Republic,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
LAO,Lao People's Democratic Republic,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
LAO,Lao People's Democratic Republic,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
LAO,Lao People's Democratic Republic,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,Y15
LAO,Lao People's Democratic Republic,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
LAO,Lao People's Democratic Republic,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
LAO,Lao People's Democratic Republic,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
LAO,Lao People's Democratic Republic,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
LAO,Lao People's Democratic Republic,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
LAO,Lao People's Democratic Republic,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
LAO,Lao People's Democratic Republic,WPRO,2023,TYPHOID_CONJ,Typhoid conjugate vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,
LAO,Lao People's Democratic Republic,WPRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6-M59
LBN,Lebanon,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
LBN,Lebanon,EMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y5
LBN,Lebanon,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
LBN,Lebanon,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
LBN,Lebanon,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
LBN,Lebanon,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
LBN,Lebanon,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
LBN,Lebanon,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
LBN,Lebanon,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
LBN,Lebanon,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
LBN,Lebanon,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LBN,Lebanon,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LBN,Lebanon,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
LBN,Lebanon,EMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
LBN,Lebanon,EMRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
LBN,Lebanon,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
LBN,Lebanon,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
LBN,Lebanon,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
LBN,Lebanon,EMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,Y4-Y5
LBN,Lebanon,EMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y10-Y12
LBN,Lebanon,EMRO,2023,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,Y16-Y18
LBN,Lebanon,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M4
LBN,Lebanon,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M6
LBN,Lebanon,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
LBN,Lebanon,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
LBN,Lebanon,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
LBN,Lebanon,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,3.0,,General/routine,NATIONAL,M6
LBN,Lebanon,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_ADO_W,General/routine,NATIONAL,Y10-Y12
LBN,Lebanon,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,Y16-Y18
LBN,Lebanon,EMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M9
LBN,Lebanon,EMRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
LBN,Lebanon,EMRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
LBR,Liberia,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B-M11
LBR,Liberia,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
LBR,Liberia,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
LBR,Liberia,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
LBR,Liberia,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
LBR,Liberia,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
LBR,Liberia,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
LBR,Liberia,AFRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
LBR,Liberia,AFRO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,M15
LBR,Liberia,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
LBR,Liberia,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
LBR,Liberia,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
LBR,Liberia,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
LBR,Liberia,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
LBR,Liberia,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
LBR,Liberia,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
LBR,Liberia,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
LBR,Liberia,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
LBR,Liberia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
LBR,Liberia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+W4
LBR,Liberia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
LBR,Liberia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+M12
LBR,Liberia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+M12
LBR,Liberia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+M12
LBR,Liberia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+M12
LBR,Liberia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
LBR,Liberia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+W4
LBR,Liberia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,1st contact
LBR,Liberia,AFRO,2023,TYPHOID_CONJ,Typhoid conjugate vaccine,1.0,,General/routine,NATIONAL,M9
LBR,Liberia,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6-M11
LBR,Liberia,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
LBY,Libya,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
LBY,Libya,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
LBY,Libya,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
LBY,Libya,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
LBY,Libya,EMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
LBY,Libya,EMRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y6
LBY,Libya,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LBY,Libya,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
LBY,Libya,EMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y12
LBY,Libya,EMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M2
LBY,Libya,EMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,3.0,FEMALE,HPV for females only,NATIONAL,+M4
LBY,Libya,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
LBY,Libya,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
LBY,Libya,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
LBY,Libya,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LBY,Libya,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LBY,Libya,EMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,M9
LBY,Libya,EMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,,General/routine,NATIONAL,M12
LBY,Libya,EMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,3.0,,General/routine,NATIONAL,Y12
LBY,Libya,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
LBY,Libya,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
LBY,Libya,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
LBY,Libya,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M9
LBY,Libya,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
LBY,Libya,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
LBY,Libya,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
LBY,Libya,EMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
LBY,Libya,EMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
LBY,Libya,EMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M6
LBY,Libya,EMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y15
LBY,Libya,EMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
LCA,Saint Lucia,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,M2
LCA,Saint Lucia,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
LCA,Saint Lucia,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5
LCA,Saint Lucia,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
LCA,Saint Lucia,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
LCA,Saint Lucia,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
LCA,Saint Lucia,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,ADULTS,Adults,NATIONAL,
LCA,Saint Lucia,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
LCA,Saint Lucia,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y11-Y12
LCA,Saint Lucia,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
LCA,Saint Lucia,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
LCA,Saint Lucia,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
LCA,Saint Lucia,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LCA,Saint Lucia,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
LCA,Saint Lucia,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
LCA,Saint Lucia,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M6
LCA,Saint Lucia,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
LCA,Saint Lucia,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
LCA,Saint Lucia,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
LCA,Saint Lucia,AMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M4
LCA,Saint Lucia,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M18
LCA,Saint Lucia,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,Y5
LCA,Saint Lucia,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y11-Y12
LCA,Saint Lucia,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
LCA,Saint Lucia,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
LCA,Saint Lucia,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
LCA,Saint Lucia,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,Y2-Y18
LCA,Saint Lucia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,
LCA,Saint Lucia,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y11-Y12
LCA,Saint Lucia,AMRO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
LCA,Saint Lucia,AMRO,2023,VARICELLA,Varicella vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+W6
LCA,Saint Lucia,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
LKA,Sri Lanka,SEARO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
LKA,Sri Lanka,SEARO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y5
LKA,Sri Lanka,SEARO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
LKA,Sri Lanka,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
LKA,Sri Lanka,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
LKA,Sri Lanka,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
LKA,Sri Lanka,SEARO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10-Y11
LKA,Sri Lanka,SEARO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
LKA,Sri Lanka,SEARO,2023,IPV_FRAC,IPVf (Inactivated polio vaccine fractional dose),1.0,,General/routine,NATIONAL,M2
LKA,Sri Lanka,SEARO,2023,IPV_FRAC,IPVf (Inactivated polio vaccine fractional dose),2.0,,General/routine,NATIONAL,M4
LKA,Sri Lanka,SEARO,2023,JE_LIVEATD,JE-Livatd (Japanese Encephalitis live-attenuated) vaccine,1.0,,General/routine,NATIONAL,Y1
LKA,Sri Lanka,SEARO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M9
LKA,Sri Lanka,SEARO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y3
LKA,Sri Lanka,SEARO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M2
LKA,Sri Lanka,SEARO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M4
LKA,Sri Lanka,SEARO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
LKA,Sri Lanka,SEARO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
LKA,Sri Lanka,SEARO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y5
LKA,Sri Lanka,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y12
LKA,Sri Lanka,SEARO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
LKA,Sri Lanka,SEARO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LKA,Sri Lanka,SEARO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
LKA,Sri Lanka,SEARO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
LKA,Sri Lanka,SEARO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
LKA,Sri Lanka,SEARO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
LKA,Sri Lanka,SEARO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
LKA,Sri Lanka,SEARO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
LKA,Sri Lanka,SEARO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
LSO,Lesotho,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
LSO,Lesotho,AFRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",4.0,,General/routine,NATIONAL,M18
LSO,Lesotho,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
LSO,Lesotho,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
LSO,Lesotho,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
LSO,Lesotho,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
LSO,Lesotho,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
LSO,Lesotho,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
LSO,Lesotho,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
LSO,Lesotho,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
LSO,Lesotho,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
LSO,Lesotho,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
LSO,Lesotho,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
LSO,Lesotho,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
LSO,Lesotho,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
LSO,Lesotho,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
LSO,Lesotho,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
LSO,Lesotho,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5
LSO,Lesotho,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y9
LSO,Lesotho,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
LSO,Lesotho,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
LSO,Lesotho,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+W4
LSO,Lesotho,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
LSO,Lesotho,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
LSO,Lesotho,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
LSO,Lesotho,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
LSO,Lesotho,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
LSO,Lesotho,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
LSO,Lesotho,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
LSO,Lesotho,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
LSO,Lesotho,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
LTU,Lithuania,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,D2-D3
LTU,Lithuania,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
LTU,Lithuania,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
LTU,Lithuania,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
LTU,Lithuania,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
LTU,Lithuania,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y6-Y7
LTU,Lithuania,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
LTU,Lithuania,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M1
LTU,Lithuania,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
LTU,Lithuania,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y11
LTU,Lithuania,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
LTU,Lithuania,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y11
LTU,Lithuania,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
LTU,Lithuania,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y18
LTU,Lithuania,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
LTU,Lithuania,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
LTU,Lithuania,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LTU,Lithuania,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y17
LTU,Lithuania,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LTU,Lithuania,EURO,2023,MEN_B,Meningococcal B vaccine,1.0,,General/routine,NATIONAL,M3
LTU,Lithuania,EURO,2023,MEN_B,Meningococcal B vaccine,2.0,,General/routine,NATIONAL,M5
LTU,Lithuania,EURO,2023,MEN_B,Meningococcal B vaccine,3.0,,General/routine,NATIONAL,M12-M15
LTU,Lithuania,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M15-M16
LTU,Lithuania,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6-Y7
LTU,Lithuania,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
LTU,Lithuania,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
LTU,Lithuania,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12-M15
LTU,Lithuania,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LTU,Lithuania,EURO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LTU,Lithuania,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
LTU,Lithuania,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
LTU,Lithuania,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M6
LTU,Lithuania,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,>Y25
LTU,Lithuania,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+Y10
LTU,Lithuania,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+Y10
LTU,Lithuania,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y10
LTU,Lithuania,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y10
LTU,Lithuania,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,ADULTS,Adults,NATIONAL,+Y10
LTU,Lithuania,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y15-Y16
LUX,Luxembourg,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
LUX,Luxembourg,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M3
LUX,Luxembourg,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M13
LUX,Luxembourg,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M4
LUX,Luxembourg,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5-Y6
LUX,Luxembourg,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,Y12
LUX,Luxembourg,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
LUX,Luxembourg,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9-Y14
LUX,Luxembourg,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
LUX,Luxembourg,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
LUX,Luxembourg,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y15
LUX,Luxembourg,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M2
LUX,Luxembourg,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
LUX,Luxembourg,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
LUX,Luxembourg,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
LUX,Luxembourg,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LUX,Luxembourg,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,<W33
LUX,Luxembourg,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LUX,Luxembourg,EURO,2023,MEN_B,Meningococcal B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M3-M12
LUX,Luxembourg,EURO,2023,MEN_B,Meningococcal B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+W8-M6
LUX,Luxembourg,EURO,2023,MEN_B,Meningococcal B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
LUX,Luxembourg,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,,General/routine,NATIONAL,M13
LUX,Luxembourg,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,2.0,,General/routine,NATIONAL,Y15-Y16
LUX,Luxembourg,EURO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",1.0,,General/routine,NATIONAL,M12
LUX,Luxembourg,EURO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",2.0,,General/routine,NATIONAL,M15-M23
LUX,Luxembourg,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
LUX,Luxembourg,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
LUX,Luxembourg,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
LUX,Luxembourg,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,M12
LUX,Luxembourg,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M3
LUX,Luxembourg,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M4
LUX,Luxembourg,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
LUX,Luxembourg,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
LUX,Luxembourg,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
LUX,Luxembourg,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+Y5
LUX,Luxembourg,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
LUX,Luxembourg,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M3
LUX,Luxembourg,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M4
LUX,Luxembourg,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y15-Y16
LVA,Latvia,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,D2-D5
LVA,Latvia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
LVA,Latvia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
LVA,Latvia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
LVA,Latvia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M12-M15
LVA,Latvia,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
LVA,Latvia,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
LVA,Latvia,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
LVA,Latvia,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y7
LVA,Latvia,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
LVA,Latvia,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,
LVA,Latvia,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,
LVA,Latvia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
LVA,Latvia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M1
LVA,Latvia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M2
LVA,Latvia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,M12-M15
LVA,Latvia,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y12
LVA,Latvia,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,Y12
LVA,Latvia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
LVA,Latvia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
LVA,Latvia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
LVA,Latvia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LVA,Latvia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M23
LVA,Latvia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LVA,Latvia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12-M15
LVA,Latvia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y7
LVA,Latvia,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
LVA,Latvia,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
LVA,Latvia,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12-M15
LVA,Latvia,EURO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
LVA,Latvia,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
LVA,Latvia,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
LVA,Latvia,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M6
LVA,Latvia,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,1.0,,General/routine,SUBNATIONAL,Y1-Y17
LVA,Latvia,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,2.0,,General/routine,SUBNATIONAL,Y1-Y17
LVA,Latvia,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,3.0,,General/routine,SUBNATIONAL,Y1-Y17
LVA,Latvia,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,4.0,,General/routine,SUBNATIONAL,Y1-Y17
LVA,Latvia,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,Y1-Y17
LVA,Latvia,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,Y1-Y17
LVA,Latvia,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,Y1-Y17
LVA,Latvia,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y1-Y17
LVA,Latvia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
LVA,Latvia,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y14
LVA,Latvia,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
LVA,Latvia,EURO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12-M15
LVA,Latvia,EURO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y7
MAC,"China, Macao SAR",WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
MAC,"China, Macao SAR",WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
MAC,"China, Macao SAR",WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
MAC,"China, Macao SAR",WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
MAC,"China, Macao SAR",WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
MAC,"China, Macao SAR",WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5-Y6
MAC,"China, Macao SAR",WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
MAC,"China, Macao SAR",WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y18
MAC,"China, Macao SAR",WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
MAC,"China, Macao SAR",WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M1
MAC,"China, Macao SAR",WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
MAC,"China, Macao SAR",WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,,General/routine,NATIONAL,M2
MAC,"China, Macao SAR",WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,,General/routine,NATIONAL,M4
MAC,"China, Macao SAR",WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,,General/routine,NATIONAL,M6
MAC,"China, Macao SAR",WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,4.0,,General/routine,NATIONAL,M15
MAC,"China, Macao SAR",WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,3.0,CATCHUP_C,Catch-up children,NATIONAL,Y15-Y17
MAC,"China, Macao SAR",WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10-Y14
MAC,"China, Macao SAR",WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
MAC,"China, Macao SAR",WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
MAC,"China, Macao SAR",WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
MAC,"China, Macao SAR",WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
MAC,"China, Macao SAR",WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MAC,"China, Macao SAR",WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,Y4-Y18
MAC,"China, Macao SAR",WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y3
MAC,"China, Macao SAR",WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MAC,"China, Macao SAR",WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
MAC,"China, Macao SAR",WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,HW,Health workers,NATIONAL,
MAC,"China, Macao SAR",WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y18
MAC,"China, Macao SAR",WPRO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",2.0,,General/routine,NATIONAL,M18
MAC,"China, Macao SAR",WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
MAC,"China, Macao SAR",WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MAC,"China, Macao SAR",WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
MAC,"China, Macao SAR",WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M15
MAC,"China, Macao SAR",WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MAC,"China, Macao SAR",WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y2
MAC,"China, Macao SAR",WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
MAC,"China, Macao SAR",WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y2
MAC,"China, Macao SAR",WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y22
MAC,"China, Macao SAR",WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,Y32
MAC,"China, Macao SAR",WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,Y42
MAC,"China, Macao SAR",WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,Y52
MAC,"China, Macao SAR",WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,Y62
MAC,"China, Macao SAR",WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,ADULTS,Adults,NATIONAL,Y72
MAC,"China, Macao SAR",WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y7
MAC,"China, Macao SAR",WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y11-Y12
MAC,"China, Macao SAR",WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
MAC,"China, Macao SAR",WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y7
MAC,"China, Macao SAR",WPRO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y7
MAC,"China, Macao SAR",WPRO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,ADULTS,Adults,NATIONAL,Y22
MAC,"China, Macao SAR",WPRO,2023,TT,TT (Tetanus toxoid) vaccine,2.0,ADULTS,Adults,NATIONAL,Y32
MAC,"China, Macao SAR",WPRO,2023,TT,TT (Tetanus toxoid) vaccine,3.0,ADULTS,Adults,NATIONAL,Y42
MAC,"China, Macao SAR",WPRO,2023,TT,TT (Tetanus toxoid) vaccine,4.0,ADULTS,Adults,NATIONAL,Y52
MAC,"China, Macao SAR",WPRO,2023,TT,TT (Tetanus toxoid) vaccine,5.0,ADULTS,Adults,NATIONAL,Y62
MAC,"China, Macao SAR",WPRO,2023,TT,TT (Tetanus toxoid) vaccine,6.0,ADULTS,Adults,NATIONAL,Y72
MAC,"China, Macao SAR",WPRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12
MAR,Morocco,EMRO,2019,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,M1
MAR,Morocco,EMRO,2019,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5
MAR,Morocco,EMRO,2019,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
MAR,Morocco,EMRO,2019,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
MAR,Morocco,EMRO,2019,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M4
MAR,Morocco,EMRO,2019,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3
MAR,Morocco,EMRO,2019,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
MAR,Morocco,EMRO,2019,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
MAR,Morocco,EMRO,2019,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
MAR,Morocco,EMRO,2019,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
MAR,Morocco,EMRO,2019,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MAR,Morocco,EMRO,2019,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M4
MAR,Morocco,EMRO,2019,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
MAR,Morocco,EMRO,2019,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
MAR,Morocco,EMRO,2019,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M2
MAR,Morocco,EMRO,2019,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M3
MAR,Morocco,EMRO,2019,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M1
MAR,Morocco,EMRO,2019,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,M18
MAR,Morocco,EMRO,2019,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M4
MAR,Morocco,EMRO,2019,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,Y5
MAR,Morocco,EMRO,2019,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MAR,Morocco,EMRO,2019,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12
MAR,Morocco,EMRO,2019,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MAR,Morocco,EMRO,2019,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MAR,Morocco,EMRO,2019,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M3
MAR,Morocco,EMRO,2019,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M4
MAR,Morocco,EMRO,2019,TT,TT (Tetanus toxoid) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
MAR,Morocco,EMRO,2019,TT,TT (Tetanus toxoid) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
MAR,Morocco,EMRO,2019,TT,TT (Tetanus toxoid) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
MAR,Morocco,EMRO,2019,TT,TT (Tetanus toxoid) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
MAR,Morocco,EMRO,2019,TT,TT (Tetanus toxoid) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
MAR,Morocco,EMRO,2019,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
MAR,Morocco,EMRO,2019,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
MAR,Morocco,EMRO,2019,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
MCO,Monaco,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,<Y5
MCO,Monaco,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
MCO,Monaco,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
MCO,Monaco,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M11
MCO,Monaco,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
MCO,Monaco,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
MCO,Monaco,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M11
MCO,Monaco,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y6
MCO,Monaco,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
MCO,Monaco,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M6-M12
MCO,Monaco,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
MCO,Monaco,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
MCO,Monaco,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
MCO,Monaco,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
MCO,Monaco,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
MCO,Monaco,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
MCO,Monaco,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
MCO,Monaco,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y11-Y14
MCO,Monaco,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
MCO,Monaco,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MCO,Monaco,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
MCO,Monaco,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
MCO,Monaco,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
MCO,Monaco,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MCO,Monaco,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>M6
MCO,Monaco,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>M6
MCO,Monaco,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,,General/routine,NATIONAL,M5
MCO,Monaco,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,2.0,,General/routine,NATIONAL,M12
MCO,Monaco,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
MCO,Monaco,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M16
MCO,Monaco,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MCO,Monaco,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MCO,Monaco,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
MCO,Monaco,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,Y65
MCO,Monaco,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y2-Y65
MCO,Monaco,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,ADULTS,Adults,NATIONAL,Y25
MCO,Monaco,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y11-Y13
MCO,Monaco,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",6.0,ADULTS,Adults,NATIONAL,Y25
MCO,Monaco,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y13
MCO,Monaco,EURO,2023,TDIPV_S,"Td-IPV (Tetanus, diphtheria for older children and adults and IPV) vaccine",1.0,ADULTS,Adults,NATIONAL,Y45
MCO,Monaco,EURO,2023,TDIPV_S,"Td-IPV (Tetanus, diphtheria for older children and adults and IPV) vaccine",2.0,ADULTS,Adults,NATIONAL,Y65
MDA,Republic of Moldova,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,D2
MDA,Republic of Moldova,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y7
MDA,Republic of Moldova,EURO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_F,General/routine,NATIONAL,Y2
MDA,Republic of Moldova,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
MDA,Republic of Moldova,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
MDA,Republic of Moldova,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
MDA,Republic of Moldova,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
MDA,Republic of Moldova,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
MDA,Republic of Moldova,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
MDA,Republic of Moldova,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
MDA,Republic of Moldova,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
MDA,Republic of Moldova,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
MDA,Republic of Moldova,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
MDA,Republic of Moldova,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,SUBNATIONAL,Y10
MDA,Republic of Moldova,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,SUBNATIONAL,+M6
MDA,Republic of Moldova,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
MDA,Republic of Moldova,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
MDA,Republic of Moldova,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MDA,Republic of Moldova,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M6
MDA,Republic of Moldova,EURO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,Y2
MDA,Republic of Moldova,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
MDA,Republic of Moldova,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y7
MDA,Republic of Moldova,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",3.0,,General/routine,NATIONAL,Y15
MDA,Republic of Moldova,EURO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M2
MDA,Republic of Moldova,EURO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M4
MDA,Republic of Moldova,EURO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
MDA,Republic of Moldova,EURO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,Y2
MDA,Republic of Moldova,EURO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y7
MDA,Republic of Moldova,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MDA,Republic of Moldova,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MDA,Republic of Moldova,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
MDA,Republic of Moldova,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,SUBNATIONAL,M2
MDA,Republic of Moldova,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,SUBNATIONAL,M4
MDA,Republic of Moldova,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y20
MDA,Republic of Moldova,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,Y30
MDA,Republic of Moldova,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,Y40
MDA,Republic of Moldova,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,Y50
MDA,Republic of Moldova,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,Y60
MDA,Republic of Moldova,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y15
MDG,Madagascar,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
MDG,Madagascar,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
MDG,Madagascar,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
MDG,Madagascar,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
MDG,Madagascar,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
MDG,Madagascar,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
MDG,Madagascar,AFRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
MDG,Madagascar,AFRO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,M15-M23
MDG,Madagascar,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
MDG,Madagascar,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
MDG,Madagascar,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
MDG,Madagascar,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
MDG,Madagascar,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,W6
MDG,Madagascar,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,W10
MDG,Madagascar,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,W14
MDG,Madagascar,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
MDG,Madagascar,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
MDG,Madagascar,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
MDG,Madagascar,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
MDG,Madagascar,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
MDG,Madagascar,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
MDG,Madagascar,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
MDV,Maldives,SEARO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
MDV,Maldives,SEARO,2023,CHOLERA,Cholera vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,>Y2
MDV,Maldives,SEARO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y4
MDV,Maldives,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
MDV,Maldives,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
MDV,Maldives,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
MDV,Maldives,SEARO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
MDV,Maldives,SEARO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10
MDV,Maldives,SEARO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
MDV,Maldives,SEARO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
MDV,Maldives,SEARO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
MDV,Maldives,SEARO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
MDV,Maldives,SEARO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MDV,Maldives,SEARO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,
MDV,Maldives,SEARO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,
MDV,Maldives,SEARO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MDV,Maldives,SEARO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M6
MDV,Maldives,SEARO,2023,MEN_ACYW_135PS,Meningococcal ACYW polysaccharide vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,>Y2
MDV,Maldives,SEARO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
MDV,Maldives,SEARO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
MDV,Maldives,SEARO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M2
MDV,Maldives,SEARO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M4
MDV,Maldives,SEARO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
MDV,Maldives,SEARO,2023,OPV,OPV (Oral polio vaccine),1.0,TRAVELLERS,Travellers,NATIONAL,>M9
MDV,Maldives,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
MDV,Maldives,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
MDV,Maldives,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
MDV,Maldives,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
MDV,Maldives,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y2
MDV,Maldives,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
MDV,Maldives,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y2
MDV,Maldives,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
MDV,Maldives,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
MDV,Maldives,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,>Y15
MDV,Maldives,SEARO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M9
MDV,Maldives,SEARO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M18
MDV,Maldives,SEARO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M24
MDV,Maldives,SEARO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M30
MDV,Maldives,SEARO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M36
MDV,Maldives,SEARO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M42
MDV,Maldives,SEARO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,>M9
MEX,Mexico,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
MEX,Mexico,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
MEX,Mexico,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
MEX,Mexico,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
MEX,Mexico,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
MEX,Mexico,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
MEX,Mexico,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,Y1
MEX,Mexico,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
MEX,Mexico,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>Y20
MEX,Mexico,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
MEX,Mexico,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y11-Y13
MEX,Mexico,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M2
MEX,Mexico,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
MEX,Mexico,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y11-Y49
MEX,Mexico,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
MEX,Mexico,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
MEX,Mexico,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
MEX,Mexico,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MEX,Mexico,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M35
MEX,Mexico,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,M36-M59
MEX,Mexico,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MEX,Mexico,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,Y1
MEX,Mexico,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18-Y6
MEX,Mexico,AMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y10
MEX,Mexico,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,ADULTS,Adults,NATIONAL,Y60
MEX,Mexico,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MEX,Mexico,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
MEX,Mexico,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MEX,Mexico,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y61
MEX,Mexico,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MEX,Mexico,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MEX,Mexico,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+Y10
MEX,Mexico,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,>=Y15
MEX,Mexico,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,>=Y10
MEX,Mexico,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
MEX,Mexico,AMRO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,Y1
MEX,Mexico,AMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6-M11
MEX,Mexico,AMRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12-M59
MHL,Marshall Islands,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
MHL,Marshall Islands,WPRO,2023,DTAPHEPBIPV,DTaP-HepB-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y6
MHL,Marshall Islands,WPRO,2023,DTAPHEPBIPV,DTaP-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
MHL,Marshall Islands,WPRO,2023,DTAPHEPBIPV,DTaP-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
MHL,Marshall Islands,WPRO,2023,DTAPHEPBIPV,DTaP-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
MHL,Marshall Islands,WPRO,2023,DTAPHEPBIPV,DTaP-HepB-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M12
MHL,Marshall Islands,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
MHL,Marshall Islands,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
MHL,Marshall Islands,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M12
MHL,Marshall Islands,WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y5
MHL,Marshall Islands,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
MHL,Marshall Islands,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M2
MHL,Marshall Islands,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
MHL,Marshall Islands,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,,General/routine,NATIONAL,M2
MHL,Marshall Islands,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,,General/routine,NATIONAL,M4
MHL,Marshall Islands,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,,General/routine,NATIONAL,M12
MHL,Marshall Islands,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y11
MHL,Marshall Islands,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
MHL,Marshall Islands,WPRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
MHL,Marshall Islands,WPRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
MHL,Marshall Islands,WPRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,Y4-Y6
MHL,Marshall Islands,WPRO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,,General/routine,NATIONAL,Y11-Y12
MHL,Marshall Islands,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
MHL,Marshall Islands,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M13
MHL,Marshall Islands,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MHL,Marshall Islands,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MHL,Marshall Islands,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
MHL,Marshall Islands,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M12
MHL,Marshall Islands,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MHL,Marshall Islands,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MHL,Marshall Islands,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M6
MHL,Marshall Islands,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,4.0,,General/routine,NATIONAL,M12
MHL,Marshall Islands,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y11-Y12
MHL,Marshall Islands,WPRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M2
MHL,Marshall Islands,WPRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,M4
MHL,Marshall Islands,WPRO,2023,VARICELLA,Varicella vaccine,3.0,,General/routine,NATIONAL,M6
MHL,Marshall Islands,WPRO,2023,VARICELLA,Varicella vaccine,4.0,,General/routine,NATIONAL,M12
MKD,North Macedonia,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
MKD,North Macedonia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
MKD,North Macedonia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
MKD,North Macedonia,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
MKD,North Macedonia,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
MKD,North Macedonia,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y7
MKD,North Macedonia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
MKD,North Macedonia,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y12
MKD,North Macedonia,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
MKD,North Macedonia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y18
MKD,North Macedonia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
MKD,North Macedonia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
MKD,North Macedonia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MKD,North Macedonia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
MKD,North Macedonia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MKD,North Macedonia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
MKD,North Macedonia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
MKD,North Macedonia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MKD,North Macedonia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MKD,North Macedonia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
MKD,North Macedonia,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MKD,North Macedonia,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MKD,North Macedonia,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M6
MKD,North Macedonia,EURO,2023,TDIPV_S,"Td-IPV (Tetanus, diphtheria for older children and adults and IPV) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y14
MKD,North Macedonia,EURO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,ADULTS,Adults,NATIONAL,Y18
MLI,Mali,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
MLI,Mali,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
MLI,Mali,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
MLI,Mali,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
MLI,Mali,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
MLI,Mali,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
MLI,Mali,AFRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
MLI,Mali,AFRO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,M12-M23
MLI,Mali,AFRO,2023,MEN_A_CONJ,Meningococcal A conjugate vaccine,1.0,,General/routine,NATIONAL,M9
MLI,Mali,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
MLI,Mali,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
MLI,Mali,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
MLI,Mali,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
MLI,Mali,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
MLI,Mali,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
MLI,Mali,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
MLI,Mali,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,W6
MLI,Mali,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,W10
MLI,Mali,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,W14
MLI,Mali,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
MLI,Mali,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
MLI,Mali,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
MLI,Mali,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
MLI,Mali,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
MLI,Mali,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
MLI,Mali,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,Y1
MLI,Mali,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
MLT,Malta,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
MLT,Malta,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
MLT,Malta,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M3
MLT,Malta,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M4
MLT,Malta,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
MLT,Malta,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
MLT,Malta,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,W4
MLT,Malta,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,W8
MLT,Malta,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,M12
MLT,Malta,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,Y13-Y14
MLT,Malta,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
MLT,Malta,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y12
MLT,Malta,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y65
MLT,Malta,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
MLT,Malta,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
MLT,Malta,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MLT,Malta,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M59
MLT,Malta,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,Y5-Y16
MLT,Malta,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MLT,Malta,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,M3
MLT,Malta,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,,General/routine,NATIONAL,M13
MLT,Malta,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,3.0,,General/routine,NATIONAL,Y14
MLT,Malta,EURO,2023,MEN_B,Meningococcal B vaccine,1.0,,General/routine,NATIONAL,M2
MLT,Malta,EURO,2023,MEN_B,Meningococcal B vaccine,2.0,,General/routine,NATIONAL,M4
MLT,Malta,EURO,2023,MEN_B,Meningococcal B vaccine,3.0,,General/routine,NATIONAL,M12
MLT,Malta,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M13
MLT,Malta,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y3-Y4
MLT,Malta,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MLT,Malta,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MLT,Malta,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12
MLT,Malta,EURO,2023,TDIPV_S,"Td-IPV (Tetanus, diphtheria for older children and adults and IPV) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y14
MMR,Myanmar,SEARO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B-M2
MMR,Myanmar,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
MMR,Myanmar,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
MMR,Myanmar,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
MMR,Myanmar,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
MMR,Myanmar,SEARO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
MMR,Myanmar,SEARO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
MMR,Myanmar,SEARO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M4
MMR,Myanmar,SEARO,2023,JE_LIVEATD,JE-Livatd (Japanese Encephalitis live-attenuated) vaccine,1.0,,General/routine,NATIONAL,M9
MMR,Myanmar,SEARO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
MMR,Myanmar,SEARO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
MMR,Myanmar,SEARO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M2
MMR,Myanmar,SEARO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M4
MMR,Myanmar,SEARO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
MMR,Myanmar,SEARO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MMR,Myanmar,SEARO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MMR,Myanmar,SEARO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
MMR,Myanmar,SEARO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MMR,Myanmar,SEARO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MMR,Myanmar,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
MMR,Myanmar,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
MMR,Myanmar,SEARO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6-M59
MNE,Montenegro,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
MNE,Montenegro,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,CATCHUP_C,Catch-up children,NATIONAL,Y6
MNE,Montenegro,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,W9
MNE,Montenegro,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,W17
MNE,Montenegro,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
MNE,Montenegro,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,W23
MNE,Montenegro,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y6
MNE,Montenegro,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
MNE,Montenegro,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,W5
MNE,Montenegro,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,W9
MNE,Montenegro,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,M13
MNE,Montenegro,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9-Y14
MNE,Montenegro,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MNE,Montenegro,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,
MNE,Montenegro,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
MNE,Montenegro,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
MNE,Montenegro,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
MNE,Montenegro,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MNE,Montenegro,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
MNE,Montenegro,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MNE,Montenegro,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M13
MNE,Montenegro,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
MNE,Montenegro,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y18
MNE,Montenegro,EURO,2023,TDIPV_S,"Td-IPV (Tetanus, diphtheria for older children and adults and IPV) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y14
MNG,Mongolia,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
MNG,Mongolia,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
MNG,Mongolia,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3
MNG,Mongolia,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M4
MNG,Mongolia,WPRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M14
MNG,Mongolia,WPRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,Y2
MNG,Mongolia,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MNG,Mongolia,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
MNG,Mongolia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
MNG,Mongolia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
MNG,Mongolia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MNG,Mongolia,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,Y2-Y5
MNG,Mongolia,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M5
MNG,Mongolia,WPRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MNG,Mongolia,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M9
MNG,Mongolia,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y2
MNG,Mongolia,WPRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
MNG,Mongolia,WPRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M2
MNG,Mongolia,WPRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M3
MNG,Mongolia,WPRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M4
MNG,Mongolia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MNG,Mongolia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MNG,Mongolia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M9
MNG,Mongolia,WPRO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MNG,Mongolia,WPRO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,1.0,RISKGROUPS,Risk group(s),,
MNG,Mongolia,WPRO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MNG,Mongolia,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_CHILD_W,General/routine,NATIONAL,Y7
MNG,Mongolia,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,B_ADO_W,General/routine,NATIONAL,Y15
MNG,Mongolia,WPRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6-M59
MNG,Mongolia,WPRO,2023,YF,YF (Yellow fever) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MNP,Northern Mariana Islands,WPRO,2023,DTAP,DTaP (acellular) vaccine,1.0,,General/routine,NATIONAL,W6
MNP,Northern Mariana Islands,WPRO,2023,DTAP,DTaP (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
MNP,Northern Mariana Islands,WPRO,2023,DTAP,DTaP (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
MNP,Northern Mariana Islands,WPRO,2023,DTAP,DTaP (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15-M18
MNP,Northern Mariana Islands,WPRO,2023,DTAP,DTaP (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y6
MNP,Northern Mariana Islands,WPRO,2023,DTAPHEPBIPV,DTaP-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,W6
MNP,Northern Mariana Islands,WPRO,2023,DTAPHEPBIPV,DTaP-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M6
MNP,Northern Mariana Islands,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,W6
MNP,Northern Mariana Islands,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
MNP,Northern Mariana Islands,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
MNP,Northern Mariana Islands,WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y6
MNP,Northern Mariana Islands,WPRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y19
MNP,Northern Mariana Islands,WPRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,ADULTS,Adults,NATIONAL,+M6
MNP,Northern Mariana Islands,WPRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M12
MNP,Northern Mariana Islands,WPRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,+M6
MNP,Northern Mariana Islands,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
MNP,Northern Mariana Islands,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,W6
MNP,Northern Mariana Islands,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
MNP,Northern Mariana Islands,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,,General/routine,NATIONAL,W6
MNP,Northern Mariana Islands,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,,General/routine,NATIONAL,M4
MNP,Northern Mariana Islands,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,,General/routine,NATIONAL,M15-M18
MNP,Northern Mariana Islands,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9-Y14
MNP,Northern Mariana Islands,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
MNP,Northern Mariana Islands,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
MNP,Northern Mariana Islands,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
MNP,Northern Mariana Islands,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
MNP,Northern Mariana Islands,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MNP,Northern Mariana Islands,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
MNP,Northern Mariana Islands,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=M6
MNP,Northern Mariana Islands,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MNP,Northern Mariana Islands,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W6
MNP,Northern Mariana Islands,WPRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
MNP,Northern Mariana Islands,WPRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
MNP,Northern Mariana Islands,WPRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,Y4-Y6
MNP,Northern Mariana Islands,WPRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,Y11
MNP,Northern Mariana Islands,WPRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,,General/routine,NATIONAL,Y16
MNP,Northern Mariana Islands,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
MNP,Northern Mariana Islands,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y4-Y6
MNP,Northern Mariana Islands,WPRO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",1.0,,General/routine,NATIONAL,M12
MNP,Northern Mariana Islands,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
MNP,Northern Mariana Islands,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MNP,Northern Mariana Islands,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
MNP,Northern Mariana Islands,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M15-M18
MNP,Northern Mariana Islands,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,W6
MNP,Northern Mariana Islands,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MNP,Northern Mariana Islands,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M6
MNP,Northern Mariana Islands,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y7-Y18
MNP,Northern Mariana Islands,WPRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12
MNP,Northern Mariana Islands,WPRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y4-Y6
MNP,Northern Mariana Islands,WPRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y50-Y85
MOZ,Mozambique,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
MOZ,Mozambique,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
MOZ,Mozambique,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3
MOZ,Mozambique,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M4
MOZ,Mozambique,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
MOZ,Mozambique,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
MOZ,Mozambique,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M4
MOZ,Mozambique,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
MOZ,Mozambique,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
MOZ,Mozambique,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
MOZ,Mozambique,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
MOZ,Mozambique,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M2
MOZ,Mozambique,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M3
MOZ,Mozambique,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M4
MOZ,Mozambique,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MOZ,Mozambique,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MOZ,Mozambique,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M9
MOZ,Mozambique,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MOZ,Mozambique,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M3
MOZ,Mozambique,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
MOZ,Mozambique,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y15-Y49
MOZ,Mozambique,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
MOZ,Mozambique,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
MOZ,Mozambique,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
MOZ,Mozambique,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
MOZ,Mozambique,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
MOZ,Mozambique,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y6
MOZ,Mozambique,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
MOZ,Mozambique,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,Y15-Y49
MOZ,Mozambique,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
MOZ,Mozambique,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_ADO_F,General/routine,NATIONAL,Y7
MOZ,Mozambique,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
MOZ,Mozambique,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
MOZ,Mozambique,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
MOZ,Mozambique,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
MOZ,Mozambique,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
MOZ,Mozambique,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
MRT,Mauritania,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
MRT,Mauritania,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
MRT,Mauritania,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
MRT,Mauritania,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
MRT,Mauritania,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
MRT,Mauritania,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
MRT,Mauritania,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
MRT,Mauritania,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
MRT,Mauritania,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
MRT,Mauritania,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M15
MRT,Mauritania,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
MRT,Mauritania,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
MRT,Mauritania,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
MRT,Mauritania,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
MRT,Mauritania,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
MRT,Mauritania,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
MRT,Mauritania,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
MRT,Mauritania,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
MRT,Mauritania,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
MRT,Mauritania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
MRT,Mauritania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
MRT,Mauritania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
MRT,Mauritania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
MRT,Mauritania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
MSR,Montserrat,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,M2
MSR,Montserrat,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y4.5
MSR,Montserrat,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,1.0,B_2YL_W,General/routine,NATIONAL,M18
MSR,Montserrat,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
MSR,Montserrat,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
MSR,Montserrat,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
MSR,Montserrat,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MSR,Montserrat,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
MSR,Montserrat,AMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,FEMALE,HPV for females only,SUBNATIONAL,Y13
MSR,Montserrat,AMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,FEMALE,HPV for females only,SUBNATIONAL,+M6
MSR,Montserrat,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
MSR,Montserrat,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
MSR,Montserrat,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MSR,Montserrat,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
MSR,Montserrat,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
MSR,Montserrat,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",3.0,ADULTS,Adults,NATIONAL,Y25-Y35
MSR,Montserrat,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
MSR,Montserrat,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
MSR,Montserrat,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
MSR,Montserrat,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
MSR,Montserrat,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4.5
MSR,Montserrat,AMRO,2023,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,Y14.5
MSR,Montserrat,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
MSR,Montserrat,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
MSR,Montserrat,AMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M6
MSR,Montserrat,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y15
MSR,Montserrat,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
MUS,Mauritius,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,M1
MUS,Mauritius,AFRO,2023,DTWPHIBHEPBIPV,DTwP-Hib-HepB-IPV (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
MUS,Mauritius,AFRO,2023,DTWPHIBHEPBIPV,DTwP-Hib-HepB-IPV (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
MUS,Mauritius,AFRO,2023,DTWPHIBHEPBIPV,DTwP-Hib-HepB-IPV (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
MUS,Mauritius,AFRO,2023,DTWPHIBHEPBIPV,DTwP-Hib-HepB-IPV (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
MUS,Mauritius,AFRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
MUS,Mauritius,AFRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
MUS,Mauritius,AFRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MUS,Mauritius,AFRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
MUS,Mauritius,AFRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
MUS,Mauritius,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
MUS,Mauritius,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
MUS,Mauritius,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
MUS,Mauritius,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MUS,Mauritius,AFRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MUS,Mauritius,AFRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
MUS,Mauritius,AFRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M9
MUS,Mauritius,AFRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M17
MUS,Mauritius,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
MUS,Mauritius,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W14
MUS,Mauritius,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M10
MUS,Mauritius,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
MUS,Mauritius,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
MUS,Mauritius,AFRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y11
MUS,Mauritius,AFRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
MUS,Mauritius,AFRO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y5
MUS,Mauritius,AFRO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MUS,Mauritius,AFRO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
MUS,Mauritius,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
MWI,Malawi,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
MWI,Malawi,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
MWI,Malawi,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
MWI,Malawi,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
MWI,Malawi,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
MWI,Malawi,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+Y1
MWI,Malawi,AFRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,W14
MWI,Malawi,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
MWI,Malawi,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M15
MWI,Malawi,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
MWI,Malawi,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
MWI,Malawi,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
MWI,Malawi,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
MWI,Malawi,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
MWI,Malawi,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
MWI,Malawi,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
MWI,Malawi,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
MWI,Malawi,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
MWI,Malawi,AFRO,2023,RTS_S,Malaria vaccine,1.0,,General/routine,SUBNATIONAL,M5
MWI,Malawi,AFRO,2023,RTS_S,Malaria vaccine,2.0,,General/routine,SUBNATIONAL,M6
MWI,Malawi,AFRO,2023,RTS_S,Malaria vaccine,3.0,,General/routine,SUBNATIONAL,M7
MWI,Malawi,AFRO,2023,RTS_S,Malaria vaccine,4.0,,General/routine,SUBNATIONAL,M22
MWI,Malawi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
MWI,Malawi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
MWI,Malawi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
MWI,Malawi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
MWI,Malawi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
MWI,Malawi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
MWI,Malawi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
MWI,Malawi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
MWI,Malawi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,1st contact
MWI,Malawi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
MWI,Malawi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
MWI,Malawi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
MWI,Malawi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
MWI,Malawi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
MWI,Malawi,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
MWI,Malawi,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
MWI,Malawi,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
MWI,Malawi,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
MWI,Malawi,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
MWI,Malawi,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
MWI,Malawi,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
MWI,Malawi,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MYS,Malaysia,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
MYS,Malaysia,WPRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y7
MYS,Malaysia,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
MYS,Malaysia,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M3
MYS,Malaysia,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M5
MYS,Malaysia,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
MYS,Malaysia,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
MYS,Malaysia,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
MYS,Malaysia,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
MYS,Malaysia,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
MYS,Malaysia,WPRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y13
MYS,Malaysia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
MYS,Malaysia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
MYS,Malaysia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
MYS,Malaysia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MYS,Malaysia,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
MYS,Malaysia,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MYS,Malaysia,WPRO,2023,JE_LIVEATD,JE-Livatd (Japanese Encephalitis live-attenuated) vaccine,1.0,,General/routine,SUBNATIONAL,M9
MYS,Malaysia,WPRO,2023,JE_LIVEATD,JE-Livatd (Japanese Encephalitis live-attenuated) vaccine,2.0,,General/routine,SUBNATIONAL,M21
MYS,Malaysia,WPRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,SUBNATIONAL,M6
MYS,Malaysia,WPRO,2023,MEN_ACYW_135PS,Meningococcal ACYW polysaccharide vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
MYS,Malaysia,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M9
MYS,Malaysia,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M12
MYS,Malaysia,WPRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,
MYS,Malaysia,WPRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M6
MYS,Malaysia,WPRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M15
MYS,Malaysia,WPRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M4
MYS,Malaysia,WPRO,2023,TT,TT (Tetanus toxoid) vaccine,6.0,,General/routine,NATIONAL,Y15
MYS,Malaysia,WPRO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,PW,Pregnant women,NATIONAL,
MYS,Malaysia,WPRO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
MYS,Malaysia,WPRO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+Y3
NAM,Namibia,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
NAM,Namibia,AFRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,B_CHILD_W,General/routine,NATIONAL,Y5
NAM,Namibia,AFRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,,General/routine,NATIONAL,Y10
NAM,Namibia,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
NAM,Namibia,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
NAM,Namibia,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
NAM,Namibia,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
NAM,Namibia,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
NAM,Namibia,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
NAM,Namibia,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
NAM,Namibia,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M15
NAM,Namibia,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
NAM,Namibia,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
NAM,Namibia,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
NAM,Namibia,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
NAM,Namibia,AFRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y5
NAM,Namibia,AFRO,2023,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,Y10
NAM,Namibia,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,W6
NAM,Namibia,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,W10
NAM,Namibia,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,W14
NAM,Namibia,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
NAM,Namibia,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
NAM,Namibia,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,3.0,,General/routine,NATIONAL,W14
NAM,Namibia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y15-Y49
NAM,Namibia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
NAM,Namibia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
NAM,Namibia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
NAM,Namibia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
NAM,Namibia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
NAM,Namibia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
NAM,Namibia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
NAM,Namibia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
NAM,Namibia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,Y15-Y49
NAM,Namibia,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
NAM,Namibia,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
NAM,Namibia,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
NAM,Namibia,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
NAM,Namibia,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
NAM,Namibia,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
NCL,New Caledonia,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
NCL,New Caledonia,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
NCL,New Caledonia,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M11
NCL,New Caledonia,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
NCL,New Caledonia,WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y6
NCL,New Caledonia,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
NCL,New Caledonia,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,Y14
NCL,New Caledonia,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9
NCL,New Caledonia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y18
NCL,New Caledonia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
NCL,New Caledonia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
NCL,New Caledonia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NCL,New Caledonia,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
NCL,New Caledonia,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NCL,New Caledonia,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
NCL,New Caledonia,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M16
NCL,New Caledonia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
NCL,New Caledonia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
NCL,New Caledonia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M11
NCL,New Caledonia,WPRO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",6.0,ADULTS,Adults,NATIONAL,Y25
NCL,New Caledonia,WPRO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y11
NCL,New Caledonia,WPRO,2023,TDIPV_S,"Td-IPV (Tetanus, diphtheria for older children and adults and IPV) vaccine",1.0,ADULTS,Adults,NATIONAL,Y45
NCL,New Caledonia,WPRO,2023,TDIPV_S,"Td-IPV (Tetanus, diphtheria for older children and adults and IPV) vaccine",2.0,ADULTS,Adults,NATIONAL,Y65
NCL,New Caledonia,WPRO,2023,TDIPV_S,"Td-IPV (Tetanus, diphtheria for older children and adults and IPV) vaccine",3.0,ADULTS,Adults,NATIONAL,Y75
NCL,New Caledonia,WPRO,2023,TDIPV_S,"Td-IPV (Tetanus, diphtheria for older children and adults and IPV) vaccine",4.0,ADULTS,Adults,NATIONAL,Y85
NER,Niger,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
NER,Niger,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
NER,Niger,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
NER,Niger,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
NER,Niger,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
NER,Niger,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
NER,Niger,AFRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
NER,Niger,AFRO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,M16
NER,Niger,AFRO,2023,MEN_A_CONJ,Meningococcal A conjugate vaccine,1.0,,General/routine,NATIONAL,M9
NER,Niger,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
NER,Niger,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
NER,Niger,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
NER,Niger,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
NER,Niger,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
NER,Niger,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
NER,Niger,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
NER,Niger,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
NER,Niger,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
NER,Niger,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
NER,Niger,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+W4
NER,Niger,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
NER,Niger,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
NER,Niger,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
NER,Niger,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
NER,Niger,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
NER,Niger,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
NER,Niger,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M23
NER,Niger,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
NGA,Nigeria,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
NGA,Nigeria,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
NGA,Nigeria,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
NGA,Nigeria,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
NGA,Nigeria,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
NGA,Nigeria,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,SUBNATIONAL,Y9
NGA,Nigeria,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W6
NGA,Nigeria,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,W14
NGA,Nigeria,AFRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
NGA,Nigeria,AFRO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,M15
NGA,Nigeria,AFRO,2023,MEN_A_CONJ,Meningococcal A conjugate vaccine,1.0,,General/routine,NATIONAL,M9
NGA,Nigeria,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
NGA,Nigeria,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
NGA,Nigeria,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
NGA,Nigeria,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
NGA,Nigeria,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,W6
NGA,Nigeria,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,W10
NGA,Nigeria,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,W14
NGA,Nigeria,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,W6
NGA,Nigeria,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,W10
NGA,Nigeria,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,W14
NGA,Nigeria,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
NGA,Nigeria,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
NGA,Nigeria,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
NGA,Nigeria,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
NGA,Nigeria,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
NGA,Nigeria,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
NGA,Nigeria,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
NGA,Nigeria,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
NIC,Nicaragua,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
NIC,Nicaragua,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
NIC,Nicaragua,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y6
NIC,Nicaragua,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
NIC,Nicaragua,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
NIC,Nicaragua,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
NIC,Nicaragua,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
NIC,Nicaragua,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
NIC,Nicaragua,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
NIC,Nicaragua,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
NIC,Nicaragua,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
NIC,Nicaragua,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
NIC,Nicaragua,AMRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10
NIC,Nicaragua,AMRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
NIC,Nicaragua,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
NIC,Nicaragua,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
NIC,Nicaragua,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NIC,Nicaragua,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NIC,Nicaragua,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
NIC,Nicaragua,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
NIC,Nicaragua,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
NIC,Nicaragua,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
NIC,Nicaragua,AMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,HW,Health workers,NATIONAL,
NIC,Nicaragua,AMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y13
NIC,Nicaragua,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
NIC,Nicaragua,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
NIC,Nicaragua,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
NIC,Nicaragua,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
NIC,Nicaragua,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
NIC,Nicaragua,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y50
NIC,Nicaragua,AMRO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
NIC,Nicaragua,AMRO,2023,RABIES,Rabies vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+D3
NIC,Nicaragua,AMRO,2023,RABIES,Rabies vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+D7
NIC,Nicaragua,AMRO,2023,RABIES,Rabies vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,+D14
NIC,Nicaragua,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
NIC,Nicaragua,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
NIC,Nicaragua,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y20
NIC,Nicaragua,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y10
NIC,Nicaragua,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
NIC,Nicaragua,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
NIC,Nicaragua,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
NIC,Nicaragua,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
NIC,Nicaragua,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,+Y1
NIC,Nicaragua,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,RISKGROUPS,Risk group(s),NATIONAL,+Y1
NIC,Nicaragua,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M9-Y59
NIC,Nicaragua,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,M9-Y59
NIU,Niue,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
NIU,Niue,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,W6
NIU,Niue,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M3
NIU,Niue,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M5
NIU,Niue,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
NIU,Niue,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,4.0,,General/routine,NATIONAL,M15
NIU,Niue,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y12
NIU,Niue,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
NIU,Niue,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
NIU,Niue,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
NIU,Niue,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
NIU,Niue,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NIU,Niue,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NIU,Niue,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M15
NIU,Niue,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y4
NIU,Niue,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
NIU,Niue,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M3
NIU,Niue,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M5
NIU,Niue,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M15
NIU,Niue,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
NIU,Niue,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M3
NIU,Niue,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y45
NIU,Niue,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,Y65
NIU,Niue,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y11
NIU,Niue,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
NIU,Niue,WPRO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",4.0,B_CHILD_W,General/routine,NATIONAL,Y4
NIU,Niue,WPRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M15
NLD,Netherlands (Kingdom of the),EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M3
NLD,Netherlands (Kingdom of the),EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M5
NLD,Netherlands (Kingdom of the),EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M11
NLD,Netherlands (Kingdom of the),EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
NLD,Netherlands (Kingdom of the),EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y4
NLD,Netherlands (Kingdom of the),EURO,2023,HEPA_HEPB,"Hepatitis A, Hepatitis B vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
NLD,Netherlands (Kingdom of the),EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NLD,Netherlands (Kingdom of the),EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,<D2
NLD,Netherlands (Kingdom of the),EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y10
NLD,Netherlands (Kingdom of the),EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
NLD,Netherlands (Kingdom of the),EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
NLD,Netherlands (Kingdom of the),EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
NLD,Netherlands (Kingdom of the),EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
NLD,Netherlands (Kingdom of the),EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NLD,Netherlands (Kingdom of the),EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NLD,Netherlands (Kingdom of the),EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,M14
NLD,Netherlands (Kingdom of the),EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,,General/routine,NATIONAL,Y14
NLD,Netherlands (Kingdom of the),EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M14
NLD,Netherlands (Kingdom of the),EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y9
NLD,Netherlands (Kingdom of the),EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M3
NLD,Netherlands (Kingdom of the),EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M5
NLD,Netherlands (Kingdom of the),EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M11
NLD,Netherlands (Kingdom of the),EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,
NLD,Netherlands (Kingdom of the),EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
NLD,Netherlands (Kingdom of the),EURO,2023,TDIPV_S,"Td-IPV (Tetanus, diphtheria for older children and adults and IPV) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y9
NOR,Norway,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,W6
NOR,Norway,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M3
NOR,Norway,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M5
NOR,Norway,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M12
NOR,Norway,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,W6
NOR,Norway,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y7
NOR,Norway,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
NOR,Norway,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M1
NOR,Norway,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M3
NOR,Norway,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,M5
NOR,Norway,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,5.0,RISKGROUPS,Risk group(s),NATIONAL,M12
NOR,Norway,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y12
NOR,Norway,EURO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
NOR,Norway,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
NOR,Norway,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
NOR,Norway,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
NOR,Norway,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NOR,Norway,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NOR,Norway,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M15
NOR,Norway,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y11
NOR,Norway,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M3
NOR,Norway,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M5
NOR,Norway,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
NOR,Norway,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
NOR,Norway,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M3
NOR,Norway,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y15
NPL,Nepal,SEARO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
NPL,Nepal,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
NPL,Nepal,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
NPL,Nepal,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
NPL,Nepal,SEARO,2023,IPV_FRAC,IPVf (Inactivated polio vaccine fractional dose),1.0,,General/routine,NATIONAL,W14
NPL,Nepal,SEARO,2023,IPV_FRAC,IPVf (Inactivated polio vaccine fractional dose),2.0,,General/routine,NATIONAL,M9
NPL,Nepal,SEARO,2023,JE_LIVEATD,JE-Livatd (Japanese Encephalitis live-attenuated) vaccine,1.0,,General/routine,NATIONAL,M12
NPL,Nepal,SEARO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
NPL,Nepal,SEARO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M15
NPL,Nepal,SEARO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
NPL,Nepal,SEARO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
NPL,Nepal,SEARO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
NPL,Nepal,SEARO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,W6
NPL,Nepal,SEARO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,W10
NPL,Nepal,SEARO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M9
NPL,Nepal,SEARO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
NPL,Nepal,SEARO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
NPL,Nepal,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
NPL,Nepal,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
NPL,Nepal,SEARO,2023,TYPHOID_CONJ,Typhoid conjugate vaccine,1.0,,General/routine,NATIONAL,M15
NPL,Nepal,SEARO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6-M59
NPL,Nepal,SEARO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,+M6
NRU,Nauru,WPRO,2021,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
NRU,Nauru,WPRO,2021,DTAP,DTaP (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
NRU,Nauru,WPRO,2021,DTAP,DTaP (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
NRU,Nauru,WPRO,2021,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
NRU,Nauru,WPRO,2021,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
NRU,Nauru,WPRO,2021,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
NRU,Nauru,WPRO,2021,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
NRU,Nauru,WPRO,2021,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y11-Y14
NRU,Nauru,WPRO,2021,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,Y11-Y14
NRU,Nauru,WPRO,2021,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
NRU,Nauru,WPRO,2021,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M12
NRU,Nauru,WPRO,2021,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M15
NRU,Nauru,WPRO,2021,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
NRU,Nauru,WPRO,2021,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
NRU,Nauru,WPRO,2021,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
NRU,Nauru,WPRO,2021,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
NRU,Nauru,WPRO,2021,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
NRU,Nauru,WPRO,2021,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
NRU,Nauru,WPRO,2021,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
NRU,Nauru,WPRO,2021,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W14
NRU,Nauru,WPRO,2021,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,
NRU,Nauru,WPRO,2021,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,
NZL,New Zealand,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
NZL,New Zealand,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M3
NZL,New Zealand,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M5
NZL,New Zealand,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,W6
NZL,New Zealand,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NZL,New Zealand,WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y4
NZL,New Zealand,WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NZL,New Zealand,WPRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NZL,New Zealand,WPRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NZL,New Zealand,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NZL,New Zealand,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
NZL,New Zealand,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,4.0,,General/routine,NATIONAL,M15
NZL,New Zealand,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y11-Y13
NZL,New Zealand,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,Y11-Y13
NZL,New Zealand,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,RISKGROUPS,Risk group(s),NATIONAL,
NZL,New Zealand,WPRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NZL,New Zealand,WPRO,2023,MEN_B,Meningococcal B vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,
NZL,New Zealand,WPRO,2023,MEN_B,Meningococcal B vaccine,1.0,,General/routine,NATIONAL,
NZL,New Zealand,WPRO,2023,MEN_B,Meningococcal B vaccine,2.0,,General/routine,NATIONAL,
NZL,New Zealand,WPRO,2023,MEN_B,Meningococcal B vaccine,3.0,,General/routine,NATIONAL,
NZL,New Zealand,WPRO,2023,MEN_B,Meningococcal B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NZL,New Zealand,WPRO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NZL,New Zealand,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M15
NZL,New Zealand,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
NZL,New Zealand,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
NZL,New Zealand,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
NZL,New Zealand,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M5
NZL,New Zealand,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
NZL,New Zealand,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NZL,New Zealand,WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NZL,New Zealand,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
NZL,New Zealand,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M3
NZL,New Zealand,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,ADULTS,Adults,NATIONAL,Y65
NZL,New Zealand,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y11-Y13
NZL,New Zealand,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
NZL,New Zealand,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,Y45
NZL,New Zealand,WPRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M15
NZL,New Zealand,WPRO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
NZL,New Zealand,WPRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y65
NZL,New Zealand,WPRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,2.0,ADULTS,Adults,NATIONAL,Y65
OMN,Oman,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
OMN,Oman,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,B_CHILD_W,General/routine,NATIONAL,Y6
OMN,Oman,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
OMN,Oman,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
OMN,Oman,EMRO,2023,DTWP,DTwP (Whole cell) vaccine,1.0,B_2YL_W,General/routine,NATIONAL,M18
OMN,Oman,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
OMN,Oman,EMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M18
OMN,Oman,EMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,M24
OMN,Oman,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
OMN,Oman,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
OMN,Oman,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
OMN,Oman,EMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
OMN,Oman,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
OMN,Oman,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
OMN,Oman,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
OMN,Oman,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
OMN,Oman,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M24
OMN,Oman,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
OMN,Oman,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,RISKGROUPS,Risk group(s),NATIONAL,
OMN,Oman,EMRO,2023,MEN_ACYW_135PS,Meningococcal ACYW polysaccharide vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
OMN,Oman,EMRO,2023,MEN_ACYW_135PS,Meningococcal ACYW polysaccharide vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
OMN,Oman,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",3.0,ADULTS,Adults,NATIONAL,>Y34
OMN,Oman,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
OMN,Oman,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
OMN,Oman,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M4
OMN,Oman,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M6
OMN,Oman,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M18
OMN,Oman,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
OMN,Oman,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
OMN,Oman,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M13
OMN,Oman,EMRO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
OMN,Oman,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_ADO_W,General/routine,NATIONAL,Y12
OMN,Oman,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,Y16
OMN,Oman,EMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,HW,Health workers,NATIONAL,
OMN,Oman,EMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
OMN,Oman,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
OMN,Oman,EMRO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
OMN,Oman,EMRO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
OMN,Oman,EMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12
OMN,Oman,EMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M12
OMN,Oman,EMRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M18
OMN,Oman,EMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
PAK,Pakistan,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
PAK,Pakistan,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
PAK,Pakistan,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
PAK,Pakistan,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
PAK,Pakistan,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,SUBNATIONAL,B
PAK,Pakistan,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
PAK,Pakistan,EMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
PAK,Pakistan,EMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
PAK,Pakistan,EMRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M15
PAK,Pakistan,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
PAK,Pakistan,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
PAK,Pakistan,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
PAK,Pakistan,EMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
PAK,Pakistan,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
PAK,Pakistan,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
PAK,Pakistan,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
PAK,Pakistan,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
PAK,Pakistan,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
PAK,Pakistan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
PAK,Pakistan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
PAK,Pakistan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
PAK,Pakistan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
PAK,Pakistan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
PAK,Pakistan,EMRO,2023,TYPHOID_CONJ,Typhoid conjugate vaccine,1.0,,General/routine,NATIONAL,M9
PAN,Panama,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
PAN,Panama,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
PAN,Panama,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
PAN,Panama,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
PAN,Panama,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
PAN,Panama,AMRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
PAN,Panama,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,HW,Health workers,NATIONAL,>=Y19
PAN,Panama,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y19
PAN,Panama,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M12
PAN,Panama,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,M18
PAN,Panama,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
PAN,Panama,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
PAN,Panama,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
PAN,Panama,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
PAN,Panama,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
PAN,Panama,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
PAN,Panama,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
PAN,Panama,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
PAN,Panama,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y10
PAN,Panama,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PAN,Panama,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
PAN,Panama,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
PAN,Panama,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
PAN,Panama,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PAN,Panama,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,<Y1
PAN,Panama,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=Y1
PAN,Panama,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PAN,Panama,AMRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
PAN,Panama,AMRO,2023,IPV,IPV (Inactivated polio vaccine),5.0,RISKGROUPS,Risk group(s),NATIONAL,Y4
PAN,Panama,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PAN,Panama,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
PAN,Panama,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
PAN,Panama,AMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,ADULTS,Adults,NATIONAL,>Y19
PAN,Panama,AMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>Y19
PAN,Panama,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>Y60
PAN,Panama,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
PAN,Panama,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
PAN,Panama,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
PAN,Panama,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PAN,Panama,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,Y60
PAN,Panama,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PAN,Panama,AMRO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
PAN,Panama,AMRO,2023,RABIES,Rabies vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+D7
PAN,Panama,AMRO,2023,RABIES,Rabies vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+D28
PAN,Panama,AMRO,2023,RABIES,Rabies vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,+Y1
PAN,Panama,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
PAN,Panama,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
PAN,Panama,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
PAN,Panama,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,>=Y6
PAN,Panama,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,
PAN,Panama,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,ADULTS,Adults,NATIONAL,
PAN,Panama,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y10
PAN,Panama,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
PAN,Panama,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,Y4-Y64
PAN,Panama,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M15
PAN,Panama,AMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y4
PAN,Panama,AMRO,2023,VARICELLA,Varicella vaccine,1.0,HW,Health workers,NATIONAL,
PAN,Panama,AMRO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PAN,Panama,AMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
PAN,Panama,AMRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
PAN,Panama,AMRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
PAN,Panama,AMRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
PAN,Panama,AMRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
PAN,Panama,AMRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
PAN,Panama,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,SUBNATIONAL,Y1
PAN,Panama,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PER,Peru,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
PER,Peru,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,M4
PER,Peru,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M6
PER,Peru,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
PER,Peru,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
PER,Peru,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
PER,Peru,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
PER,Peru,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
PER,Peru,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M15
PER,Peru,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,Y5
PER,Peru,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,CATCHUP_C,Catch-up children,NATIONAL,+M1
PER,Peru,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,CATCHUP_C,Catch-up children,NATIONAL,+M1
PER,Peru,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
PER,Peru,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M4
PER,Peru,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M6
PER,Peru,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9
PER,Peru,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
PER,Peru,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
PER,Peru,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
PER,Peru,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M11
PER,Peru,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,Y1-Y4
PER,Peru,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
PER,Peru,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
PER,Peru,AMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
PER,Peru,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
PER,Peru,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
PER,Peru,AMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M18
PER,Peru,AMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,Y4
PER,Peru,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>Y60
PER,Peru,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
PER,Peru,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
PER,Peru,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
PER,Peru,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
PER,Peru,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
PER,Peru,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,CATCHUP_C,Catch-up children,NATIONAL,+M2
PER,Peru,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,CATCHUP_C,Catch-up children,NATIONAL,+M6
PER,Peru,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_ADO_W,General/routine,NATIONAL,Y12
PER,Peru,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
PER,Peru,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12
PER,Peru,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M15
PHL,Philippines,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
PHL,Philippines,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
PHL,Philippines,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
PHL,Philippines,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
PHL,Philippines,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
PHL,Philippines,WPRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,SUBNATIONAL,Y9-Y14
PHL,Philippines,WPRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,SUBNATIONAL,+M6
PHL,Philippines,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
PHL,Philippines,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
PHL,Philippines,WPRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
PHL,Philippines,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M9
PHL,Philippines,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M12
PHL,Philippines,WPRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,Y5-Y6
PHL,Philippines,WPRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,Y12-Y13
PHL,Philippines,WPRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
PHL,Philippines,WPRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
PHL,Philippines,WPRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
PHL,Philippines,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
PHL,Philippines,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
PHL,Philippines,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
PHL,Philippines,WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,Y60
PHL,Philippines,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y6
PHL,Philippines,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_ADO_W,General/routine,NATIONAL,Y10
PHL,Philippines,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
PHL,Philippines,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
PLW,Palau,WPRO,2023,DTAP,DTaP (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
PLW,Palau,WPRO,2023,DTAP,DTaP (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15
PLW,Palau,WPRO,2023,DTAP,DTaP (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y6
PLW,Palau,WPRO,2023,DTAPHEPBIPV,DTaP-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
PLW,Palau,WPRO,2023,DTAPHEPBIPV,DTaP-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
PLW,Palau,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
PLW,Palau,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,,General/routine,NATIONAL,M2
PLW,Palau,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,,General/routine,NATIONAL,M4
PLW,Palau,WPRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,,General/routine,NATIONAL,M6
PLW,Palau,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,1st contact
PLW,Palau,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
PLW,Palau,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
PLW,Palau,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
PLW,Palau,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
PLW,Palau,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PLW,Palau,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,
PLW,Palau,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,
PLW,Palau,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PLW,Palau,WPRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M3
PLW,Palau,WPRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,Y4-Y6
PLW,Palau,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
PLW,Palau,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M15
PLW,Palau,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M3
PLW,Palau,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M5
PLW,Palau,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M7
PLW,Palau,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M15
PLW,Palau,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
PLW,Palau,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
PLW,Palau,WPRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M6
PLW,Palau,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,>=Y10
PNG,Papua New Guinea,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B-M11
PNG,Papua New Guinea,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M1
PNG,Papua New Guinea,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M2
PNG,Papua New Guinea,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M3
PNG,Papua New Guinea,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
PNG,Papua New Guinea,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M3
PNG,Papua New Guinea,WPRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
PNG,Papua New Guinea,WPRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
PNG,Papua New Guinea,WPRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
PNG,Papua New Guinea,WPRO,2023,MR,MR (Measles and rubella) vaccine,3.0,,General/routine,NATIONAL,Y7
PNG,Papua New Guinea,WPRO,2023,MR,MR (Measles and rubella) vaccine,4.0,,General/routine,NATIONAL,Y13
PNG,Papua New Guinea,WPRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M1
PNG,Papua New Guinea,WPRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M2
PNG,Papua New Guinea,WPRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M3
PNG,Papua New Guinea,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M1
PNG,Papua New Guinea,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M2
PNG,Papua New Guinea,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M3
PNG,Papua New Guinea,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
PNG,Papua New Guinea,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
PNG,Papua New Guinea,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
PNG,Papua New Guinea,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
PNG,Papua New Guinea,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
PNG,Papua New Guinea,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_ADO_W,General/routine,NATIONAL,Y13
PNG,Papua New Guinea,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y7
PNG,Papua New Guinea,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
PNG,Papua New Guinea,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
PNG,Papua New Guinea,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
PNG,Papua New Guinea,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
PNG,Papua New Guinea,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
PNG,Papua New Guinea,WPRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
PNG,Papua New Guinea,WPRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M18
POL,Poland,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
POL,Poland,EURO,2023,D_S,Diphtheria vaccine for older children and adults,1.0,RISKGROUPS,Risk group(s),NATIONAL,
POL,Poland,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,W7-W8
POL,Poland,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M3-M4
POL,Poland,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,M5-M6
POL,Poland,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",4.0,RISKGROUPS,Risk group(s),NATIONAL,M16-M18
POL,Poland,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,W7-W8
POL,Poland,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M3-M4
POL,Poland,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M5-M6
POL,Poland,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,M16-M18
POL,Poland,EURO,2023,DTWP,DTwP (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W7-W8
POL,Poland,EURO,2023,DTWP,DTwP (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3-M4
POL,Poland,EURO,2023,DTWP,DTwP (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M5-M6
POL,Poland,EURO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M16-M18
POL,Poland,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
POL,Poland,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
POL,Poland,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,W7-W8
POL,Poland,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M7
POL,Poland,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,,General/routine,NATIONAL,M2
POL,Poland,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,,General/routine,NATIONAL,M4
POL,Poland,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,,General/routine,NATIONAL,M5-M6
POL,Poland,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,4.0,,General/routine,NATIONAL,M16-M18
POL,Poland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
POL,Poland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
POL,Poland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
POL,Poland,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
POL,Poland,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>M6
POL,Poland,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
POL,Poland,EURO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M16-M18
POL,Poland,EURO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,Y6
POL,Poland,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M4
POL,Poland,EURO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M5-M6
POL,Poland,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M13-M15
POL,Poland,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
POL,Poland,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
POL,Poland,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
POL,Poland,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M13-M15
POL,Poland,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
POL,Poland,EURO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
POL,Poland,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y19
POL,Poland,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
POL,Poland,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y6
POL,Poland,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y14
POL,Poland,EURO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
POL,Poland,EURO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,<Y12
PRK,Democratic People's Republic of Korea,SEARO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
PRK,Democratic People's Republic of Korea,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
PRK,Democratic People's Republic of Korea,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
PRK,Democratic People's Republic of Korea,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
PRK,Democratic People's Republic of Korea,SEARO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
PRK,Democratic People's Republic of Korea,SEARO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
PRK,Democratic People's Republic of Korea,SEARO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
PRK,Democratic People's Republic of Korea,SEARO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
PRK,Democratic People's Republic of Korea,SEARO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRK,Democratic People's Republic of Korea,SEARO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,
PRK,Democratic People's Republic of Korea,SEARO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,
PRK,Democratic People's Republic of Korea,SEARO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRK,Democratic People's Republic of Korea,SEARO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,W14
PRK,Democratic People's Republic of Korea,SEARO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
PRK,Democratic People's Republic of Korea,SEARO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
PRK,Democratic People's Republic of Korea,SEARO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M15
PRK,Democratic People's Republic of Korea,SEARO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
PRK,Democratic People's Republic of Korea,SEARO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
PRK,Democratic People's Republic of Korea,SEARO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
PRK,Democratic People's Republic of Korea,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,
PRK,Democratic People's Republic of Korea,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,
PRK,Democratic People's Republic of Korea,SEARO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6-M11
PRK,Democratic People's Republic of Korea,SEARO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12-M59
PRT,Portugal,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,D0-Y5
PRT,Portugal,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
PRT,Portugal,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
PRT,Portugal,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
PRT,Portugal,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
PRT,Portugal,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
PRT,Portugal,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
PRT,Portugal,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5
PRT,Portugal,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRT,Portugal,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRT,Portugal,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
PRT,Portugal,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRT,Portugal,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
PRT,Portugal,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRT,Portugal,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y10
PRT,Portugal,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
PRT,Portugal,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
PRT,Portugal,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
PRT,Portugal,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
PRT,Portugal,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRT,Portugal,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRT,Portugal,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,HW,Health workers,NATIONAL,
PRT,Portugal,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRT,Portugal,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,TRAVELLERS,Travellers,NATIONAL,
PRT,Portugal,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRT,Portugal,EURO,2023,MEN_B,Meningococcal B vaccine,1.0,,General/routine,NATIONAL,M2
PRT,Portugal,EURO,2023,MEN_B,Meningococcal B vaccine,2.0,,General/routine,NATIONAL,M4
PRT,Portugal,EURO,2023,MEN_B,Meningococcal B vaccine,3.0,,General/routine,NATIONAL,M12
PRT,Portugal,EURO,2023,MEN_B,Meningococcal B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRT,Portugal,EURO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,,General/routine,NATIONAL,M12
PRT,Portugal,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y5
PRT,Portugal,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
PRT,Portugal,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,HW,Health workers,NATIONAL,
PRT,Portugal,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,TRAVELLERS,Travellers,NATIONAL,
PRT,Portugal,EURO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
PRT,Portugal,EURO,2023,MPOX,Mpox (monkeypox) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,D28
PRT,Portugal,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
PRT,Portugal,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
PRT,Portugal,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
PRT,Portugal,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRT,Portugal,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRT,Portugal,EURO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRT,Portugal,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
PRT,Portugal,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
PRT,Portugal,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
PRT,Portugal,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
PRT,Portugal,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
PRT,Portugal,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
PRT,Portugal,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y25
PRT,Portugal,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,Y45
PRT,Portugal,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,Y65
PRT,Portugal,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y10
PRT,Portugal,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y10
PRT,Portugal,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y10
PRT,Portugal,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRT,Portugal,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
PRT,Portugal,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
PRT,Portugal,EURO,2023,TYPHOID_CONJ,Typhoid conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
PRT,Portugal,EURO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
PRY,Paraguay,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
PRY,Paraguay,AMRO,2023,DTAP,DTaP (acellular) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
PRY,Paraguay,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
PRY,Paraguay,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
PRY,Paraguay,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
PRY,Paraguay,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
PRY,Paraguay,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
PRY,Paraguay,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
PRY,Paraguay,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M15
PRY,Paraguay,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
PRY,Paraguay,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
PRY,Paraguay,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
PRY,Paraguay,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
PRY,Paraguay,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
PRY,Paraguay,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
PRY,Paraguay,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
PRY,Paraguay,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+M1
PRY,Paraguay,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,TRAVELLERS,Travellers,NATIONAL,+M6
PRY,Paraguay,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
PRY,Paraguay,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
PRY,Paraguay,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M2
PRY,Paraguay,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9-Y14
PRY,Paraguay,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
PRY,Paraguay,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
PRY,Paraguay,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
PRY,Paraguay,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
PRY,Paraguay,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRY,Paraguay,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M35
PRY,Paraguay,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=Y3
PRY,Paraguay,AMRO,2023,IPV,IPV (Inactivated polio vaccine),5.0,,General/routine,NATIONAL,Y4
PRY,Paraguay,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
PRY,Paraguay,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
PRY,Paraguay,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,HW,Health workers,NATIONAL,
PRY,Paraguay,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+Y5
PRY,Paraguay,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
PRY,Paraguay,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
PRY,Paraguay,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
PRY,Paraguay,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
PRY,Paraguay,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
PRY,Paraguay,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
PRY,Paraguay,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
PRY,Paraguay,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,Y1
PRY,Paraguay,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
PRY,Paraguay,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PRY,Paraguay,AMRO,2023,RABIES,Rabies vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+Y1
PRY,Paraguay,AMRO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
PRY,Paraguay,AMRO,2023,RABIES,Rabies vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+D7
PRY,Paraguay,AMRO,2023,RABIES,Rabies vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+D7
PRY,Paraguay,AMRO,2023,RABIES,Rabies vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
PRY,Paraguay,AMRO,2023,RABIES,Rabies vaccine,3.0,TRAVELLERS,Travellers,NATIONAL,+Y1
PRY,Paraguay,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
PRY,Paraguay,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
PRY,Paraguay,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,CATCHUP_A,Catch-up adults,NATIONAL,+Y1
PRY,Paraguay,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,CATCHUP_A,Catch-up adults,NATIONAL,+Y1
PRY,Paraguay,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,CATCHUP_A,Catch-up adults,NATIONAL,+Y1
PRY,Paraguay,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,CATCHUP_A,Catch-up adults,NATIONAL,1st contact
PRY,Paraguay,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,CATCHUP_A,Catch-up adults,NATIONAL,+M1
PRY,Paraguay,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,CATCHUP_C,Catch-up children,NATIONAL,+M1
PRY,Paraguay,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,>=Y7
PRY,Paraguay,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,CATCHUP_C,Catch-up children,NATIONAL,+Y1
PRY,Paraguay,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,CATCHUP_C,Catch-up children,NATIONAL,+Y1
PRY,Paraguay,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,CATCHUP_C,Catch-up children,NATIONAL,+Y1
PRY,Paraguay,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y10
PRY,Paraguay,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,HW,Health workers,NATIONAL,
PRY,Paraguay,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
PRY,Paraguay,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
PRY,Paraguay,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M15
PRY,Paraguay,AMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y5
PRY,Paraguay,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M12
PRY,Paraguay,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y2-Y59
PRY,Paraguay,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,Y2-Y59
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,W1
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y6
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M1
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M2
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M2
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M4
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y6
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,3.0,,General/routine,NATIONAL,M6
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y15
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,
PSE,"occupied Palestinian territory, including east Jerusalem",EMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
PYF,French Polynesia,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
PYF,French Polynesia,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
PYF,French Polynesia,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M10
PYF,French Polynesia,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
PYF,French Polynesia,WPRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y6
PYF,French Polynesia,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
PYF,French Polynesia,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
PYF,French Polynesia,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
PYF,French Polynesia,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
PYF,French Polynesia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y60
PYF,French Polynesia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
PYF,French Polynesia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
PYF,French Polynesia,WPRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PYF,French Polynesia,WPRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
PYF,French Polynesia,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
PYF,French Polynesia,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
PYF,French Polynesia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
PYF,French Polynesia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M10
PYF,French Polynesia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
PYF,French Polynesia,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
PYF,French Polynesia,WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,,General/routine,NATIONAL,Y5
PYF,French Polynesia,WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M2
PYF,French Polynesia,WPRO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y11
QAT,Qatar,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
QAT,Qatar,EMRO,2023,DTAP,DTaP (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y6
QAT,Qatar,EMRO,2023,DTAPHIB,DTaP-Hib (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
QAT,Qatar,EMRO,2023,DTAPHIBHEPB,DTaP-Hib-HepB (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
QAT,Qatar,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
QAT,Qatar,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
QAT,Qatar,EMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
QAT,Qatar,EMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+M6
QAT,Qatar,EMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M12
QAT,Qatar,EMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,M18
QAT,Qatar,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
QAT,Qatar,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M2
QAT,Qatar,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
QAT,Qatar,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
QAT,Qatar,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M2
QAT,Qatar,EMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
QAT,Qatar,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
QAT,Qatar,EMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9-Y14
QAT,Qatar,EMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
QAT,Qatar,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
QAT,Qatar,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
QAT,Qatar,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
QAT,Qatar,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
QAT,Qatar,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y5
QAT,Qatar,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>Y6
QAT,Qatar,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
QAT,Qatar,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,RISKGROUPS,Risk group(s),NATIONAL,
QAT,Qatar,EMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y2
QAT,Qatar,EMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,>=Y2
QAT,Qatar,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
QAT,Qatar,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
QAT,Qatar,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M6
QAT,Qatar,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M18
QAT,Qatar,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,Y4-Y6
QAT,Qatar,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
QAT,Qatar,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
QAT,Qatar,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
QAT,Qatar,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M15
QAT,Qatar,EMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y2
QAT,Qatar,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
QAT,Qatar,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
QAT,Qatar,EMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y13-Y18
QAT,Qatar,EMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12
QAT,Qatar,EMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y4-Y6
ROU,Romania,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
ROU,Romania,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
ROU,Romania,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
ROU,Romania,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M11
ROU,Romania,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y6
ROU,Romania,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,
ROU,Romania,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,
ROU,Romania,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,
ROU,Romania,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
ROU,Romania,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y11-Y18
ROU,Romania,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
ROU,Romania,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
ROU,Romania,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
ROU,Romania,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ROU,Romania,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y3
ROU,Romania,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>Y3
ROU,Romania,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ROU,Romania,EURO,2023,MEN_AC_CONJ,Meningococcal AC conjugate vaccine,1.0,TRAVELLERS,Travellers,SUBNATIONAL,
ROU,Romania,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,TRAVELLERS,Travellers,SUBNATIONAL,
ROU,Romania,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
ROU,Romania,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y5
ROU,Romania,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
ROU,Romania,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
ROU,Romania,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M11
ROU,Romania,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,
ROU,Romania,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y14
ROU,Romania,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
ROU,Romania,EURO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ROU,Romania,EURO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,TRAVELLERS,Travellers,SUBNATIONAL,
ROU,Romania,EURO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ROU,Romania,EURO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,SUBNATIONAL,
RUS,Russian Federation,EURO,2023,ANTHRAX,Anthrax vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,1st contact
RUS,Russian Federation,EURO,2023,ANTHRAX,Anthrax vaccine,2.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+М1
RUS,Russian Federation,EURO,2023,ANTHRAX,Anthrax vaccine,3.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+Y1-Y2
RUS,Russian Federation,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,D3
RUS,Russian Federation,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,2.0,,General/routine,NATIONAL,Y7
RUS,Russian Federation,EURO,2023,D_S,Diphtheria vaccine for older children and adults,1.0,ADULTS,Adults,NATIONAL,
RUS,Russian Federation,EURO,2023,DIP,"Diphtheria vaccine, children's dose",1.0,,General/routine,NATIONAL,>=Y6
RUS,Russian Federation,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,M3
RUS,Russian Federation,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M4.5
RUS,Russian Federation,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
RUS,Russian Federation,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
RUS,Russian Federation,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,RISKGROUPS,Risk group(s),NATIONAL,Y6
RUS,Russian Federation,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M3
RUS,Russian Federation,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4.5
RUS,Russian Federation,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
RUS,Russian Federation,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
RUS,Russian Federation,EURO,2023,DTWP,DTwP (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M3
RUS,Russian Federation,EURO,2023,DTWP,DTwP (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4.5
RUS,Russian Federation,EURO,2023,DTWP,DTwP (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
RUS,Russian Federation,EURO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
RUS,Russian Federation,EURO,2023,DTWPHEPB,DTwP-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
RUS,Russian Federation,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,HW,Health workers,SUBNATIONAL,1st contact
RUS,Russian Federation,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,HW,Health workers,SUBNATIONAL,+M6-M12
RUS,Russian Federation,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,1st contact
RUS,Russian Federation,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+M6-M12
RUS,Russian Federation,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,SUBNATIONAL,1st contact
RUS,Russian Federation,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,TRAVELLERS,Travellers,SUBNATIONAL,+M6-M12
RUS,Russian Federation,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,SUBNATIONAL,+M6-M12
RUS,Russian Federation,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,SUBNATIONAL,>M12
RUS,Russian Federation,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+M6-M12
RUS,Russian Federation,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,1st contact
RUS,Russian Federation,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,SUBNATIONAL,1st contact
RUS,Russian Federation,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,TRAVELLERS,Travellers,SUBNATIONAL,+M6-M12
RUS,Russian Federation,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
RUS,Russian Federation,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
RUS,Russian Federation,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
RUS,Russian Federation,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
RUS,Russian Federation,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M1
RUS,Russian Federation,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
RUS,Russian Federation,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,,General/routine,NATIONAL,М3
RUS,Russian Federation,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,,General/routine,NATIONAL,M4.5
RUS,Russian Federation,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,,General/routine,NATIONAL,М6
RUS,Russian Federation,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,4.0,,General/routine,NATIONAL,М18
RUS,Russian Federation,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,SUBNATIONAL,Y12-Y14
RUS,Russian Federation,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,SUBNATIONAL,+M2
RUS,Russian Federation,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,3.0,FEMALE,HPV for females only,SUBNATIONAL,+M6
RUS,Russian Federation,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
RUS,Russian Federation,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
RUS,Russian Federation,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
RUS,Russian Federation,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
RUS,Russian Federation,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>Y7
RUS,Russian Federation,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y7
RUS,Russian Federation,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
RUS,Russian Federation,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M3
RUS,Russian Federation,EURO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4.5
RUS,Russian Federation,EURO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
RUS,Russian Federation,EURO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,M18
RUS,Russian Federation,EURO,2023,IPV,IPV (Inactivated polio vaccine),5.0,RISKGROUPS,Risk group(s),NATIONAL,M20
RUS,Russian Federation,EURO,2023,IPV,IPV (Inactivated polio vaccine),6.0,RISKGROUPS,Risk group(s),NATIONAL,Y6
RUS,Russian Federation,EURO,2023,MEASLES,Measles vaccine,3.0,ADULTS,Adults,NATIONAL,Y18-Y35
RUS,Russian Federation,EURO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,Y6
RUS,Russian Federation,EURO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M12
RUS,Russian Federation,EURO,2023,MEASLES,Measles vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y36-Y55
RUS,Russian Federation,EURO,2023,MEN_A_PS,Meningococcal A polysaccharide vaccine,1.0,ADULTS,Adults,SUBNATIONAL,>Y18
RUS,Russian Federation,EURO,2023,MEN_A_PS,Meningococcal A polysaccharide vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,>Y1
RUS,Russian Federation,EURO,2023,MEN_AC_PS,Meningococcal AC polysaccharide vaccine,1.0,ADULTS,Adults,SUBNATIONAL,Y18-Y60
RUS,Russian Federation,EURO,2023,MEN_AC_PS,Meningococcal AC polysaccharide vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,>Y18
RUS,Russian Federation,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,1st contact
RUS,Russian Federation,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+Y3
RUS,Russian Federation,EURO,2023,MM,MM (Measles and mumps) vaccine,1.0,,General/routine,NATIONAL,M12
RUS,Russian Federation,EURO,2023,MM,MM (Measles and mumps) vaccine,2.0,,General/routine,NATIONAL,Y6
RUS,Russian Federation,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
RUS,Russian Federation,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
RUS,Russian Federation,EURO,2023,MUMPS,Mumps vaccine,1.0,,General/routine,NATIONAL,M12
RUS,Russian Federation,EURO,2023,MUMPS,Mumps vaccine,2.0,,General/routine,NATIONAL,Y6
RUS,Russian Federation,EURO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M20
RUS,Russian Federation,EURO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,Y6
RUS,Russian Federation,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
RUS,Russian Federation,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4.5
RUS,Russian Federation,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M15
RUS,Russian Federation,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,SUBNATIONAL,>Y18
RUS,Russian Federation,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,2.0,ADULTS,Adults,SUBNATIONAL,+Y3
RUS,Russian Federation,EURO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,1st contact
RUS,Russian Federation,EURO,2023,RABIES,Rabies vaccine,2.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+D7
RUS,Russian Federation,EURO,2023,RABIES,Rabies vaccine,3.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+D30
RUS,Russian Federation,EURO,2023,RABIES,Rabies vaccine,4.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+Y1
RUS,Russian Federation,EURO,2023,RABIES,Rabies vaccine,5.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+Y3
RUS,Russian Federation,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,SUBNATIONAL,M2
RUS,Russian Federation,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,SUBNATIONAL,M3
RUS,Russian Federation,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,SUBNATIONAL,М4.5
RUS,Russian Federation,EURO,2023,RUBELLA,Rubella vaccine,1.0,,General/routine,NATIONAL,M12
RUS,Russian Federation,EURO,2023,RUBELLA,Rubella vaccine,2.0,,General/routine,NATIONAL,Y6
RUS,Russian Federation,EURO,2023,RUBELLA,Rubella vaccine,3.0,,General/routine,NATIONAL,Y18-Y25
RUS,Russian Federation,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,1.0,ADULTS,Adults,SUBNATIONAL,1st contact
RUS,Russian Federation,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,2.0,ADULTS,Adults,SUBNATIONAL,+М1
RUS,Russian Federation,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,3.0,ADULTS,Adults,SUBNATIONAL,+Y1
RUS,Russian Federation,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,4.0,ADULTS,Adults,SUBNATIONAL,+Y3
RUS,Russian Federation,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,4.0,TRAVELLERS,Travellers,SUBNATIONAL,+Y3
RUS,Russian Federation,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,3.0,TRAVELLERS,Travellers,SUBNATIONAL,+Y1
RUS,Russian Federation,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,2.0,TRAVELLERS,Travellers,SUBNATIONAL,+М1
RUS,Russian Federation,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,1.0,TRAVELLERS,Travellers,SUBNATIONAL,1st contact
RUS,Russian Federation,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,1.0,,General/routine,SUBNATIONAL,Y3
RUS,Russian Federation,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,2.0,,General/routine,SUBNATIONAL,+М1
RUS,Russian Federation,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,3.0,,General/routine,SUBNATIONAL,+Y1
RUS,Russian Federation,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,4.0,,General/routine,SUBNATIONAL,+Y3
RUS,Russian Federation,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,1.0,TRAVELLERS,Travellers,SUBNATIONAL,1st contact
RUS,Russian Federation,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,2.0,TRAVELLERS,Travellers,SUBNATIONAL,+М1
RUS,Russian Federation,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,3.0,TRAVELLERS,Travellers,SUBNATIONAL,+Y1
RUS,Russian Federation,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,4.0,TRAVELLERS,Travellers,SUBNATIONAL,+Y3
RUS,Russian Federation,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,Y24
RUS,Russian Federation,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y10
RUS,Russian Federation,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_CHILD_W,General/routine,NATIONAL,Y6-Y7
RUS,Russian Federation,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,B_ADO_W,General/routine,NATIONAL,Y14
RUS,Russian Federation,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,ADULTS,Adults,SUBNATIONAL,
RUS,Russian Federation,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,>Y6
RUS,Russian Federation,EURO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
RUS,Russian Federation,EURO,2023,TT,TT (Tetanus toxoid) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M6-M12
RUS,Russian Federation,EURO,2023,TULAREMIA,Tularemia vaccine,1.0,ADULTS,Adults,SUBNATIONAL,1st contact
RUS,Russian Federation,EURO,2023,TULAREMIA,Tularemia vaccine,2.0,ADULTS,Adults,SUBNATIONAL,+Y5
RUS,Russian Federation,EURO,2023,TULAREMIA,Tularemia vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,1st contact
RUS,Russian Federation,EURO,2023,TULAREMIA,Tularemia vaccine,2.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+Y5
RUS,Russian Federation,EURO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,1st contact
RUS,Russian Federation,EURO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,2.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+Y3
RUS,Russian Federation,EURO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,SUBNATIONAL,>=М12
RUS,Russian Federation,EURO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,SUBNATIONAL,>М9
RUS,Russian Federation,EURO,2023,YF,YF (Yellow fever) vaccine,2.0,TRAVELLERS,Travellers,SUBNATIONAL,+Y10
RWA,Rwanda,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
RWA,Rwanda,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
RWA,Rwanda,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
RWA,Rwanda,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
RWA,Rwanda,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y12
RWA,Rwanda,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
RWA,Rwanda,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
RWA,Rwanda,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
RWA,Rwanda,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
RWA,Rwanda,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M15
RWA,Rwanda,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
RWA,Rwanda,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
RWA,Rwanda,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
RWA,Rwanda,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
RWA,Rwanda,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
RWA,Rwanda,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
RWA,Rwanda,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
RWA,Rwanda,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
RWA,Rwanda,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
RWA,Rwanda,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
RWA,Rwanda,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
RWA,Rwanda,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
RWA,Rwanda,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
RWA,Rwanda,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
SAU,Saudi Arabia,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,M6
SAU,Saudi Arabia,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,<Y7
SAU,Saudi Arabia,EMRO,2023,DTAP,DTaP (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y6
SAU,Saudi Arabia,EMRO,2023,DTAPHIB,DTaP-Hib (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
SAU,Saudi Arabia,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
SAU,Saudi Arabia,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
SAU,Saudi Arabia,EMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
SAU,Saudi Arabia,EMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M18
SAU,Saudi Arabia,EMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,M24
SAU,Saudi Arabia,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
SAU,Saudi Arabia,EMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,,General/routine,NATIONAL,Y11
SAU,Saudi Arabia,EMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,,General/routine,NATIONAL,Y12
SAU,Saudi Arabia,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y18
SAU,Saudi Arabia,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
SAU,Saudi Arabia,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
SAU,Saudi Arabia,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SAU,Saudi Arabia,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>Y5
SAU,Saudi Arabia,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y5
SAU,Saudi Arabia,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SAU,Saudi Arabia,EMRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
SAU,Saudi Arabia,EMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,M9
SAU,Saudi Arabia,EMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,,General/routine,NATIONAL,M12
SAU,Saudi Arabia,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
SAU,Saudi Arabia,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",3.0,,General/routine,NATIONAL,Y4-Y6
SAU,Saudi Arabia,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
SAU,Saudi Arabia,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,+D30
SAU,Saudi Arabia,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,Y18
SAU,Saudi Arabia,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M6
SAU,Saudi Arabia,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M12
SAU,Saudi Arabia,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M18
SAU,Saudi Arabia,EMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,Y4-Y6
SAU,Saudi Arabia,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
SAU,Saudi Arabia,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
SAU,Saudi Arabia,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
SAU,Saudi Arabia,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M12
SAU,Saudi Arabia,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y18
SAU,Saudi Arabia,EMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
SAU,Saudi Arabia,EMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
SAU,Saudi Arabia,EMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M6
SAU,Saudi Arabia,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,>=Y7
SAU,Saudi Arabia,EMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
SAU,Saudi Arabia,EMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M18
SAU,Saudi Arabia,EMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y4-Y6
SAU,Saudi Arabia,EMRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y50
SAU,Saudi Arabia,EMRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M2-M6
SDN,Sudan,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
SDN,Sudan,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
SDN,Sudan,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
SDN,Sudan,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
SDN,Sudan,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W6
SDN,Sudan,EMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,W14
SDN,Sudan,EMRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
SDN,Sudan,EMRO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,M18
SDN,Sudan,EMRO,2023,MEN_A_CONJ,Meningococcal A conjugate vaccine,1.0,,General/routine,NATIONAL,M9
SDN,Sudan,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
SDN,Sudan,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
SDN,Sudan,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
SDN,Sudan,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
SDN,Sudan,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
SDN,Sudan,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
SDN,Sudan,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
SDN,Sudan,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
SDN,Sudan,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,3.0,,General/routine,NATIONAL,W14
SDN,Sudan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
SDN,Sudan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
SDN,Sudan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
SDN,Sudan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
SDN,Sudan,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
SEN,Senegal,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
SEN,Senegal,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
SEN,Senegal,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
SEN,Senegal,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
SEN,Senegal,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
SEN,Senegal,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
SEN,Senegal,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
SEN,Senegal,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W6
SEN,Senegal,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,W14
SEN,Senegal,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
SEN,Senegal,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M15
SEN,Senegal,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
SEN,Senegal,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
SEN,Senegal,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
SEN,Senegal,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
SEN,Senegal,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
SEN,Senegal,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
SEN,Senegal,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
SEN,Senegal,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
SEN,Senegal,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
SEN,Senegal,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,3.0,,General/routine,NATIONAL,W14
SEN,Senegal,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
SEN,Senegal,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
SEN,Senegal,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
SEN,Senegal,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
SEN,Senegal,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
SEN,Senegal,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
SEN,Senegal,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
SEN,Senegal,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
SEN,Senegal,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
SEN,Senegal,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
SEN,Senegal,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
SEN,Senegal,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
SEN,Senegal,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
SEN,Senegal,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
SEN,Senegal,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
SEN,Senegal,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
SEN,Senegal,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
SGP,Singapore,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
SGP,Singapore,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
SGP,Singapore,WPRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
SGP,Singapore,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
SGP,Singapore,WPRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
SGP,Singapore,WPRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,CATCHUP_A,Catch-up adults,NATIONAL,
SGP,Singapore,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
SGP,Singapore,WPRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,
SGP,Singapore,WPRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y13
SGP,Singapore,WPRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,Y14
SGP,Singapore,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,CATCHUP_A,Catch-up adults,NATIONAL,
SGP,Singapore,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
SGP,Singapore,WPRO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",2.0,,General/routine,NATIONAL,M15
SGP,Singapore,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M4
SGP,Singapore,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M6
SGP,Singapore,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
SGP,Singapore,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SGP,Singapore,WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,,General/routine,NATIONAL,Y2-Y17
SGP,Singapore,WPRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SGP,Singapore,WPRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
SGP,Singapore,WPRO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y11
SGP,Singapore,WPRO,2023,VARICELLA,Varicella vaccine,1.0,CATCHUP_A,Catch-up adults,NATIONAL,
SGP,Singapore,WPRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12
SLB,Solomon Islands,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
SLB,Solomon Islands,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
SLB,Solomon Islands,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
SLB,Solomon Islands,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
SLB,Solomon Islands,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
SLB,Solomon Islands,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
SLB,Solomon Islands,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
SLB,Solomon Islands,WPRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M12
SLB,Solomon Islands,WPRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
SLB,Solomon Islands,WPRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
SLB,Solomon Islands,WPRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
SLB,Solomon Islands,WPRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
SLB,Solomon Islands,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
SLB,Solomon Islands,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
SLB,Solomon Islands,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
SLB,Solomon Islands,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
SLB,Solomon Islands,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
SLB,Solomon Islands,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
SLB,Solomon Islands,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
SLB,Solomon Islands,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
SLB,Solomon Islands,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
SLE,Sierra Leone,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
SLE,Sierra Leone,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
SLE,Sierra Leone,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
SLE,Sierra Leone,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
SLE,Sierra Leone,AFRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10
SLE,Sierra Leone,AFRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
SLE,Sierra Leone,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
SLE,Sierra Leone,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
SLE,Sierra Leone,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
SLE,Sierra Leone,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M15
SLE,Sierra Leone,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
SLE,Sierra Leone,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
SLE,Sierra Leone,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
SLE,Sierra Leone,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
SLE,Sierra Leone,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
SLE,Sierra Leone,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
SLE,Sierra Leone,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
SLE,Sierra Leone,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
SLE,Sierra Leone,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
SLE,Sierra Leone,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
SLE,Sierra Leone,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
SLE,Sierra Leone,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
SLE,Sierra Leone,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
SLE,Sierra Leone,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
SLE,Sierra Leone,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
SLE,Sierra Leone,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
SLE,Sierra Leone,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
SLE,Sierra Leone,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
SLE,Sierra Leone,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,1st contact
SLE,Sierra Leone,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
SLE,Sierra Leone,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
SLE,Sierra Leone,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
SLE,Sierra Leone,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
SLE,Sierra Leone,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
SLE,Sierra Leone,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
SLE,Sierra Leone,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
SLV,El Salvador,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
SLV,El Salvador,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
SLV,El Salvador,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
SLV,El Salvador,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
SLV,El Salvador,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",4.0,RISKGROUPS,Risk group(s),NATIONAL,M15-M18
SLV,El Salvador,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,RISKGROUPS,Risk group(s),NATIONAL,Y4
SLV,El Salvador,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,4.0,,General/routine,NATIONAL,M18
SLV,El Salvador,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
SLV,El Salvador,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
SLV,El Salvador,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
SLV,El Salvador,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
SLV,El Salvador,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15-M18
SLV,El Salvador,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M15
SLV,El Salvador,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,M24
SLV,El Salvador,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
SLV,El Salvador,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
SLV,El Salvador,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
SLV,El Salvador,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
SLV,El Salvador,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
SLV,El Salvador,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
SLV,El Salvador,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
SLV,El Salvador,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
SLV,El Salvador,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
SLV,El Salvador,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y60
SLV,El Salvador,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
SLV,El Salvador,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
SLV,El Salvador,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SLV,El Salvador,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y4
SLV,El Salvador,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
SLV,El Salvador,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
SLV,El Salvador,AMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
SLV,El Salvador,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
SLV,El Salvador,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M15-M18
SLV,El Salvador,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M15-M18
SLV,El Salvador,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4
SLV,El Salvador,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>Y60
SLV,El Salvador,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
SLV,El Salvador,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,Y1
SLV,El Salvador,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
SLV,El Salvador,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SLV,El Salvador,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>Y60
SLV,El Salvador,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SLV,El Salvador,AMRO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SLV,El Salvador,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
SLV,El Salvador,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
SLV,El Salvador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,
SLV,El Salvador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y10
SLV,El Salvador,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,
SLV,El Salvador,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,HW,Health workers,NATIONAL,
SLV,El Salvador,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
SLV,El Salvador,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M15
SLV,El Salvador,AMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y4
SLV,El Salvador,AMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
SLV,El Salvador,AMRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M11
SLV,El Salvador,AMRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,Y1
SLV,El Salvador,AMRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,Y4
SLV,El Salvador,AMRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,Y5
SLV,El Salvador,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,>=Y1
SMR,San Marino,EURO,2023,CHOLERA,Cholera vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
SMR,San Marino,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M3
SMR,San Marino,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M5
SMR,San Marino,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M11
SMR,San Marino,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y5
SMR,San Marino,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,,General/routine,NATIONAL,Y15
SMR,San Marino,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SMR,San Marino,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
SMR,San Marino,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SMR,San Marino,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
SMR,San Marino,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SMR,San Marino,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
SMR,San Marino,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SMR,San Marino,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y11-Y14
SMR,San Marino,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
SMR,San Marino,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y65
SMR,San Marino,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
SMR,San Marino,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
SMR,San Marino,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SMR,San Marino,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SMR,San Marino,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,TRAVELLERS,Travellers,NATIONAL,
SMR,San Marino,EURO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
SMR,San Marino,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,M13
SMR,San Marino,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,,General/routine,NATIONAL,Y13
SMR,San Marino,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SMR,San Marino,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
SMR,San Marino,EURO,2023,MEN_B,Meningococcal B vaccine,1.0,,General/routine,NATIONAL,M4
SMR,San Marino,EURO,2023,MEN_B,Meningococcal B vaccine,2.0,,General/routine,NATIONAL,M6
SMR,San Marino,EURO,2023,MEN_B,Meningococcal B vaccine,3.0,,General/routine,NATIONAL,M13
SMR,San Marino,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M15
SMR,San Marino,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
SMR,San Marino,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M3
SMR,San Marino,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M5
SMR,San Marino,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M11
SMR,San Marino,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SMR,San Marino,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SMR,San Marino,EURO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SMR,San Marino,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SMR,San Marino,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,ADULTS,Adults,NATIONAL,Y25
SMR,San Marino,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",2.0,ADULTS,Adults,NATIONAL,+Y10
SMR,San Marino,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",3.0,ADULTS,Adults,NATIONAL,+Y10
SMR,San Marino,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",4.0,ADULTS,Adults,NATIONAL,+Y10
SMR,San Marino,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,ADULTS,Adults,NATIONAL,+Y10
SMR,San Marino,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,ADULTS,Adults,NATIONAL,+Y10
SMR,San Marino,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y15
SMR,San Marino,EURO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,ADULTS,Adults,NATIONAL,Y25
SMR,San Marino,EURO,2023,TT,TT (Tetanus toxoid) vaccine,2.0,ADULTS,Adults,NATIONAL,+Y10
SMR,San Marino,EURO,2023,TT,TT (Tetanus toxoid) vaccine,3.0,ADULTS,Adults,NATIONAL,+Y10
SMR,San Marino,EURO,2023,TT,TT (Tetanus toxoid) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y10
SMR,San Marino,EURO,2023,TT,TT (Tetanus toxoid) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y10
SMR,San Marino,EURO,2023,TT,TT (Tetanus toxoid) vaccine,6.0,ADULTS,Adults,NATIONAL,+Y10
SMR,San Marino,EURO,2023,TYPHOID_CONJ,Typhoid conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
SMR,San Marino,EURO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
SMR,San Marino,EURO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M15
SMR,San Marino,EURO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y6
SMR,San Marino,EURO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
SMR,San Marino,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SOM,Somalia,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
SOM,Somalia,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
SOM,Somalia,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
SOM,Somalia,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
SOM,Somalia,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
SOM,Somalia,EMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
SOM,Somalia,EMRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
SOM,Somalia,EMRO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,M15
SOM,Somalia,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
SOM,Somalia,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
SOM,Somalia,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
SOM,Somalia,EMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
SOM,Somalia,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
SOM,Somalia,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
SOM,Somalia,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
SOM,Somalia,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
SOM,Somalia,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
SOM,Somalia,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
SOM,Somalia,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
SOM,Somalia,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
SOM,Somalia,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
SOM,Somalia,EMRO,2023,TT,TT (Tetanus toxoid) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
SOM,Somalia,EMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M36
SRB,Serbia,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
SRB,Serbia,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,W8
SRB,Serbia,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,W14
SRB,Serbia,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,W20
SRB,Serbia,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
SRB,Serbia,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y7
SRB,Serbia,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
SRB,Serbia,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
SRB,Serbia,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SRB,Serbia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
SRB,Serbia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,W4
SRB,Serbia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
SRB,Serbia,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SRB,Serbia,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9-Y19
SRB,Serbia,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
SRB,Serbia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y65
SRB,Serbia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
SRB,Serbia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
SRB,Serbia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SRB,Serbia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SRB,Serbia,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,HW,Health workers,NATIONAL,
SRB,Serbia,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SRB,Serbia,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
SRB,Serbia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
SRB,Serbia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y7
SRB,Serbia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,HW,Health workers,NATIONAL,
SRB,Serbia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
SRB,Serbia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W20
SRB,Serbia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M18
SRB,Serbia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W8
SRB,Serbia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SRB,Serbia,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SRB,Serbia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y14
SRB,Serbia,EURO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SRB,Serbia,EURO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
SRB,Serbia,EURO,2023,VARICELLA,Varicella vaccine,1.0,HW,Health workers,NATIONAL,
SRB,Serbia,EURO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SRB,Serbia,EURO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
SSD,South Sudan,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
SSD,South Sudan,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
SSD,South Sudan,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
SSD,South Sudan,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
SSD,South Sudan,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
SSD,South Sudan,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
SSD,South Sudan,AFRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
SSD,South Sudan,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
SSD,South Sudan,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
SSD,South Sudan,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
SSD,South Sudan,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
SSD,South Sudan,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
SSD,South Sudan,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
SSD,South Sudan,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
SSD,South Sudan,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
SSD,South Sudan,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
SSD,South Sudan,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
SSD,South Sudan,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
SSD,South Sudan,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,Y15
SSD,South Sudan,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
STP,Sao Tome and Principe,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
STP,Sao Tome and Principe,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
STP,Sao Tome and Principe,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
STP,Sao Tome and Principe,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
STP,Sao Tome and Principe,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
STP,Sao Tome and Principe,AFRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,W14
STP,Sao Tome and Principe,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
STP,Sao Tome and Principe,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
STP,Sao Tome and Principe,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
STP,Sao Tome and Principe,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
STP,Sao Tome and Principe,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
STP,Sao Tome and Principe,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
STP,Sao Tome and Principe,AFRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,M15
STP,Sao Tome and Principe,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
STP,Sao Tome and Principe,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
STP,Sao Tome and Principe,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
STP,Sao Tome and Principe,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,W6
STP,Sao Tome and Principe,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,W10
STP,Sao Tome and Principe,AFRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,W14
STP,Sao Tome and Principe,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
STP,Sao Tome and Principe,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
STP,Sao Tome and Principe,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
STP,Sao Tome and Principe,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
STP,Sao Tome and Principe,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y2
STP,Sao Tome and Principe,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
STP,Sao Tome and Principe,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
STP,Sao Tome and Principe,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
STP,Sao Tome and Principe,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
STP,Sao Tome and Principe,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
STP,Sao Tome and Principe,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
STP,Sao Tome and Principe,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,RISKGROUPS,Risk group(s),NATIONAL,
STP,Sao Tome and Principe,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
SUR,Suriname,AMRO,2023,DTAP,DTaP (acellular) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
SUR,Suriname,AMRO,2023,DTAP,DTaP (acellular) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
SUR,Suriname,AMRO,2023,DTAP,DTaP (acellular) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
SUR,Suriname,AMRO,2023,DTAP,DTaP (acellular) vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
SUR,Suriname,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
SUR,Suriname,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y5
SUR,Suriname,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
SUR,Suriname,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
SUR,Suriname,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
SUR,Suriname,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
SUR,Suriname,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
SUR,Suriname,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
SUR,Suriname,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
SUR,Suriname,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
SUR,Suriname,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
SUR,Suriname,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
SUR,Suriname,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
SUR,Suriname,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
SUR,Suriname,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
SUR,Suriname,AMRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9-Y13
SUR,Suriname,AMRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
SUR,Suriname,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,,>Y18
SUR,Suriname,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,,
SUR,Suriname,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,,
SUR,Suriname,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),,
SUR,Suriname,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
SUR,Suriname,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SUR,Suriname,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
SUR,Suriname,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
SUR,Suriname,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
SUR,Suriname,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
SUR,Suriname,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
SUR,Suriname,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
SUR,Suriname,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
SUR,Suriname,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
SUR,Suriname,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4-Y5
SUR,Suriname,AMRO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
SUR,Suriname,AMRO,2023,RABIES,Rabies vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+D3
SUR,Suriname,AMRO,2023,RABIES,Rabies vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+D7
SUR,Suriname,AMRO,2023,RABIES,Rabies vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,+D14
SUR,Suriname,AMRO,2023,RABIES,Rabies vaccine,5.0,RISKGROUPS,Risk group(s),NATIONAL,+D28
SUR,Suriname,AMRO,2023,RABIES,Rabies vaccine,5.0,TRAVELLERS,Travellers,NATIONAL,+D28
SUR,Suriname,AMRO,2023,RABIES,Rabies vaccine,4.0,TRAVELLERS,Travellers,NATIONAL,+D14
SUR,Suriname,AMRO,2023,RABIES,Rabies vaccine,3.0,TRAVELLERS,Travellers,NATIONAL,+D7
SUR,Suriname,AMRO,2023,RABIES,Rabies vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+D3
SUR,Suriname,AMRO,2023,RABIES,Rabies vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
SUR,Suriname,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
SUR,Suriname,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+Y1
SUR,Suriname,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M6
SUR,Suriname,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
SUR,Suriname,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+Y1
SUR,Suriname,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
SUR,Suriname,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M12
SUR,Suriname,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
SVK,Slovakia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
SVK,Slovakia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
SVK,Slovakia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M10
SVK,Slovakia,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y5
SVK,Slovakia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
SVK,Slovakia,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y12
SVK,Slovakia,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M5-M13
SVK,Slovakia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
SVK,Slovakia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
SVK,Slovakia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
SVK,Slovakia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVK,Slovakia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y15
SVK,Slovakia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>Y15
SVK,Slovakia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVK,Slovakia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M14
SVK,Slovakia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y4-Y10
SVK,Slovakia,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
SVK,Slovakia,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
SVK,Slovakia,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M10
SVK,Slovakia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
SVK,Slovakia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
SVK,Slovakia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M10
SVK,Slovakia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,ADULTS,Adults,NATIONAL,Y30
SVK,Slovakia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,7.0,ADULTS,Adults,NATIONAL,+Y15
SVK,Slovakia,EURO,2023,TDAP_S_IPV,"Tdap-IPV (Tetanus, diphtheria for older children and adults, acellular pertussis and IPV) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y12
SVN,Slovenia,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
SVN,Slovenia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M3
SVN,Slovenia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M5
SVN,Slovenia,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M11-M18
SVN,Slovenia,EURO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,HEPA_HEPB,"Hepatitis A, Hepatitis B vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
SVN,Slovenia,EURO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,Y5
SVN,Slovenia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,Y5
SVN,Slovenia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,Y6
SVN,Slovenia,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
SVN,Slovenia,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y11
SVN,Slovenia,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,Y12
SVN,Slovenia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
SVN,Slovenia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
SVN,Slovenia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
SVN,Slovenia,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-M23
SVN,Slovenia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,Y2-Y18
SVN,Slovenia,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,MEN_B,Meningococcal B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y5
SVN,Slovenia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M11-M18
SVN,Slovenia,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M3
SVN,Slovenia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M5
SVN,Slovenia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M11-M18
SVN,Slovenia,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,PCV20,PCV-20 (Pneumococcal conjugate vaccine 20-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,>Y65
SVN,Slovenia,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,1.0,ADULTS,Adults,NATIONAL,Y49
SVN,Slovenia,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1-M3
SVN,Slovenia,EURO,2023,TBE_ADULT,Adult TBE (tick borne encephalitis) vaccine,3.0,ADULTS,Adults,NATIONAL,+M5-M12
SVN,Slovenia,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,1.0,,General/routine,NATIONAL,Y1
SVN,Slovenia,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,2.0,,General/routine,NATIONAL,+M1-M3
SVN,Slovenia,EURO,2023,TBE_PEDIATRIC,Pediatric TBE (tick borne encephalitis) vaccine,3.0,,General/routine,NATIONAL,+M5-M12
SVN,Slovenia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,
SVN,Slovenia,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,B_ADO_F,General/routine,NATIONAL,Y8
SVN,Slovenia,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
SVN,Slovenia,EURO,2023,TT,TT (Tetanus toxoid) vaccine,6.0,,General/routine,NATIONAL,Y17
SVN,Slovenia,EURO,2023,VARICELLA,Varicella vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SVN,Slovenia,EURO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SWE,Sweden,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,W6-M6
SWE,Sweden,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M3
SWE,Sweden,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M5
SWE,Sweden,EURO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M12
SWE,Sweden,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y5
SWE,Sweden,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,B
SWE,Sweden,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M1
SWE,Sweden,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y10-Y11
SWE,Sweden,EURO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,Y11-Y12
SWE,Sweden,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y65
SWE,Sweden,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
SWE,Sweden,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
SWE,Sweden,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SWE,Sweden,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SWE,Sweden,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M18
SWE,Sweden,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6-Y8
SWE,Sweden,EURO,2023,MPOX,Mpox (monkeypox) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SWE,Sweden,EURO,2023,PCV_15_VALENT,PCV-15 (Pneumococcal conjugate vaccine 15-valent) vaccine,1.0,,General/routine,NATIONAL,M3
SWE,Sweden,EURO,2023,PCV_15_VALENT,PCV-15 (Pneumococcal conjugate vaccine 15-valent) vaccine,2.0,,General/routine,NATIONAL,M5
SWE,Sweden,EURO,2023,PCV_15_VALENT,PCV-15 (Pneumococcal conjugate vaccine 15-valent) vaccine,3.0,,General/routine,NATIONAL,M12
SWE,Sweden,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M3
SWE,Sweden,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M5
SWE,Sweden,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12
SWE,Sweden,EURO,2023,PCV20,PCV-20 (Pneumococcal conjugate vaccine 20-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SWE,Sweden,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,Y75
SWE,Sweden,EURO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y65
SWE,Sweden,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
SWE,Sweden,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M3
SWE,Sweden,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,W6
SWE,Sweden,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M3
SWE,Sweden,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M5
SWE,Sweden,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",5.0,B_ADO_W,General/routine,NATIONAL,Y14-Y16
SWE,Sweden,EURO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,SUBNATIONAL,
SWZ,Eswatini,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
SWZ,Eswatini,AFRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,B_CHILD_W,General/routine,NATIONAL,Y5
SWZ,Eswatini,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
SWZ,Eswatini,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
SWZ,Eswatini,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
SWZ,Eswatini,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
SWZ,Eswatini,AFRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
SWZ,Eswatini,AFRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+W4
SWZ,Eswatini,AFRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+W4
SWZ,Eswatini,AFRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+W4
SWZ,Eswatini,AFRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+W4
SWZ,Eswatini,AFRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
SWZ,Eswatini,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
SWZ,Eswatini,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
SWZ,Eswatini,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
SWZ,Eswatini,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
SWZ,Eswatini,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
SWZ,Eswatini,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
SWZ,Eswatini,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
SWZ,Eswatini,AFRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,M18
SWZ,Eswatini,AFRO,2023,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,Y5
SWZ,Eswatini,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
SWZ,Eswatini,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
SWZ,Eswatini,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
SWZ,Eswatini,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
SWZ,Eswatini,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
SWZ,Eswatini,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
SWZ,Eswatini,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+W4
SWZ,Eswatini,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
SWZ,Eswatini,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
SWZ,Eswatini,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
SWZ,Eswatini,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,PW,Pregnant women,NATIONAL,+Y1
SWZ,Eswatini,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
SWZ,Eswatini,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
SWZ,Eswatini,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
SWZ,Eswatini,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
SWZ,Eswatini,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
SWZ,Eswatini,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
SWZ,Eswatini,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,,
SXM,Sint Maarten (Dutch part),AMRO,2019,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M4
SXM,Sint Maarten (Dutch part),AMRO,2019,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
SXM,Sint Maarten (Dutch part),AMRO,2019,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M3
SXM,Sint Maarten (Dutch part),AMRO,2019,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M12
SXM,Sint Maarten (Dutch part),AMRO,2019,DTIPV,DT-IPV (Diphtheria and tetanus toxoid and IPV) vaccine,6.0,,General/routine,NATIONAL,Y9
SXM,Sint Maarten (Dutch part),AMRO,2019,DTIPV,DT-IPV (Diphtheria and tetanus toxoid and IPV) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
SXM,Sint Maarten (Dutch part),AMRO,2019,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M7
SXM,Sint Maarten (Dutch part),AMRO,2019,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
SXM,Sint Maarten (Dutch part),AMRO,2019,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
SXM,Sint Maarten (Dutch part),AMRO,2019,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M3
SXM,Sint Maarten (Dutch part),AMRO,2019,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
SXM,Sint Maarten (Dutch part),AMRO,2019,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,M2
SXM,Sint Maarten (Dutch part),AMRO,2019,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,+M6
SXM,Sint Maarten (Dutch part),AMRO,2019,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,Y9-Y11
SXM,Sint Maarten (Dutch part),AMRO,2019,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,Y1
SXM,Sint Maarten (Dutch part),AMRO,2019,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y4
SXM,Sint Maarten (Dutch part),AMRO,2019,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M6
SXM,Sint Maarten (Dutch part),AMRO,2019,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M15
SXM,Sint Maarten (Dutch part),AMRO,2019,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M4
SXM,Sint Maarten (Dutch part),AMRO,2019,YF,YF (Yellow fever) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
SYC,Seychelles,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
SYC,Seychelles,AFRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y6
SYC,Seychelles,AFRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
SYC,Seychelles,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M3
SYC,Seychelles,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
SYC,Seychelles,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M5
SYC,Seychelles,AFRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
SYC,Seychelles,AFRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
SYC,Seychelles,AFRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
SYC,Seychelles,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
SYC,Seychelles,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10
SYC,Seychelles,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,Y11
SYC,Seychelles,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M4
SYC,Seychelles,AFRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M15
SYC,Seychelles,AFRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
SYC,Seychelles,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,ADULTS,Adults,NATIONAL,
SYC,Seychelles,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M3
SYC,Seychelles,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M4
SYC,Seychelles,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M5
SYC,Seychelles,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
SYC,Seychelles,AFRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y6
SYC,Seychelles,AFRO,2023,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,Y15
SYC,Seychelles,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M3
SYC,Seychelles,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
SYC,Seychelles,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M5
SYC,Seychelles,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M3
SYC,Seychelles,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
SYC,Seychelles,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y25
SYC,Seychelles,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y15
SYC,Seychelles,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,
SYC,Seychelles,AFRO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y25
SYC,Seychelles,AFRO,2023,TT,TT (Tetanus toxoid) vaccine,6.0,,General/routine,NATIONAL,Y15
SYC,Seychelles,AFRO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,PW,Pregnant women,NATIONAL,
SYC,Seychelles,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M12
SYC,Seychelles,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
SYR,Syrian Arab Republic,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
SYR,Syrian Arab Republic,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y6
SYR,Syrian Arab Republic,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W8
SYR,Syrian Arab Republic,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W16
SYR,Syrian Arab Republic,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W24
SYR,Syrian Arab Republic,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
SYR,Syrian Arab Republic,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
SYR,Syrian Arab Republic,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y55
SYR,Syrian Arab Republic,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SYR,Syrian Arab Republic,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
SYR,Syrian Arab Republic,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
SYR,Syrian Arab Republic,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W8
SYR,Syrian Arab Republic,EMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,W16
SYR,Syrian Arab Republic,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
SYR,Syrian Arab Republic,EMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
SYR,Syrian Arab Republic,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
SYR,Syrian Arab Republic,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W24
SYR,Syrian Arab Republic,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M12
SYR,Syrian Arab Republic,EMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
SYR,Syrian Arab Republic,EMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y6
SYR,Syrian Arab Republic,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
SYR,Syrian Arab Republic,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
SYR,Syrian Arab Republic,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
SYR,Syrian Arab Republic,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
SYR,Syrian Arab Republic,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
SYR,Syrian Arab Republic,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y12
SYR,Syrian Arab Republic,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
SYR,Syrian Arab Republic,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
SYR,Syrian Arab Republic,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
SYR,Syrian Arab Republic,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
SYR,Syrian Arab Republic,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
SYR,Syrian Arab Republic,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
SYR,Syrian Arab Republic,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
SYR,Syrian Arab Republic,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
SYR,Syrian Arab Republic,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,+Y1
SYR,Syrian Arab Republic,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,RISKGROUPS,Risk group(s),NATIONAL,+Y1
SYR,Syrian Arab Republic,EMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M12
SYR,Syrian Arab Republic,EMRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M18
TCA,Turks and Caicos Islands,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B-M24
TCA,Turks and Caicos Islands,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,CATCHUP_C,Catch-up children,NATIONAL,Y7-Y11
TCA,Turks and Caicos Islands,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
TCA,Turks and Caicos Islands,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_F,General/routine,NATIONAL,Y3
TCA,Turks and Caicos Islands,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
TCA,Turks and Caicos Islands,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
TCA,Turks and Caicos Islands,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
TCA,Turks and Caicos Islands,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,>=Y15
TCA,Turks and Caicos Islands,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,CATCHUP_C,Catch-up children,NATIONAL,+M1
TCA,Turks and Caicos Islands,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,CATCHUP_C,Catch-up children,NATIONAL,+M6
TCA,Turks and Caicos Islands,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
TCA,Turks and Caicos Islands,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y11
TCA,Turks and Caicos Islands,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
TCA,Turks and Caicos Islands,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
TCA,Turks and Caicos Islands,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
TCA,Turks and Caicos Islands,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
TCA,Turks and Caicos Islands,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
TCA,Turks and Caicos Islands,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=M6
TCA,Turks and Caicos Islands,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
TCA,Turks and Caicos Islands,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
TCA,Turks and Caicos Islands,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
TCA,Turks and Caicos Islands,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,Y1
TCA,Turks and Caicos Islands,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y3
TCA,Turks and Caicos Islands,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
TCA,Turks and Caicos Islands,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
TCA,Turks and Caicos Islands,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y3
TCA,Turks and Caicos Islands,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,CATCHUP_A,Catch-up adults,NATIONAL,1st contact
TCA,Turks and Caicos Islands,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,CATCHUP_A,Catch-up adults,NATIONAL,+M1
TCA,Turks and Caicos Islands,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,CATCHUP_A,Catch-up adults,NATIONAL,+M6
TCA,Turks and Caicos Islands,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,CATCHUP_C,Catch-up children,NATIONAL,+M1
TCA,Turks and Caicos Islands,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,CATCHUP_C,Catch-up children,NATIONAL,+M6
TCA,Turks and Caicos Islands,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,CATCHUP_C,Catch-up children,NATIONAL,1st contact
TCA,Turks and Caicos Islands,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y11-Y12
TCA,Turks and Caicos Islands,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
TCA,Turks and Caicos Islands,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
TCA,Turks and Caicos Islands,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
TCA,Turks and Caicos Islands,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,>=M9
TCD,Chad,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
TCD,Chad,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
TCD,Chad,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
TCD,Chad,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
TCD,Chad,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
TCD,Chad,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
TCD,Chad,AFRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
TCD,Chad,AFRO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,M15
TCD,Chad,AFRO,2023,MEN_A_CONJ,Meningococcal A conjugate vaccine,1.0,,General/routine,NATIONAL,M9
TCD,Chad,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
TCD,Chad,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
TCD,Chad,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
TCD,Chad,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
TCD,Chad,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
TCD,Chad,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
TCD,Chad,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
TCD,Chad,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
TCD,Chad,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
TCD,Chad,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
TCD,Chad,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
TCD,Chad,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
TCD,Chad,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
TCD,Chad,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
TCD,Chad,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M9
TCD,Chad,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
TGO,Togo,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
TGO,Togo,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
TGO,Togo,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
TGO,Togo,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
TGO,Togo,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
TGO,Togo,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
TGO,Togo,AFRO,2023,MEN_A_CONJ,Meningococcal A conjugate vaccine,1.0,,General/routine,NATIONAL,M15
TGO,Togo,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
TGO,Togo,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M15
TGO,Togo,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
TGO,Togo,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
TGO,Togo,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
TGO,Togo,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
TGO,Togo,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
TGO,Togo,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
TGO,Togo,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
TGO,Togo,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
TGO,Togo,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
TGO,Togo,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
TGO,Togo,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
TGO,Togo,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
TGO,Togo,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
TGO,Togo,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
TGO,Togo,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M9
TGO,Togo,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
THA,Thailand,SEARO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
THA,Thailand,SEARO,2023,DTWP,DTwP (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
THA,Thailand,SEARO,2023,DTWP,DTwP (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
THA,Thailand,SEARO,2023,DTWP,DTwP (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
THA,Thailand,SEARO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,Y1.5
THA,Thailand,SEARO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
THA,Thailand,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
THA,Thailand,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
THA,Thailand,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
THA,Thailand,SEARO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
THA,Thailand,SEARO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
THA,Thailand,SEARO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
THA,Thailand,SEARO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
THA,Thailand,SEARO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
THA,Thailand,SEARO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M1
THA,Thailand,SEARO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y11
THA,Thailand,SEARO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
THA,Thailand,SEARO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
THA,Thailand,SEARO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
THA,Thailand,SEARO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
THA,Thailand,SEARO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
THA,Thailand,SEARO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
THA,Thailand,SEARO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
THA,Thailand,SEARO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
THA,Thailand,SEARO,2023,JE_LIVEATD,JE-Livatd (Japanese Encephalitis live-attenuated) vaccine,1.0,,General/routine,NATIONAL,Y1
THA,Thailand,SEARO,2023,JE_LIVEATD,JE-Livatd (Japanese Encephalitis live-attenuated) vaccine,2.0,,General/routine,NATIONAL,Y2.5
THA,Thailand,SEARO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M9-Y55
THA,Thailand,SEARO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+Y5
THA,Thailand,SEARO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,M9-Y55
THA,Thailand,SEARO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+Y5
THA,Thailand,SEARO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M9
THA,Thailand,SEARO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y1.5
THA,Thailand,SEARO,2023,MR,MR (Measles and rubella) vaccine,1.0,HW,Health workers,NATIONAL,
THA,Thailand,SEARO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
THA,Thailand,SEARO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,Y1.5
THA,Thailand,SEARO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4
THA,Thailand,SEARO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
THA,Thailand,SEARO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
THA,Thailand,SEARO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M6
THA,Thailand,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
THA,Thailand,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
THA,Thailand,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
THA,Thailand,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y10
THA,Thailand,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y10
THA,Thailand,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,ADULTS,Adults,NATIONAL,+Y10
THA,Thailand,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_ADO_W,General/routine,NATIONAL,Y12
THA,Thailand,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
THA,Thailand,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
THA,Thailand,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
THA,Thailand,SEARO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,>=M9
TJK,Tajikistan,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,D3-D5
TJK,Tajikistan,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,B_CHILD_W,General/routine,NATIONAL,Y6
TJK,Tajikistan,EURO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,М16-M23
TJK,Tajikistan,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,М2
TJK,Tajikistan,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,М3
TJK,Tajikistan,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,М4
TJK,Tajikistan,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
TJK,Tajikistan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
TJK,Tajikistan,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,М3
TJK,Tajikistan,EURO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
TJK,Tajikistan,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
TJK,Tajikistan,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
TJK,Tajikistan,EURO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
TJK,Tajikistan,EURO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,М2
TJK,Tajikistan,EURO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,М3
TJK,Tajikistan,EURO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,М4
TJK,Tajikistan,EURO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,М12
TJK,Tajikistan,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,М2
TJK,Tajikistan,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,М4
TJK,Tajikistan,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,М12
TJK,Tajikistan,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,М2
TJK,Tajikistan,EURO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,М3
TJK,Tajikistan,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,Y26
TJK,Tajikistan,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,Y36
TJK,Tajikistan,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,Y46
TJK,Tajikistan,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,Y56
TJK,Tajikistan,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_ADO_F,General/routine,NATIONAL,Y16
TKL,Tokelau,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
TKL,Tokelau,WPRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y5
TKL,Tokelau,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
TKL,Tokelau,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
TKL,Tokelau,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
TKL,Tokelau,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
TKL,Tokelau,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,,Y9
TKL,Tokelau,WPRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,,+M6
TKL,Tokelau,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W6
TKL,Tokelau,WPRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,W10
TKL,Tokelau,WPRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,W14
TKL,Tokelau,WPRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,M18
TKL,Tokelau,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
TKL,Tokelau,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M15
TKL,Tokelau,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_ADO_W,General/routine,NATIONAL,Y11
TKL,Tokelau,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,
TKM,Turkmenistan,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,D2-D3
TKM,Turkmenistan,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,2.0,,General/routine,NATIONAL,Y14
TKM,Turkmenistan,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y6
TKM,Turkmenistan,EURO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
TKM,Turkmenistan,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
TKM,Turkmenistan,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3
TKM,Turkmenistan,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M4
TKM,Turkmenistan,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M18
TKM,Turkmenistan,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
TKM,Turkmenistan,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9
TKM,Turkmenistan,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
TKM,Turkmenistan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>=Y18
TKM,Turkmenistan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
TKM,Turkmenistan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
TKM,Turkmenistan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
TKM,Turkmenistan,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
TKM,Turkmenistan,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
TKM,Turkmenistan,EURO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M3
TKM,Turkmenistan,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12-M15
TKM,Turkmenistan,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
TKM,Turkmenistan,EURO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,D2-D3
TKM,Turkmenistan,EURO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M2
TKM,Turkmenistan,EURO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M3
TKM,Turkmenistan,EURO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M4
TKM,Turkmenistan,EURO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,M18
TKM,Turkmenistan,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
TKM,Turkmenistan,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
TKM,Turkmenistan,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12
TKM,Turkmenistan,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
TKM,Turkmenistan,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M3
TKM,Turkmenistan,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M4
TKM,Turkmenistan,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y15
TLS,Timor-Leste,SEARO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
TLS,Timor-Leste,SEARO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y6
TLS,Timor-Leste,SEARO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
TLS,Timor-Leste,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
TLS,Timor-Leste,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
TLS,Timor-Leste,SEARO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
TLS,Timor-Leste,SEARO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
TLS,Timor-Leste,SEARO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
TLS,Timor-Leste,SEARO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
TLS,Timor-Leste,SEARO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
TLS,Timor-Leste,SEARO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
TLS,Timor-Leste,SEARO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
TLS,Timor-Leste,SEARO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
TLS,Timor-Leste,SEARO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
TLS,Timor-Leste,SEARO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,,W6
TLS,Timor-Leste,SEARO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,,W10
TLS,Timor-Leste,SEARO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,,W14
TLS,Timor-Leste,SEARO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,W6
TLS,Timor-Leste,SEARO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,W10
TLS,Timor-Leste,SEARO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,W14
TLS,Timor-Leste,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
TLS,Timor-Leste,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
TLS,Timor-Leste,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
TLS,Timor-Leste,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
TLS,Timor-Leste,SEARO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
TLS,Timor-Leste,SEARO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
TLS,Timor-Leste,SEARO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
TLS,Timor-Leste,SEARO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
TLS,Timor-Leste,SEARO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
TLS,Timor-Leste,SEARO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
TLS,Timor-Leste,SEARO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
TON,Tonga,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
TON,Tonga,WPRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
TON,Tonga,WPRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5
TON,Tonga,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
TON,Tonga,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
TON,Tonga,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
TON,Tonga,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
TON,Tonga,WPRO,2023,HPV,HPV (Human Papilloma Virus) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10-Y17
TON,Tonga,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
TON,Tonga,WPRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M12
TON,Tonga,WPRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
TON,Tonga,WPRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
TON,Tonga,WPRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
TON,Tonga,WPRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
TON,Tonga,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
TON,Tonga,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
TON,Tonga,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
TON,Tonga,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
TON,Tonga,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
TON,Tonga,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_ADO_F,General/routine,NATIONAL,Y16
TON,Tonga,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
TON,Tonga,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
TON,Tonga,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
TON,Tonga,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
TON,Tonga,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
TTO,Trinidad and Tobago,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
TTO,Trinidad and Tobago,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4-Y5
TTO,Trinidad and Tobago,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
TTO,Trinidad and Tobago,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
TTO,Trinidad and Tobago,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
TTO,Trinidad and Tobago,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,>=Y10
TTO,Trinidad and Tobago,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
TTO,Trinidad and Tobago,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
TTO,Trinidad and Tobago,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>M12
TTO,Trinidad and Tobago,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y9-Y15
TTO,Trinidad and Tobago,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
TTO,Trinidad and Tobago,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
TTO,Trinidad and Tobago,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
TTO,Trinidad and Tobago,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
TTO,Trinidad and Tobago,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
TTO,Trinidad and Tobago,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
TTO,Trinidad and Tobago,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=M6
TTO,Trinidad and Tobago,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
TTO,Trinidad and Tobago,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
TTO,Trinidad and Tobago,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
TTO,Trinidad and Tobago,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,HW,Health workers,NATIONAL,1st contact
TTO,Trinidad and Tobago,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
TTO,Trinidad and Tobago,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
TTO,Trinidad and Tobago,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y2
TTO,Trinidad and Tobago,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
TTO,Trinidad and Tobago,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
TTO,Trinidad and Tobago,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4-Y5
TTO,Trinidad and Tobago,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
TTO,Trinidad and Tobago,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
TTO,Trinidad and Tobago,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
TTO,Trinidad and Tobago,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M18
TTO,Trinidad and Tobago,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,2.0,ADULTS,Adults,NATIONAL,Y65
TTO,Trinidad and Tobago,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,Y60
TTO,Trinidad and Tobago,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,
TTO,Trinidad and Tobago,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y9-Y12
TTO,Trinidad and Tobago,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,
TTO,Trinidad and Tobago,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12
TTO,Trinidad and Tobago,AMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,M14
TTO,Trinidad and Tobago,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,Y1
TUN,Tunisia,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
TUN,Tunisia,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
TUN,Tunisia,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M3
TUN,Tunisia,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
TUN,Tunisia,EMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",4.0,RISKGROUPS,Risk group(s),NATIONAL,M18
TUN,Tunisia,EMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
TUN,Tunisia,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
TUN,Tunisia,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3
TUN,Tunisia,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
TUN,Tunisia,EMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M12
TUN,Tunisia,EMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,Y6
TUN,Tunisia,EMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
TUN,Tunisia,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y65
TUN,Tunisia,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
TUN,Tunisia,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
TUN,Tunisia,EMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
TUN,Tunisia,EMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
TUN,Tunisia,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
TUN,Tunisia,EMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M3
TUN,Tunisia,EMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
TUN,Tunisia,EMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M12
TUN,Tunisia,EMRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
TUN,Tunisia,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M18
TUN,Tunisia,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,Y6
TUN,Tunisia,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,Y12
TUN,Tunisia,EMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,Y18
TUN,Tunisia,EMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
TUN,Tunisia,EMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M4
TUN,Tunisia,EMRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M11
TUN,Tunisia,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y18
TUN,Tunisia,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y7
TUN,Tunisia,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y12
TUR,Türkiye,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,M2
TUR,Türkiye,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
TUR,Türkiye,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
TUR,Türkiye,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
TUR,Türkiye,EURO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
TUR,Türkiye,EURO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,M48
TUR,Türkiye,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M18
TUR,Türkiye,EURO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,M24
TUR,Türkiye,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
TUR,Türkiye,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M1
TUR,Türkiye,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
TUR,Türkiye,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
TUR,Türkiye,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M48
TUR,Türkiye,EURO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M6
TUR,Türkiye,EURO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M18
TUR,Türkiye,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
TUR,Türkiye,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
TUR,Türkiye,EURO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
TUR,Türkiye,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_ADO_W,General/routine,NATIONAL,Y13
TUR,Türkiye,EURO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12
TUV,Tuvalu,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
TUV,Tuvalu,WPRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y5-Y6
TUV,Tuvalu,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
TUV,Tuvalu,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
TUV,Tuvalu,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
TUV,Tuvalu,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
TUV,Tuvalu,WPRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10
TUV,Tuvalu,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W6
TUV,Tuvalu,WPRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,W10
TUV,Tuvalu,WPRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,W14
TUV,Tuvalu,WPRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,M12
TUV,Tuvalu,WPRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M12
TUV,Tuvalu,WPRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
TUV,Tuvalu,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
TUV,Tuvalu,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W14
TUV,Tuvalu,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M12
TUV,Tuvalu,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
TUV,Tuvalu,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W14
TUV,Tuvalu,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
TUV,Tuvalu,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
TUV,Tuvalu,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
TUV,Tuvalu,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
TUV,Tuvalu,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
TUV,Tuvalu,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,RISKGROUPS,Risk group(s),NATIONAL,+Y1
TUV,Tuvalu,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,+Y1
TUV,Tuvalu,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
TUV,Tuvalu,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
TUV,Tuvalu,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
TZA,United Republic of Tanzania,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
TZA,United Republic of Tanzania,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
TZA,United Republic of Tanzania,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
TZA,United Republic of Tanzania,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
TZA,United Republic of Tanzania,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y14
TZA,United Republic of Tanzania,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
TZA,United Republic of Tanzania,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
TZA,United Republic of Tanzania,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
TZA,United Republic of Tanzania,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
TZA,United Republic of Tanzania,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
TZA,United Republic of Tanzania,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
TZA,United Republic of Tanzania,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
TZA,United Republic of Tanzania,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
TZA,United Republic of Tanzania,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
TZA,United Republic of Tanzania,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
TZA,United Republic of Tanzania,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
TZA,United Republic of Tanzania,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
TZA,United Republic of Tanzania,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,3.0,,General/routine,NATIONAL,W14
TZA,United Republic of Tanzania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
TZA,United Republic of Tanzania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st Contact
TZA,United Republic of Tanzania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
TZA,United Republic of Tanzania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
TZA,United Republic of Tanzania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
TZA,United Republic of Tanzania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
TZA,United Republic of Tanzania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
TZA,United Republic of Tanzania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,1st Contact
TZA,United Republic of Tanzania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
TZA,United Republic of Tanzania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
TZA,United Republic of Tanzania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
TZA,United Republic of Tanzania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st Contact
TZA,United Republic of Tanzania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
TZA,United Republic of Tanzania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
TZA,United Republic of Tanzania,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
UGA,Uganda,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
UGA,Uganda,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
UGA,Uganda,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
UGA,Uganda,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
UGA,Uganda,AFRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,ADULTS,Adults,SUBNATIONAL,1st contact
UGA,Uganda,AFRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,ADULTS,Adults,SUBNATIONAL,+M1
UGA,Uganda,AFRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,ADULTS,Adults,SUBNATIONAL,+M5
UGA,Uganda,AFRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
UGA,Uganda,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10
UGA,Uganda,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
UGA,Uganda,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W6
UGA,Uganda,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,W14
UGA,Uganda,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
UGA,Uganda,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
UGA,Uganda,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
UGA,Uganda,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
UGA,Uganda,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
UGA,Uganda,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
UGA,Uganda,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,W6
UGA,Uganda,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,W10
UGA,Uganda,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,W14
UGA,Uganda,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
UGA,Uganda,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
UGA,Uganda,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
UGA,Uganda,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
UGA,Uganda,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
UGA,Uganda,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
UGA,Uganda,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
UGA,Uganda,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,Y15-Y49
UGA,Uganda,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
UGA,Uganda,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
UGA,Uganda,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
UGA,Uganda,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
UGA,Uganda,AFRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M9
UKR,Ukraine,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,D3
UKR,Ukraine,EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,B_CHILD_W,General/routine,NATIONAL,Y6
UKR,Ukraine,EURO,2023,DTWP,DTwP (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
UKR,Ukraine,EURO,2023,DTWP,DTwP (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
UKR,Ukraine,EURO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
UKR,Ukraine,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
UKR,Ukraine,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,D1
UKR,Ukraine,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
UKR,Ukraine,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,,General/routine,NATIONAL,M4
UKR,Ukraine,EURO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,,General/routine,NATIONAL,M12
UKR,Ukraine,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
UKR,Ukraine,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
UKR,Ukraine,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
UKR,Ukraine,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
UKR,Ukraine,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
UKR,Ukraine,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
UKR,Ukraine,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
UKR,Ukraine,EURO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
UKR,Ukraine,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
UKR,Ukraine,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
UKR,Ukraine,EURO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
UKR,Ukraine,EURO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
UKR,Ukraine,EURO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y6
UKR,Ukraine,EURO,2023,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,Y14
UKR,Ukraine,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,Y26
UKR,Ukraine,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,Y36
UKR,Ukraine,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,Y46
UKR,Ukraine,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,Y56
UKR,Ukraine,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,ADULTS,Adults,NATIONAL,Y66
UKR,Ukraine,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_ADO_F,General/routine,NATIONAL,Y16
URY,Uruguay,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
URY,Uruguay,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
URY,Uruguay,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
URY,Uruguay,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
URY,Uruguay,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",4.0,RISKGROUPS,Risk group(s),NATIONAL,M15
URY,Uruguay,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5
URY,Uruguay,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
URY,Uruguay,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
URY,Uruguay,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
URY,Uruguay,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15
URY,Uruguay,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,HW,Health workers,NATIONAL,
URY,Uruguay,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y10
URY,Uruguay,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y10
URY,Uruguay,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M15
URY,Uruguay,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,M21
URY,Uruguay,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
URY,Uruguay,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>=Y12
URY,Uruguay,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
URY,Uruguay,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
URY,Uruguay,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
URY,Uruguay,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,M15
URY,Uruguay,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
URY,Uruguay,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
URY,Uruguay,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
URY,Uruguay,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,M15
URY,Uruguay,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y11
URY,Uruguay,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
URY,Uruguay,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y9-Y26
URY,Uruguay,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
URY,Uruguay,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
URY,Uruguay,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
URY,Uruguay,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
URY,Uruguay,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y2
URY,Uruguay,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=Y3
URY,Uruguay,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
URY,Uruguay,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
URY,Uruguay,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
URY,Uruguay,AMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
URY,Uruguay,AMRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,Y5
URY,Uruguay,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,HW,Health workers,NATIONAL,
URY,Uruguay,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
URY,Uruguay,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
URY,Uruguay,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M15
URY,Uruguay,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,RISKGROUPS,Risk group(s),,>=Y5
URY,Uruguay,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,RISKGROUPS,Risk group(s),,>=Y5
URY,Uruguay,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
URY,Uruguay,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
URY,Uruguay,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,Y1
URY,Uruguay,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
URY,Uruguay,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
URY,Uruguay,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y45
URY,Uruguay,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,Y65
URY,Uruguay,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",6.0,B_ADO_W,General/routine,NATIONAL,Y11
URY,Uruguay,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,HW,Health workers,NATIONAL,
URY,Uruguay,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
URY,Uruguay,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,
URY,Uruguay,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,Y1
URY,Uruguay,AMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y5
URY,Uruguay,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,M9-Y60
USA,United States of America,AMRO,2023,ANTHRAX,Anthrax vaccine,1.0,RISKGROUPS,Risk group(s),,
USA,United States of America,AMRO,2023,CHOLERA,Cholera vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y2-Y18
USA,United States of America,AMRO,2023,CHOLERA,Cholera vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,Y2-Y18
USA,United States of America,AMRO,2023,DENGUE,Dengue vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,Y9
USA,United States of America,AMRO,2023,DENGUE,Dengue vaccine,2.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+M6
USA,United States of America,AMRO,2023,DENGUE,Dengue vaccine,3.0,RISKGROUPS,Risk group(s),SUBNATIONAL,+M6
USA,United States of America,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
USA,United States of America,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
USA,United States of America,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
USA,United States of America,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",4.0,RISKGROUPS,Risk group(s),NATIONAL,Y4
USA,United States of America,AMRO,2023,DTAP,DTaP (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
USA,United States of America,AMRO,2023,DTAP,DTaP (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
USA,United States of America,AMRO,2023,DTAP,DTaP (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
USA,United States of America,AMRO,2023,DTAP,DTaP (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15
USA,United States of America,AMRO,2023,DTAP,DTaP (acellular) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
USA,United States of America,AMRO,2023,DTAPHEPBIPV,DTaP-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
USA,United States of America,AMRO,2023,DTAPHEPBIPV,DTaP-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
USA,United States of America,AMRO,2023,DTAPHEPBIPV,DTaP-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
USA,United States of America,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
USA,United States of America,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
USA,United States of America,AMRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
USA,United States of America,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
USA,United States of America,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
USA,United States of America,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M6
USA,United States of America,AMRO,2023,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15
USA,United States of America,AMRO,2023,DTAPIPV,DTaP-IPV (acellular) vaccine,1.0,B_CHILD_W,General/routine,NATIONAL,Y4
USA,United States of America,AMRO,2023,EBOLA,Ebola vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y18
USA,United States of America,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,1.0,ADULTS,Adults,NATIONAL,Y19
USA,United States of America,AMRO,2023,HEPA_ADULT,Adult Hepatitis A vaccine,2.0,ADULTS,Adults,NATIONAL,+M6
USA,United States of America,AMRO,2023,HEPA_HEPB,"Hepatitis A, Hepatitis B vaccine",1.0,RISKGROUPS,Risk group(s),NATIONAL,Y18
USA,United States of America,AMRO,2023,HEPA_HEPB,"Hepatitis A, Hepatitis B vaccine",2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
USA,United States of America,AMRO,2023,HEPA_HEPB,"Hepatitis A, Hepatitis B vaccine",3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
USA,United States of America,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,1.0,,General/routine,NATIONAL,M12
USA,United States of America,AMRO,2023,HEPA_PEDIATRIC,Pediatric Hepatitis A vaccine,2.0,,General/routine,NATIONAL,M18
USA,United States of America,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,ADULTS,Adults,NATIONAL,Y19
USA,United States of America,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
USA,United States of America,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,ADULTS,Adults,NATIONAL,+M4
USA,United States of America,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,2.0,,General/routine,NATIONAL,M1
USA,United States of America,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,3.0,,General/routine,NATIONAL,M6
USA,United States of America,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
USA,United States of America,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,1.0,,General/routine,NATIONAL,M2
USA,United States of America,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,2.0,,General/routine,NATIONAL,M4
USA,United States of America,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,3.0,,General/routine,NATIONAL,M6
USA,United States of America,AMRO,2023,HIB,Hib (Haemophilus influenzae type B) vaccine,4.0,,General/routine,NATIONAL,M12
USA,United States of America,AMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,1.0,BOTH,HPV administered to females and males,NATIONAL,Y11-Y12
USA,United States of America,AMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,2.0,BOTH,HPV administered to females and males,NATIONAL,+M6
USA,United States of America,AMRO,2023,HPV9,HPV-9 (Human Papilloma Virus 9-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,
USA,United States of America,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
USA,United States of America,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
USA,United States of America,AMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
USA,United States of America,AMRO,2023,IPV,IPV (Inactivated polio vaccine),4.0,,General/routine,NATIONAL,Y4
USA,United States of America,AMRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
USA,United States of America,AMRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
USA,United States of America,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,1.0,,General/routine,NATIONAL,Y11
USA,United States of America,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,2.0,,General/routine,NATIONAL,Y16
USA,United States of America,AMRO,2023,MEN_ACYW_135CONJ,Meningococcal ACYW conjugate vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+Y5
USA,United States of America,AMRO,2023,MEN_B,Meningococcal B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
USA,United States of America,AMRO,2023,MEN_B,Meningococcal B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
USA,United States of America,AMRO,2023,MEN_B,Meningococcal B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
USA,United States of America,AMRO,2023,MEN_B,Meningococcal B vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,M12
USA,United States of America,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
USA,United States of America,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y4
USA,United States of America,AMRO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",1.0,,General/routine,NATIONAL,M12
USA,United States of America,AMRO,2023,MMRV,"MMRV (Measles, mumps, rubella and varicella) vaccine",2.0,,General/routine,NATIONAL,Y4
USA,United States of America,AMRO,2023,PCV_15_VALENT,PCV-15 (Pneumococcal conjugate vaccine 15-valent) vaccine,1.0,ADULTS,Adults,,Y65
USA,United States of America,AMRO,2023,PCV_15_VALENT,PCV-15 (Pneumococcal conjugate vaccine 15-valent) vaccine,1.0,,General/routine,,
USA,United States of America,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
USA,United States of America,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
USA,United States of America,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M6
USA,United States of America,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,4.0,,General/routine,NATIONAL,M12
USA,United States of America,AMRO,2023,PCV20,PCV-20 (Pneumococcal conjugate vaccine 20-valent) vaccine,1.0,ADULTS,Adults,NATIONAL,Y65
USA,United States of America,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,ADULTS,Adults,NATIONAL,Y66
USA,United States of America,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,Y7
USA,United States of America,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y2
USA,United States of America,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
USA,United States of America,AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
USA,United States of America,AMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
USA,United States of America,AMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M4
USA,United States of America,AMRO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,M6
USA,United States of America,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y21
USA,United States of America,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+Y10
USA,United States of America,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,ADULTS,Adults,NATIONAL,Y21
USA,United States of America,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",2.0,ADULTS,Adults,NATIONAL,+Y10
USA,United States of America,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,B_ADO_W,General/routine,NATIONAL,Y11-Y12
USA,United States of America,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
USA,United States of America,AMRO,2023,TYPHOID_CONJ,Typhoid conjugate vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,Y6
USA,United States of America,AMRO,2023,TYPHOID_CONJ,Typhoid conjugate vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+Y5
USA,United States of America,AMRO,2023,TYPHOID_PS,Typhoid polysaccharide vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y2
USA,United States of America,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,M12
USA,United States of America,AMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y4
USA,United States of America,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M9
USA,United States of America,AMRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,1.0,ADULTS,Adults,NATIONAL,Y50
USA,United States of America,AMRO,2023,ZOSTER,Shingles (Herpes zoster for older adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M2
UZB,Uzbekistan,EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,D3
UZB,Uzbekistan,EURO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M16
UZB,Uzbekistan,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
UZB,Uzbekistan,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3
UZB,Uzbekistan,EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M4
UZB,Uzbekistan,EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
UZB,Uzbekistan,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
UZB,Uzbekistan,EURO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
UZB,Uzbekistan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
UZB,Uzbekistan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
UZB,Uzbekistan,EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
UZB,Uzbekistan,EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,
UZB,Uzbekistan,EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M4
UZB,Uzbekistan,EURO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
UZB,Uzbekistan,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
UZB,Uzbekistan,EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6
UZB,Uzbekistan,EURO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M2
UZB,Uzbekistan,EURO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M3
UZB,Uzbekistan,EURO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M4
UZB,Uzbekistan,EURO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M16
UZB,Uzbekistan,EURO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y7
UZB,Uzbekistan,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,M2
UZB,Uzbekistan,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,M3
UZB,Uzbekistan,EURO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,M12
UZB,Uzbekistan,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,1.0,,General/routine,NATIONAL,M2
UZB,Uzbekistan,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,2.0,,General/routine,NATIONAL,M3
UZB,Uzbekistan,EURO,2023,ROTAVIRUS_5,RV-5 (Rotavirus 5-valent) vaccine,3.0,,General/routine,NATIONAL,
UZB,Uzbekistan,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y7
UZB,Uzbekistan,EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_F,General/routine,NATIONAL,Y16
VCT,Saint Vincent and the Grenadines,AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B-M12
VCT,Saint Vincent and the Grenadines,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,B_CHILD_W,General/routine,NATIONAL,Y4
VCT,Saint Vincent and the Grenadines,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
VCT,Saint Vincent and the Grenadines,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
VCT,Saint Vincent and the Grenadines,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
VCT,Saint Vincent and the Grenadines,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
VCT,Saint Vincent and the Grenadines,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
VCT,Saint Vincent and the Grenadines,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
VCT,Saint Vincent and the Grenadines,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M5
VCT,Saint Vincent and the Grenadines,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
VCT,Saint Vincent and the Grenadines,AMRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y11-Y12
VCT,Saint Vincent and the Grenadines,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
VCT,Saint Vincent and the Grenadines,AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
VCT,Saint Vincent and the Grenadines,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,RISKGROUPS,Risk group(s),NATIONAL,
VCT,Saint Vincent and the Grenadines,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
VCT,Saint Vincent and the Grenadines,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
VCT,Saint Vincent and the Grenadines,AMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,ADULTS,Adults,NATIONAL,
VCT,Saint Vincent and the Grenadines,AMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,>Y10
VCT,Saint Vincent and the Grenadines,AMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
VCT,Saint Vincent and the Grenadines,AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
VCT,Saint Vincent and the Grenadines,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
VCT,Saint Vincent and the Grenadines,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4
VCT,Saint Vincent and the Grenadines,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y10
VCT,Saint Vincent and the Grenadines,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,1st contact
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,HW,Health workers,NATIONAL,+M1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,HW,Health workers,NATIONAL,+M6
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M6
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M4
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,MEN_BC,Meningococcal BC vaccine,1.0,HW,Health workers,NATIONAL,1st contact
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,MEN_BC,Meningococcal BC vaccine,2.0,HW,Health workers,NATIONAL,+M1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,MEN_BC,Meningococcal BC vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,MEN_BC,Meningococcal BC vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,MEN_BC,Meningococcal BC vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+M1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,MEN_BC,Meningococcal BC vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,TRAVELLERS,Travellers,NATIONAL,Y6-Y39
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y5
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M6
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M18
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,RABIES,Rabies vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,RABIES,Rabies vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+D3
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,RABIES,Rabies vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+D7
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,RABIES,Rabies vaccine,4.0,RISKGROUPS,Risk group(s),NATIONAL,+D14
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,RABIES,Rabies vaccine,5.0,RISKGROUPS,Risk group(s),NATIONAL,+D28
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,M4
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,M2
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y10
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,HW,Health workers,NATIONAL,+Y1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,HW,Health workers,NATIONAL,+Y1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,HW,Health workers,NATIONAL,+M6
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,HW,Health workers,NATIONAL,+M1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,HW,Health workers,NATIONAL,1st contact
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,TRAVELLERS,Travellers,NATIONAL,+Y1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,TRAVELLERS,Travellers,NATIONAL,+Y1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,TRAVELLERS,Travellers,NATIONAL,+M6
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,TRAVELLERS,Travellers,NATIONAL,+M1
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,1st contact
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,,General/routine,NATIONAL,M12
VEN,Venezuela (Bolivarian Republic of),AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,Y2-Y59
VGB,British Virgin Islands,AMRO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",5.0,CATCHUP_C,Catch-up children,NATIONAL,Y5
VGB,British Virgin Islands,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
VGB,British Virgin Islands,AMRO,2023,DTWP,DTwP (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y4
VGB,British Virgin Islands,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
VGB,British Virgin Islands,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M4
VGB,British Virgin Islands,AMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M6
VGB,British Virgin Islands,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,HW,Health workers,NATIONAL,
VGB,British Virgin Islands,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>Y14
VGB,British Virgin Islands,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M1
VGB,British Virgin Islands,AMRO,2023,HEPB_ADULT,Adult Hepatitis B vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M5
VGB,British Virgin Islands,AMRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
VGB,British Virgin Islands,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y11-Y14
VGB,British Virgin Islands,AMRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
VGB,British Virgin Islands,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,
VGB,British Virgin Islands,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
VGB,British Virgin Islands,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
VGB,British Virgin Islands,AMRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
VGB,British Virgin Islands,AMRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
VGB,British Virgin Islands,AMRO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M6
VGB,British Virgin Islands,AMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
VGB,British Virgin Islands,AMRO,2023,MEN_C_CONJ,Meningococcal C conjugate vaccine,1.0,,General/routine,NATIONAL,Y15
VGB,British Virgin Islands,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
VGB,British Virgin Islands,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M15
VGB,British Virgin Islands,AMRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,HW,Health workers,NATIONAL,
VGB,British Virgin Islands,AMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M4
VGB,British Virgin Islands,AMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
VGB,British Virgin Islands,AMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,Y4
VGB,British Virgin Islands,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,M2
VGB,British Virgin Islands,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,M4
VGB,British Virgin Islands,AMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,M6
VGB,British Virgin Islands,AMRO,2023,PPV23,PPV-23 (Pneumococcal polysaccharide 23 valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,1st contact
VGB,British Virgin Islands,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,CATCHUP_C,Catch-up children,NATIONAL,>Y7
VGB,British Virgin Islands,AMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y14
VGB,British Virgin Islands,AMRO,2023,TDAP_S,"Tdap (Tetanus, diphtheria for older children and adults and acellular pertussis) vaccine",1.0,PW,Pregnant women,NATIONAL,
VGB,British Virgin Islands,AMRO,2023,VARICELLA,Varicella vaccine,1.0,,General/routine,NATIONAL,Y1
VGB,British Virgin Islands,AMRO,2023,VARICELLA,Varicella vaccine,2.0,,General/routine,NATIONAL,Y4
VGB,British Virgin Islands,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,>Y3
VGB,British Virgin Islands,AMRO,2023,YF,YF (Yellow fever) vaccine,1.0,TRAVELLERS,Travellers,NATIONAL,
VNM,Viet Nam,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
VNM,Viet Nam,WPRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
VNM,Viet Nam,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
VNM,Viet Nam,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3
VNM,Viet Nam,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M4
VNM,Viet Nam,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
VNM,Viet Nam,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M5
VNM,Viet Nam,WPRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
VNM,Viet Nam,WPRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,1.0,,General/routine,NATIONAL,M12
VNM,Viet Nam,WPRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,2.0,,General/routine,NATIONAL,M12
VNM,Viet Nam,WPRO,2023,JE_INACTD,JE-Inact (Japanese Encephalitis inactivated) vaccine,3.0,,General/routine,NATIONAL,Y2
VNM,Viet Nam,WPRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M9
VNM,Viet Nam,WPRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
VNM,Viet Nam,WPRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M2
VNM,Viet Nam,WPRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,M3
VNM,Viet Nam,WPRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,M4
VNM,Viet Nam,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,B_CHILD_W,General/routine,SUBNATIONAL,Y7
VNM,Viet Nam,WPRO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
VNM,Viet Nam,WPRO,2023,TT,TT (Tetanus toxoid) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
VNM,Viet Nam,WPRO,2023,TT,TT (Tetanus toxoid) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
VNM,Viet Nam,WPRO,2023,TT,TT (Tetanus toxoid) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
VNM,Viet Nam,WPRO,2023,TT,TT (Tetanus toxoid) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
VNM,Viet Nam,WPRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6-M36
VUT,Vanuatu,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
VUT,Vanuatu,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
VUT,Vanuatu,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
VUT,Vanuatu,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
VUT,Vanuatu,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
VUT,Vanuatu,WPRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,,General/routine,NATIONAL,Y9
VUT,Vanuatu,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
VUT,Vanuatu,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
VUT,Vanuatu,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M18
VUT,Vanuatu,WPRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
VUT,Vanuatu,WPRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
VUT,Vanuatu,WPRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
VUT,Vanuatu,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
VUT,Vanuatu,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
VUT,Vanuatu,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
VUT,Vanuatu,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
VUT,Vanuatu,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
VUT,Vanuatu,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y6
VUT,Vanuatu,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_ADO_W,General/routine,NATIONAL,Y11
WLF,Wallis and Futuna,WPRO,2019,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,M1
WLF,Wallis and Futuna,WPRO,2019,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,M2
WLF,Wallis and Futuna,WPRO,2019,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,M11
WLF,Wallis and Futuna,WPRO,2019,DTAPHIBIPV,DTaP-Hib-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,M4
WLF,Wallis and Futuna,WPRO,2019,DTAPIPV,DTaP-IPV (acellular) vaccine,4.0,B_CHILD_W,General/routine,NATIONAL,Y6
WLF,Wallis and Futuna,WPRO,2019,DTIPV,DT-IPV (Diphtheria and tetanus toxoid and IPV) vaccine,5.0,,General/routine,NATIONAL,Y11
WLF,Wallis and Futuna,WPRO,2019,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
WLF,Wallis and Futuna,WPRO,2019,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
WLF,Wallis and Futuna,WPRO,2019,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M16
WLF,Wallis and Futuna,WPRO,2019,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,M4
WLF,Wallis and Futuna,WPRO,2019,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,M2
WLF,Wallis and Futuna,WPRO,2019,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M11
WSM,Samoa,WPRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
WSM,Samoa,WPRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M15
WSM,Samoa,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
WSM,Samoa,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
WSM,Samoa,WPRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
WSM,Samoa,WPRO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
WSM,Samoa,WPRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y13
WSM,Samoa,WPRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
WSM,Samoa,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M9
WSM,Samoa,WPRO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,M15
WSM,Samoa,WPRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
WSM,Samoa,WPRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
WSM,Samoa,WPRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
WSM,Samoa,WPRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M15
WSM,Samoa,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
WSM,Samoa,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
WSM,Samoa,WPRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M9
WSM,Samoa,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
WSM,Samoa,WPRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
WSM,Samoa,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y10
WSM,Samoa,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5
WSM,Samoa,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
WSM,Samoa,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
WSM,Samoa,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+W4
WSM,Samoa,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
WSM,Samoa,WPRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
WSM,Samoa,WPRO,2023,TYPHOID_CONJ,Typhoid conjugate vaccine,1.0,,General/routine,NATIONAL,M9
WSM,Samoa,WPRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M9
WSM,Samoa,WPRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M15
WSM,Samoa,WPRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,Y2
WSM,Samoa,WPRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,Y2.5
WSM,Samoa,WPRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,Y3
WSM,Samoa,WPRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,Y3.5
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,DT,"DT (Tetanus toxoid and diphtheria, children's dose) vaccine",1.0,B_CHILD_W,General/routine,NATIONAL,Y6-Y7
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M12
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,M2
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,M3
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,M4
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,HEPB_PEDIATRIC,Pediatric Hepatitis B vaccine,1.0,,General/routine,NATIONAL,B
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y65
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,M6-Y5
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,M2
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M3
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,IPV,IPV (Inactivated polio vaccine),3.0,,General/routine,NATIONAL,M4
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",1.0,,General/routine,NATIONAL,M12
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,MMR,"MMR (Measles, mumps and rubella) vaccine",2.0,,General/routine,NATIONAL,Y6-Y7
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,M12
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,Y6-Y7
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,Y12-Y13
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,Y17-Y18
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,Y17-Y18
XKX,Kosovo (in accordance with UN Security Council resolution 1244 (1999)),EURO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,B_ADO_W,General/routine,NATIONAL,Y12-Y13
YEM,Yemen,EMRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
YEM,Yemen,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
YEM,Yemen,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
YEM,Yemen,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
YEM,Yemen,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
YEM,Yemen,EMRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y5-Y7
YEM,Yemen,EMRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
YEM,Yemen,EMRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
YEM,Yemen,EMRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
YEM,Yemen,EMRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
YEM,Yemen,EMRO,2023,MR,MR (Measles and rubella) vaccine,3.0,,General/routine,NATIONAL,Y5-Y7
YEM,Yemen,EMRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
YEM,Yemen,EMRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
YEM,Yemen,EMRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W10
YEM,Yemen,EMRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,W14
YEM,Yemen,EMRO,2023,OPV,OPV (Oral polio vaccine),5.0,,General/routine,NATIONAL,M9
YEM,Yemen,EMRO,2023,OPV,OPV (Oral polio vaccine),6.0,,General/routine,NATIONAL,M18
YEM,Yemen,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
YEM,Yemen,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
YEM,Yemen,EMRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
YEM,Yemen,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
YEM,Yemen,EMRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
YEM,Yemen,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
YEM,Yemen,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
YEM,Yemen,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
YEM,Yemen,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
YEM,Yemen,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
YEM,Yemen,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,,General/routine,NATIONAL,+M1
YEM,Yemen,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,,General/routine,NATIONAL,+M6
YEM,Yemen,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,,General/routine,NATIONAL,Y15-Y49
YEM,Yemen,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,,General/routine,NATIONAL,+Y1
YEM,Yemen,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,,General/routine,NATIONAL,+Y1
YEM,Yemen,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
YEM,Yemen,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
YEM,Yemen,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
YEM,Yemen,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
YEM,Yemen,EMRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
YEM,Yemen,EMRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M9
YEM,Yemen,EMRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M18
YEM,Yemen,EMRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,Y5-Y7
ZAF,South Africa,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
ZAF,South Africa,AFRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,1.0,,General/routine,NATIONAL,W6
ZAF,South Africa,AFRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,2.0,,General/routine,NATIONAL,W10
ZAF,South Africa,AFRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,3.0,,General/routine,NATIONAL,W14
ZAF,South Africa,AFRO,2023,DTAPHIBHEPBIPV,DTaP-Hib-HepB-IPV (acellular) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
ZAF,South Africa,AFRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9
ZAF,South Africa,AFRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,+M6
ZAF,South Africa,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,ADULTS,Adults,NATIONAL,>Y18
ZAF,South Africa,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,HW,Health workers,NATIONAL,
ZAF,South Africa,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,PW,Pregnant women,NATIONAL,
ZAF,South Africa,AFRO,2023,INFLUENZA_ADULT,Adult seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ZAF,South Africa,AFRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,,General/routine,NATIONAL,>=M6
ZAF,South Africa,AFRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,2.0,,General/routine,NATIONAL,>=M6
ZAF,South Africa,AFRO,2023,INFLUENZA_PEDIATRIC,Pediatric seasonal influenza vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,
ZAF,South Africa,AFRO,2023,MEASLES,Measles vaccine,1.0,,General/routine,NATIONAL,M6
ZAF,South Africa,AFRO,2023,MEASLES,Measles vaccine,2.0,,General/routine,NATIONAL,M12
ZAF,South Africa,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,B
ZAF,South Africa,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W6
ZAF,South Africa,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
ZAF,South Africa,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W14
ZAF,South Africa,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,M9
ZAF,South Africa,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
ZAF,South Africa,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W14
ZAF,South Africa,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,B_CHILD_W,General/routine,NATIONAL,Y6
ZAF,South Africa,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,6.0,B_ADO_W,General/routine,NATIONAL,Y12
ZAF,South Africa,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
ZAF,South Africa,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
ZAF,South Africa,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
ZAF,South Africa,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
ZAF,South Africa,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
ZAF,South Africa,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
ZMB,Zambia,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,W1
ZMB,Zambia,AFRO,2023,CHOLERA,Cholera vaccine,1.0,,General/routine,SUBNATIONAL,>=Y1
ZMB,Zambia,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
ZMB,Zambia,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
ZMB,Zambia,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
ZMB,Zambia,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y9-Y14
ZMB,Zambia,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,1.0,RISKGROUPS,Risk group(s),NATIONAL,Y9
ZMB,Zambia,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,2.0,RISKGROUPS,Risk group(s),NATIONAL,+M2
ZMB,Zambia,AFRO,2023,HPV4,HPV-4 (Human Papilloma Virus 4-valent) vaccine,3.0,RISKGROUPS,Risk group(s),NATIONAL,+M4
ZMB,Zambia,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
ZMB,Zambia,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
ZMB,Zambia,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
ZMB,Zambia,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
ZMB,Zambia,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
ZMB,Zambia,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
ZMB,Zambia,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,1.0,,General/routine,NATIONAL,W6
ZMB,Zambia,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,2.0,,General/routine,NATIONAL,W10
ZMB,Zambia,AFRO,2023,PCV10,PCV-10 (Pneumococcal conjugate vaccine 10-valent) vaccine,3.0,,General/routine,NATIONAL,W14
ZMB,Zambia,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
ZMB,Zambia,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
ZMB,Zambia,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,3.0,,General/routine,NATIONAL,W14
ZMB,Zambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,ADULTS,Adults,NATIONAL,1st contact
ZMB,Zambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,ADULTS,Adults,NATIONAL,+M1
ZMB,Zambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,ADULTS,Adults,NATIONAL,+M6
ZMB,Zambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,ADULTS,Adults,NATIONAL,+Y1
ZMB,Zambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,ADULTS,Adults,NATIONAL,+Y1
ZMB,Zambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y1
ZMB,Zambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
ZMB,Zambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
ZMB,Zambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
ZMB,Zambia,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
ZMB,Zambia,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
ZMB,Zambia,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
ZMB,Zambia,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
ZMB,Zambia,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
ZMB,Zambia,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M36
ZMB,Zambia,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M48
ZWE,Zimbabwe,AFRO,2023,BCG,BCG (Baccille Calmette Guérin) vaccine,1.0,,General/routine,NATIONAL,B
ZWE,Zimbabwe,AFRO,2023,CHOLERA,Cholera vaccine,1.0,RISKGROUPS,Risk group(s),SUBNATIONAL,Y1-Y45
ZWE,Zimbabwe,AFRO,2023,DTWP,DTwP (Whole cell) vaccine,4.0,B_2YL_W,General/routine,NATIONAL,M18
ZWE,Zimbabwe,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,1.0,,General/routine,NATIONAL,W6
ZWE,Zimbabwe,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,2.0,,General/routine,NATIONAL,W10
ZWE,Zimbabwe,AFRO,2023,DTWPHIBHEPB,DTwP-Hib-HepB (Whole cell) vaccine,3.0,,General/routine,NATIONAL,W14
ZWE,Zimbabwe,AFRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,1.0,FEMALE,HPV for females only,NATIONAL,Y10
ZWE,Zimbabwe,AFRO,2023,HPV2,HPV-2 (Human Papilloma Virus 2-valent) vaccine,2.0,FEMALE,HPV for females only,NATIONAL,Y11
ZWE,Zimbabwe,AFRO,2023,IPV,IPV (Inactivated polio vaccine),1.0,,General/routine,NATIONAL,W14
ZWE,Zimbabwe,AFRO,2023,IPV,IPV (Inactivated polio vaccine),2.0,,General/routine,NATIONAL,M9
ZWE,Zimbabwe,AFRO,2023,MR,MR (Measles and rubella) vaccine,1.0,,General/routine,NATIONAL,M9
ZWE,Zimbabwe,AFRO,2023,MR,MR (Measles and rubella) vaccine,2.0,,General/routine,NATIONAL,M18
ZWE,Zimbabwe,AFRO,2023,OPV,OPV (Oral polio vaccine),1.0,,General/routine,NATIONAL,W6
ZWE,Zimbabwe,AFRO,2023,OPV,OPV (Oral polio vaccine),2.0,,General/routine,NATIONAL,W10
ZWE,Zimbabwe,AFRO,2023,OPV,OPV (Oral polio vaccine),3.0,,General/routine,NATIONAL,W14
ZWE,Zimbabwe,AFRO,2023,OPV,OPV (Oral polio vaccine),4.0,,General/routine,NATIONAL,M18
ZWE,Zimbabwe,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,1.0,,General/routine,NATIONAL,W6
ZWE,Zimbabwe,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,2.0,,General/routine,NATIONAL,W10
ZWE,Zimbabwe,AFRO,2023,PCV13,PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine,3.0,,General/routine,NATIONAL,W14
ZWE,Zimbabwe,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,1.0,,General/routine,NATIONAL,W6
ZWE,Zimbabwe,AFRO,2023,ROTAVIRUS_1,RV-1 (Rotavirus 1-valent) vaccine,2.0,,General/routine,NATIONAL,W10
ZWE,Zimbabwe,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
ZWE,Zimbabwe,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
ZWE,Zimbabwe,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
ZWE,Zimbabwe,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
ZWE,Zimbabwe,AFRO,2023,TD_S,Td (Tetanus toxoid and diphtheria for older children and adults) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y2
ZWE,Zimbabwe,AFRO,2023,TT,TT (Tetanus toxoid) vaccine,1.0,PW,Pregnant women,NATIONAL,1st contact
ZWE,Zimbabwe,AFRO,2023,TT,TT (Tetanus toxoid) vaccine,2.0,PW,Pregnant women,NATIONAL,+M1
ZWE,Zimbabwe,AFRO,2023,TT,TT (Tetanus toxoid) vaccine,3.0,PW,Pregnant women,NATIONAL,+M6
ZWE,Zimbabwe,AFRO,2023,TT,TT (Tetanus toxoid) vaccine,4.0,PW,Pregnant women,NATIONAL,+Y1
ZWE,Zimbabwe,AFRO,2023,TT,TT (Tetanus toxoid) vaccine,5.0,PW,Pregnant women,NATIONAL,+Y2
ZWE,Zimbabwe,AFRO,2023,TYPHOID_CONJ,Typhoid conjugate vaccine,1.0,,General/routine,SUBNATIONAL,
ZWE,Zimbabwe,AFRO,2023,VITAMINA,Vitamin A supplements,1.0,,General/routine,NATIONAL,M6
ZWE,Zimbabwe,AFRO,2023,VITAMINA,Vitamin A supplements,2.0,,General/routine,NATIONAL,M12
ZWE,Zimbabwe,AFRO,2023,VITAMINA,Vitamin A supplements,3.0,,General/routine,NATIONAL,M18
ZWE,Zimbabwe,AFRO,2023,VITAMINA,Vitamin A supplements,4.0,,General/routine,NATIONAL,M24
ZWE,Zimbabwe,AFRO,2023,VITAMINA,Vitamin A supplements,5.0,,General/routine,NATIONAL,M30
ZWE,Zimbabwe,AFRO,2023,VITAMINA,Vitamin A supplements,6.0,,General/routine,NATIONAL,M36
